<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Pathog</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plospath</journal-id><journal-title-group><journal-title>PLoS Pathogens</journal-title></journal-title-group><issn pub-type="ppub">1553-7366</issn><issn pub-type="epub">1553-7374</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5814058</article-id><article-id pub-id-type="doi">10.1371/journal.ppat.1006770</article-id><article-id pub-id-type="publisher-id">PPATHOGENS-D-17-01863</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Influenza</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pulmonology</subject><subj-group><subject>Respiratory Infections</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza Viruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza Viruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza Viruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza Viruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Co-Infections</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogenesis</subject><subj-group><subject>Host-Pathogen Interactions</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: A key role for mathematical modelling</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8348-700X</contrib-id><name><surname>Opatowski</surname><given-names>Lulla</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3867-1953</contrib-id><name><surname>Baguelin</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0362-6717</contrib-id><name><surname>Eggo</surname><given-names>Rosalind M.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Universit&#x000e9; de Versailles Saint Quentin, Institut Pasteur, Inserm, Paris, France</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>London School of Hygiene &#x00026; Tropical Medicine, London, United Kingdom</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Public Health England, London, United Kingdom</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Hobman</surname><given-names>Tom C.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of Alberta, CANADA</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>lulla.opatowski@pasteur.fr</email></corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2018</year></pub-date><volume>14</volume><issue>2</issue><elocation-id>e1006770</elocation-id><permissions><copyright-statement>&#x000a9; 2018 Opatowski et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Opatowski et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="ppat.1006770.pdf"/><abstract><p>Evidence is mounting that influenza virus interacts with other pathogens colonising or infecting the human respiratory tract. Taking into account interactions with other pathogens may be critical to determining the real influenza burden and the full impact of public health policies targeting influenza. This is particularly true for mathematical modelling studies, which have become critical in public health decision-making. Yet models usually focus on influenza virus acquisition and infection alone, thereby making broad oversimplifications of pathogen ecology. Herein, we report evidence of influenza virus interactions with bacteria and viruses and systematically review the modelling studies that have incorporated interactions.</p><p>Despite the many studies examining possible associations between influenza and <italic>Streptococcus pneumoniae</italic>, <italic>Staphylococcus aureus</italic>, <italic>Haemophilus influenzae</italic>, <italic>Neisseria meningitidis</italic>, respiratory syncytial virus (RSV), human rhinoviruses, human parainfluenza viruses, etc., very few mathematical models have integrated other pathogens alongside influenza. The notable exception is the pneumococcus&#x02013;influenza interaction, for which several recent modelling studies demonstrate the power of dynamic modelling as an approach to test biological hypotheses on interaction mechanisms and estimate the strength of those interactions.</p><p>We explore how different interference mechanisms may lead to unexpected incidence trends and possible misinterpretation, and we illustrate the impact of interactions on public health surveillance using simple transmission models. We demonstrate that the development of multipathogen models is essential to assessing the true public health burden of influenza and that it is needed to help improve planning and evaluation of control measures. Finally, we identify the public health, surveillance, modelling, and biological challenges and propose avenues of research for the coming years.</p></abstract><abstract abstract-type="summary"><title>Author summary</title><p>Influenza is responsible for major morbidity and mortality burdens worldwide. Mathematical models of influenza virus transmission have been critical to understanding the virus epidemiology and planning public health strategies for infection control. It is increasingly clear that microbes do not act in isolation but potentially interact within the host. Therefore, studying influenza alone may lead to misinterpretation of transmission or severity patterns. Here, we review the literature on bacteria and viruses that interact with influenza, proposed interaction mechanisms, and mathematical modelling studies that include interactions. We report evidence that, beyond the classic secondary bacterial infections, many pathogenic bacteria and viruses probably interact with influenza. Public health relevance of these pathogen interactions is detailed, showing how possible misreading or a narrow outlook could lead to mistaken public health decision-making. We describe the role of mechanistic transmission models in investigating this complex system and obtaining insight into interactions between influenza and other pathogens. Finally, we highlight the benefits and challenges in modelling and speculate on new opportunities made possible by taking a broader view, including basic science, clinically, and for public health.</p></abstract><funding-group><funding-statement>LO acknowledges funding from the French Government&#x02019;s &#x0201c;Investissement d&#x02019;Avenir&#x0201d; program, Laboratoire d&#x02019;Excellence &#x0201c;Integrative Biology of Emerging Infectious Diseases&#x0201d; (grant no. ANR-10-LABX-62-IBEID), and from R&#x000e9;gion &#x000ce;le-de-France (Domaine d&#x02019;Int&#x000e9;r&#x000ea;t Majeur Maladies Infectieuses). RME and MB acknowledge funding from the National Institute for Health Research through the Health Protection Research Unit in Immunisation at the London School of Hygiene &#x00026; Tropical Medicine in partnership with Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="2"/><page-count count="28"/></counts></article-meta></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Influenza virus is a major contributor to the global disease burden, and exploration of its pathogenesis, epidemiology, and evolution has occupied generations of scientists. Its complex seasonality, antigenic drift of surface proteins, wide spectrum of severity, and capacity to cross species and cause epidemics or pandemics are all characteristics that make the virus so difficult to control [<xref rid="ppat.1006770.ref001" ref-type="bibr">1</xref>].</p><p>The human respiratory tract is an important reservoir of bacteria, fungi, viruses, bacteriophages, archaea, and eukaryotes [<xref rid="ppat.1006770.ref002" ref-type="bibr">2</xref>], harboring diverse communities of commensal, opportunistic, and pathogenic microorganisms. It has been suggested that some exist in nonneutral relationships [<xref rid="ppat.1006770.ref003" ref-type="bibr">3</xref>], with competition for resources, synergism with the host immune system, or physiological modifications that alter the normal colonization or infection processes. The contribution of species-level interactions to the influenza burden is largely unknown.</p><p>In terms of public health, our current understanding of influenza transmission or severity may therefore be incomplete or misguided due to ignorance of the effect of interacting pathogens. On one hand, large-scale influenza vaccination programs may unexpectedly impact other infections due to an indirect rise or fall in the risk of contracting them [<xref rid="ppat.1006770.ref004" ref-type="bibr">4</xref>]. For example, if influenza outcompetes another virus and holds it at bay, an influenza vaccination program could result in an upsurge in the competitor. On the other hand, the introduction of measures to control bacterial infections (e.g., pneumococcal vaccines) may decrease the risk of secondary bacterial pneumonia often associated with severe outcomes of influenza.</p><p>Seasonal influenza generates a large burden each year during the wintertime in temperate regions and with more complex seasonal patterns in tropical regions [<xref rid="ppat.1006770.ref005" ref-type="bibr">5</xref>]. Influenza pandemics frequently occur outside of the usual season and generate an unpredictable and often large burden in morbidity, mortality, and cost [<xref rid="ppat.1006770.ref006" ref-type="bibr">6</xref>,<xref rid="ppat.1006770.ref007" ref-type="bibr">7</xref>]. This burden has historically been the result of secondary bacterial infections [<xref rid="ppat.1006770.ref008" ref-type="bibr">8</xref>,<xref rid="ppat.1006770.ref009" ref-type="bibr">9</xref>]. Lung specimens from 1918 to 1919 influenza fatalities were found to be, in more than 90% of cases, positive for at least one bacterium [<xref rid="ppat.1006770.ref010" ref-type="bibr">10</xref>]. Bacteriologic and histopathologic results from published autopsy series also suggest that deaths from the 1918 influenza pandemic mostly resulted from pneumonia with <italic>Streptococcus pneumoniae</italic>, <italic>Haemophilus influenzae</italic>, <italic>Staphylococcus aureus</italic>, and <italic>Streptococcus pyogenes</italic>, multiple infections being common [<xref rid="ppat.1006770.ref010" ref-type="bibr">10</xref>]. Deaths during the 1957 and 1968 pandemics were less closely related to bacterial pneumonia [<xref rid="ppat.1006770.ref010" ref-type="bibr">10</xref>]. Because emergence and circulation of pandemic influenza take place out of season, and therefore in different climatic and ecological milieus than seasonal strains, pandemic strains may encounter different coinfecting pathogens. It is therefore critically important to pandemic preparedness to understand competitive and synergistic relationships with other species, both at the individual level from a clinical perspective or at a population level from an epidemiological perspective. It is vital to improve our understanding and control of transmission and the risk of developing disease on infection.</p><p>Mathematical modelling has been a key tool in infectious diseases for many years, allowing researchers to probe the complex intricacies of transmission and play forward the effects on an individual to see the impact on population-level infection dynamics [<xref rid="ppat.1006770.ref011" ref-type="bibr">11</xref>]. Counterfactuals, or &#x02018;what if&#x02019; scenarios, can easily be tested and compared, where vaccination rates, contact patterns, health behaviours, or any number of other factors are varied, to assess impact.</p><p>Models of influenza virus transmission have proved very useful in expanding knowledge of influenza biology, evolution, and epidemiology. For example, models of evolutionary change and immunity aim to predict the dominant strain of influenza in the coming season [<xref rid="ppat.1006770.ref012" ref-type="bibr">12</xref>]. Spatially explicit models have convincingly linked commuting movements to the spread of influenza in the United States [<xref rid="ppat.1006770.ref013" ref-type="bibr">13</xref>]. Models have also been crucial to public health, contributing to the optimization of control strategies, including the use of vaccines and antivirals [<xref rid="ppat.1006770.ref014" ref-type="bibr">14</xref>&#x02013;<xref rid="ppat.1006770.ref020" ref-type="bibr">20</xref>]. As the modelling field has developed, there has been an effort to improve realism by incorporating heterogeneity in human contact patterns, age-related susceptibility, cross immunity after previous infections [<xref rid="ppat.1006770.ref019" ref-type="bibr">19</xref>,<xref rid="ppat.1006770.ref021" ref-type="bibr">21</xref>&#x02013;<xref rid="ppat.1006770.ref024" ref-type="bibr">24</xref>], and the potential effect of environmental variables on transmission [<xref rid="ppat.1006770.ref013" ref-type="bibr">13</xref>,<xref rid="ppat.1006770.ref025" ref-type="bibr">25</xref>]. Notably, the vast majority of modelling work has neglected the microbial environment: most mathematical and computational models of influenza are focused on single or sequential influenza infections and have broadly simplified pathogen ecology. For example, despite secondary bacterial infections being recognized as an important cause of mortality, models have not been exploited to estimate the indirect effect of seasonal influenza vaccination on the incidence of severe bacterial infections in the elderly. Furthermore, modelling used to plan vaccine interventions during the 2009 pandemic in the United Kingdom considered influenza transmission alone [<xref rid="ppat.1006770.ref026" ref-type="bibr">26</xref>].</p><p>The authors of relatively recent literature reviews gathered biological and epidemiological evidence for interactions between influenza virus and respiratory bacteria or viruses [<xref rid="ppat.1006770.ref003" ref-type="bibr">3</xref>,<xref rid="ppat.1006770.ref027" ref-type="bibr">27</xref>,<xref rid="ppat.1006770.ref028" ref-type="bibr">28</xref>] but did not consider mechanistic transmission models. Mathematical models make it possible to investigate mechanisms of interaction and visualize the pathological and epidemiological patterns that result from them. Comparison of model outputs to data enables estimation of both the probability of such interactions and the strength of the interaction. Estimation can be made across geographic regions (e.g., winter seasonal vs year-round transmission), for different virus subtypes (e.g., seasonal vs pandemic), and in different age groups (e.g., infants vs elderly). Computational and mathematical models to study influenza with other respiratory pathogens are currently underutilized.</p><p>In this article, we report evidence of interaction of influenza with other pathogens and systematically review modelling studies on influenza coinfection. Our aim is to build a case for a more expansive use of mathematical models including influenza with other pathogens. For this, we address how different interference mechanisms might lead to unexpected epidemiological patterns and misinterpretations, identify public health needs, identify modelling and biological challenges, and propose avenues of research for the future.</p></sec><sec id="sec002"><title>Mechanisms of interaction</title><p>Here, &#x02018;interaction&#x02019; refers to any process by which infection caused by one pathogen affects the probability, timing, or natural history of infection by another. This process includes a wide range of mechanisms that can involve direct connections between the two pathogens, e.g., at the cellular level, or indirect interactions through an intermediate factor that influences the other. The indirect consequences of these interactions are described later. For influenza virus, interactions with bacterial or viral species can occur at several scales (<xref ref-type="fig" rid="ppat.1006770.g001">Fig 1</xref>). Interacting pathogens may have two distinct profiles: natural human commensals&#x02014;usually bacteria&#x02014;which cause mainly asymptomatic carriage or mild symptoms often for long durations of weeks to months, or epidemic pathogens causing infection for shorter durations, from a few days to a few weeks. These two distinct epidemic profiles potentially involve different modes of interaction and lead to different levels of consequences. Here, we detail proven and potential interaction mechanisms (<xref ref-type="fig" rid="ppat.1006770.g001">Fig 1</xref>).</p><fig id="ppat.1006770.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1006770.g001</object-id><label>Fig 1</label><caption><title>Influenza interactions with other pathogens occur within host or at the population level.</title><p>Each interaction could either inhibit or enhance coinfection, depending on the combination of pathogens. (A) Cellular-level interactions: (1) direct interactions between viral products; (2) altered receptor presentation; (3) cell damage, e.g., its surface receptors; (4) modification of release of immune system mediators; (5) competition for host resources among influenza and other pathogens. (B) Host-level interactions: (1) change of transmissibility due to symptoms; (2) individual variation in commensal microbiota; (3) effect of symptomatic responses to infection; (4) tissue damage, e.g., in the nasopharynx or lung; (5) competition for host resources, e.g., target cells for infection; (6) immune cell&#x02013;mediated interaction; (7) immune signalling&#x02013;mediated interaction; (8) antibody-mediated interaction. (C) Population-level interaction: (1) behavioural responses to disease; (2) medication use; (3) vaccination behaviour. Bacterial interaction mechanisms include A1&#x02013;5, B1&#x02013;4 and 7, C1&#x02013;3. Viral interaction mechanisms include A1&#x02013;2 and 4&#x02013;5, B1&#x02013;3 and 4&#x02013;8, C1&#x02013;3.</p></caption><graphic xlink:href="ppat.1006770.g001"/></fig><sec id="sec003"><title>Within-host interactions</title><p>At the cellular level, interactions involve both direct and indirect mechanisms. First, influenza genes or gene products can enhance or inhibit the replication of other viruses or potential infection by bacteria by direct interaction with pathogen proteins or nucleic acids [<xref rid="ppat.1006770.ref029" ref-type="bibr">29</xref>]. Furthermore, indirect competition for host resources can occur, when pathogens compete for target cells, receptors, or cellular products required for replication. Influenza-infected cells may also release cell signalling molecules that could increase or decrease the probability of coinfection.</p><p>During infection, influenza virus impairs innate and adaptive host defences [<xref rid="ppat.1006770.ref030" ref-type="bibr">30</xref>,<xref rid="ppat.1006770.ref031" ref-type="bibr">31</xref>]. Mechanisms include altered neutrophil recruitment and function, leading to defective bacterial clearance, diminished production of alveolar macrophages [<xref rid="ppat.1006770.ref032" ref-type="bibr">32</xref>], and inhibition of T cell&#x02013;mediated immunity [<xref rid="ppat.1006770.ref031" ref-type="bibr">31</xref>]. Infection with a second virus could be modulated similarly, e.g., by the production of cross-reactive antibodies or cell-mediated immunity that prevents or facilitates this infection. Physiological changes induced by the host response to infection have consequences on other pathogens. For instance, lung tissue damage [<xref rid="ppat.1006770.ref032" ref-type="bibr">32</xref>] and the induction of type-1 interferon signalling were shown to promote bacterial colonization [<xref rid="ppat.1006770.ref031" ref-type="bibr">31</xref>] and broadly inhibit viral replication [<xref rid="ppat.1006770.ref033" ref-type="bibr">33</xref>]. Damage to lung cells caused by influenza infection, such as influenza neuraminidase stripping sialic acids from the cell surface, amplifies bacterial adherence and invasion [<xref rid="ppat.1006770.ref027" ref-type="bibr">27</xref>] and could potentially change the likelihood of infection by another virus. Symptomatic responses to infection, like fever, have also been shown to act as &#x02018;danger signals&#x02019; for bacteria, e.g., meningococci, which react by enhancing bacterial defences against human immune cells [<xref rid="ppat.1006770.ref034" ref-type="bibr">34</xref>]. In contrast, fever may diminish viral replication rate, thereby lowering the probability of coinfection. From the other side, the &#x02018;influenza preinfection&#x02019; respiratory flora of individuals may also partially account for the variability of severity and outcome [<xref rid="ppat.1006770.ref028" ref-type="bibr">28</xref>]. For example, <italic>Staphylococcus aureus</italic> colonization was shown to trigger viral load rebounds and reduce influenza virus clearance in animal studies [<xref rid="ppat.1006770.ref035" ref-type="bibr">35</xref>&#x02013;<xref rid="ppat.1006770.ref037" ref-type="bibr">37</xref>].</p></sec><sec id="sec004"><title>Population-level interactions</title><p>Human behavioural responses to influenza infection can also indirectly impact transmission of bacteria or other viruses. For example, people with severe influenza symptoms are likely to stay home, modifying their contact patterns and making acquisition of second infections unlikely [<xref rid="ppat.1006770.ref038" ref-type="bibr">38</xref>,<xref rid="ppat.1006770.ref039" ref-type="bibr">39</xref>]. On the other hand, individuals with milder symptoms may maintain their regular activities, which could increase bacterial transmission to other individuals (as observed for tuberculosis [<xref rid="ppat.1006770.ref040" ref-type="bibr">40</xref>]) or increase the chance of acquiring a second infection. Person-to-person variation in care seeking and medication use, such as antivirals, antibiotics, antipyretics, or vaccine(s) uptake, also influences the risk of coinfection. For example, use of the pneumococcal conjugate vaccine has decreased carriage of the pneumococcal vaccine strains in some contexts [<xref rid="ppat.1006770.ref041" ref-type="bibr">41</xref>,<xref rid="ppat.1006770.ref042" ref-type="bibr">42</xref>], and vaccination against <italic>H</italic>. <italic>influenzae</italic> type b has decreased carriage of the bacteria [<xref rid="ppat.1006770.ref043" ref-type="bibr">43</xref>,<xref rid="ppat.1006770.ref044" ref-type="bibr">44</xref>]. These vaccination campaigns may therefore decrease the chance of observing influenza&#x02013;bacteria coinfections.</p></sec></sec><sec id="sec005"><title>Evidence of interaction</title><p>Several literature reviews have described evidence of interactions between influenza and other respiratory bacterial or viral pathogens [<xref rid="ppat.1006770.ref003" ref-type="bibr">3</xref>,<xref rid="ppat.1006770.ref027" ref-type="bibr">27</xref>]. In this section, we briefly summarize the viral and bacterial species with evidence for interaction with influenza in recent laboratory and epidemiological studies (details on the search strategies are provided in <xref ref-type="supplementary-material" rid="ppat.1006770.s003">S1 Appendix</xref>, section A).</p><sec id="sec006"><title>Influenza&#x02013;bacteria interactions</title><p>Experimental results suggest that most of the pathogenic and commensal bacteria in the nasopharynx may directly or indirectly interfere with influenza infection during host colonization or infection (<xref ref-type="table" rid="ppat.1006770.t001">Table 1</xref>). The best-studied influenza&#x02013;bacteria interaction is with <italic>Streptococcus pneumoniae</italic> [<xref rid="ppat.1006770.ref003" ref-type="bibr">3</xref>]. Influenza is thought to increase bacterial adherence and facilitate the progression from carriage to severe disease [<xref rid="ppat.1006770.ref028" ref-type="bibr">28</xref>,<xref rid="ppat.1006770.ref045" ref-type="bibr">45</xref>], although evidence from population studies is not so clear-cut [<xref rid="ppat.1006770.ref046" ref-type="bibr">46</xref>&#x02013;<xref rid="ppat.1006770.ref049" ref-type="bibr">49</xref>]. Influenza was also shown to impair methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) clearance in coinfected mice, thereby increasing their susceptibility to MRSA infection [<xref rid="ppat.1006770.ref050" ref-type="bibr">50</xref>]. Similarly, in mice, increased severity of <italic>H</italic>. <italic>influenzae</italic> induced by influenza was suggested, based on experiments of sequential infection with sublethal influenza then <italic>H</italic>. <italic>influenzae</italic> doses [<xref rid="ppat.1006770.ref051" ref-type="bibr">51</xref>]. Notably, ecological studies revealed a positive association between influenza and <italic>Neisseria meningitidis</italic> incidence [<xref rid="ppat.1006770.ref052" ref-type="bibr">52</xref>] and in vitro studies suggested that direct interaction between influenza A neuraminidase and the <italic>N</italic>. <italic>meningitidis</italic> capsule enhanced bacterial adhesion to cultured epithelial cells [<xref rid="ppat.1006770.ref053" ref-type="bibr">53</xref>]. Lastly, in patients with pulmonary tuberculosis, there is evidence of increased risk of severe outcomes on influenza infection [<xref rid="ppat.1006770.ref054" ref-type="bibr">54</xref>]. This finding was supported by experiments in mice [<xref rid="ppat.1006770.ref055" ref-type="bibr">55</xref>] that demonstrated that <italic>Mycobacterium tuberculosis</italic> and influenza coinfected mice mounted weaker immune responses specific to <italic>M</italic>. <italic>bovis</italic> Bacillus Calmette&#x02013;Guerin (BCG) in the lungs compared with mice infected with BCG alone.</p><table-wrap id="ppat.1006770.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1006770.t001</object-id><label>Table 1</label><caption><title>Bacteria whose colonization or infection course may be affected by interaction with influenza.</title></caption><alternatives><graphic id="ppat.1006770.t001g" xlink:href="ppat.1006770.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Bacterial species</th><th align="left" rowspan="1" colspan="1">Study system</th><th align="left" rowspan="1" colspan="1">Effect</th><th align="left" rowspan="1" colspan="1">Illustrative publications</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1"><italic>S. pneumoniae</italic><break/></td><td align="left" rowspan="1" colspan="1">Animal</td><td align="left" rowspan="1" colspan="1">Synergistic/Facilitating</td><td align="left" rowspan="1" colspan="1">Smith 2013 [<xref rid="ppat.1006770.ref097" ref-type="bibr">97</xref>]; Wolf 2014 [<xref rid="ppat.1006770.ref137" ref-type="bibr">137</xref>]; Siegel 2014 [<xref rid="ppat.1006770.ref138" ref-type="bibr">138</xref>]; McCullers 2010 [<xref rid="ppat.1006770.ref139" ref-type="bibr">139</xref>]; Ghoneim 2013 [<xref rid="ppat.1006770.ref032" ref-type="bibr">32</xref>]; Peltola 2006 [<xref rid="ppat.1006770.ref140" ref-type="bibr">140</xref>]; Walters 2016 [<xref rid="ppat.1006770.ref141" ref-type="bibr">141</xref>]; Nakamura 2011 [<xref rid="ppat.1006770.ref142" ref-type="bibr">142</xref>];</td></tr><tr><td align="left" rowspan="2" colspan="1">Human</td><td align="left" rowspan="1" colspan="1">Synergistic/Facilitating</td><td align="left" rowspan="1" colspan="1">Walter 2010 [<xref rid="ppat.1006770.ref143" ref-type="bibr">143</xref>]; Nelson 2012 [<xref rid="ppat.1006770.ref144" ref-type="bibr">144</xref>]; Opatowski 2013 [<xref rid="ppat.1006770.ref102" ref-type="bibr">102</xref>]; Shrestha 2013 [<xref rid="ppat.1006770.ref107" ref-type="bibr">107</xref>]; Weinberger 2013 [<xref rid="ppat.1006770.ref089" ref-type="bibr">89</xref>]; Jansen 2008 [<xref rid="ppat.1006770.ref145" ref-type="bibr">145</xref>]; Kuster 2011 [<xref rid="ppat.1006770.ref146" ref-type="bibr">146</xref>]; Nicoli 2013 [<xref rid="ppat.1006770.ref088" ref-type="bibr">88</xref>]; Ampofo 2008&#x000a0;[<xref rid="ppat.1006770.ref147" ref-type="bibr">147</xref>]; Grabowska 2006 [<xref rid="ppat.1006770.ref148" ref-type="bibr">148</xref>]; Murdoch 2008 [<xref rid="ppat.1006770.ref149" ref-type="bibr">149</xref>]; Edwards 2011 [<xref rid="ppat.1006770.ref150" ref-type="bibr">150</xref>]; Weinberger 2014 [<xref rid="ppat.1006770.ref151" ref-type="bibr">151</xref>]; Grijalva 2014 [<xref rid="ppat.1006770.ref152" ref-type="bibr">152</xref>];</td></tr><tr><td align="left" rowspan="1" colspan="1">Neutral/Unclear</td><td align="left" rowspan="1" colspan="1">Kim et al. 1996 [<xref rid="ppat.1006770.ref047" ref-type="bibr">47</xref>]; Watson 2006 [<xref rid="ppat.1006770.ref048" ref-type="bibr">48</xref>]; Toschke 2008 [<xref rid="ppat.1006770.ref049" ref-type="bibr">49</xref>]; Zhou 2012 [<xref rid="ppat.1006770.ref153" ref-type="bibr">153</xref>]; Damasio 2015 [<xref rid="ppat.1006770.ref154" ref-type="bibr">154</xref>]; Hendricks 2017 [<xref rid="ppat.1006770.ref091" ref-type="bibr">91</xref>]</td></tr><tr><td align="left" rowspan="3" colspan="1"><italic>S. aureus</italic><break/></td><td align="left" rowspan="1" colspan="1">In vitro and Animal</td><td align="left" rowspan="1" colspan="1">Synergistic/Facilitating</td><td align="left" rowspan="1" colspan="1">Niemann 2012 [<xref rid="ppat.1006770.ref155" ref-type="bibr">155</xref>]; Davison 1982 [<xref rid="ppat.1006770.ref156" ref-type="bibr">156</xref>]; Tashiro 1987 [<xref rid="ppat.1006770.ref037" ref-type="bibr">37</xref>]; Zhang 1996 [<xref rid="ppat.1006770.ref157" ref-type="bibr">157</xref>]; Chertow 2016 [<xref rid="ppat.1006770.ref158" ref-type="bibr">158</xref>]; Sun 2014 [<xref rid="ppat.1006770.ref050" ref-type="bibr">50</xref>]; Braun 2007 [<xref rid="ppat.1006770.ref035" ref-type="bibr">35</xref>]; Iverson 2011 [<xref rid="ppat.1006770.ref159" ref-type="bibr">159</xref>]; Robinson 2013 [<xref rid="ppat.1006770.ref160" ref-type="bibr">160</xref>]</td></tr><tr><td align="left" rowspan="2" colspan="1">Human</td><td align="left" rowspan="1" colspan="1">Synergistic/Facilitating</td><td align="left" rowspan="1" colspan="1">Sherertz 1996 [<xref rid="ppat.1006770.ref161" ref-type="bibr">161</xref>]; Hageman 2006 [<xref rid="ppat.1006770.ref162" ref-type="bibr">162</xref>]; Finelli 2008 [<xref rid="ppat.1006770.ref163" ref-type="bibr">163</xref>]; Reed 2009 [<xref rid="ppat.1006770.ref164" ref-type="bibr">164</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Neutral</td><td align="left" rowspan="1" colspan="1">Kobayashi 2013 [<xref rid="ppat.1006770.ref165" ref-type="bibr">165</xref>]</td></tr><tr><td align="left" rowspan="2" colspan="1"><italic>H. influenzae</italic><break/></td><td align="left" rowspan="1" colspan="1">Animal</td><td align="left" rowspan="1" colspan="1">Synergistic/Facilitating</td><td align="left" rowspan="1" colspan="1">Lee 2010 [<xref rid="ppat.1006770.ref051" ref-type="bibr">51</xref>]; Michaels 1977 [<xref rid="ppat.1006770.ref166" ref-type="bibr">166</xref>]; Bakaletz 1988 [<xref rid="ppat.1006770.ref167" ref-type="bibr">167</xref>]; Francis 1945 [<xref rid="ppat.1006770.ref168" ref-type="bibr">168</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Human</td><td align="left" rowspan="1" colspan="1">Synergistic/Facilitating</td><td align="left" rowspan="1" colspan="1">Morens 2008 [<xref rid="ppat.1006770.ref010" ref-type="bibr">10</xref>]</td></tr><tr><td align="left" rowspan="3" colspan="1"><italic>N. meningitidis</italic><break/></td><td align="left" rowspan="2" colspan="1">In vitro and Animal</td><td align="left" rowspan="1" colspan="1">Synergistic/Facilitating</td><td align="left" rowspan="1" colspan="1">Rameix-Welti 2009 [<xref rid="ppat.1006770.ref053" ref-type="bibr">53</xref>]; Loh 2013 [<xref rid="ppat.1006770.ref034" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Neutral</td><td align="left" rowspan="1" colspan="1">Read 1999 [<xref rid="ppat.1006770.ref169" ref-type="bibr">169</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Human</td><td align="left" rowspan="1" colspan="1">Synergistic/Facilitating</td><td align="left" rowspan="1" colspan="1">Cartwright 1991 [<xref rid="ppat.1006770.ref170" ref-type="bibr">170</xref>]; Hubert 1992 [<xref rid="ppat.1006770.ref052" ref-type="bibr">52</xref>]; Jacobs 2014 [<xref rid="ppat.1006770.ref171" ref-type="bibr">171</xref>]; Brundage 2006 [<xref rid="ppat.1006770.ref172" ref-type="bibr">172</xref>]; Jansen 2008 [<xref rid="ppat.1006770.ref145" ref-type="bibr">145</xref>]; Jacobs 2014 [<xref rid="ppat.1006770.ref171" ref-type="bibr">171</xref>]; Makras 2001 [<xref rid="ppat.1006770.ref173" ref-type="bibr">173</xref>]</td></tr><tr><td align="left" rowspan="3" colspan="1"><italic>M. tuberculosis</italic><break/></td><td align="left" rowspan="1" colspan="1">Animal</td><td align="left" rowspan="1" colspan="1">Synergistic/Facilitating</td><td align="left" rowspan="1" colspan="1">Florido 2015 [<xref rid="ppat.1006770.ref174" ref-type="bibr">174</xref>]; Florido 2013[<xref rid="ppat.1006770.ref055" ref-type="bibr">55</xref>]; Volkert 1947 [<xref rid="ppat.1006770.ref175" ref-type="bibr">175</xref>]; Redford 2014 [<xref rid="ppat.1006770.ref176" ref-type="bibr">176</xref>]</td></tr><tr><td align="left" rowspan="2" colspan="1">Human</td><td align="left" rowspan="1" colspan="1">Synergistic/Facilitating</td><td align="left" rowspan="1" colspan="1">Walaza 2015 [<xref rid="ppat.1006770.ref177" ref-type="bibr">177</xref>]; Oei 2012[<xref rid="ppat.1006770.ref178" ref-type="bibr">178</xref>]; Noymer 2011 [<xref rid="ppat.1006770.ref179" ref-type="bibr">179</xref>]; Noymer 2009 [<xref rid="ppat.1006770.ref180" ref-type="bibr">180</xref>]; Zurcher 2016 [<xref rid="ppat.1006770.ref181" ref-type="bibr">181</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Neutral</td><td align="left" rowspan="1" colspan="1">Roth 2013[<xref rid="ppat.1006770.ref182" ref-type="bibr">182</xref>]</td></tr><tr><td align="left" rowspan="3" colspan="1"><italic>S. pyogenes</italic><break/></td><td align="left" rowspan="1" colspan="1">Animal</td><td align="left" rowspan="1" colspan="1">Synergistic/Facilitating</td><td align="left" rowspan="1" colspan="1">Klonoski 2014 [<xref rid="ppat.1006770.ref183" ref-type="bibr">183</xref>]; Okamoto 2003 [<xref rid="ppat.1006770.ref184" ref-type="bibr">184</xref>]; Okamoto 2004 [<xref rid="ppat.1006770.ref185" ref-type="bibr">185</xref>]; Hafez 2010 [<xref rid="ppat.1006770.ref186" ref-type="bibr">186</xref>]</td></tr><tr><td align="left" rowspan="2" colspan="1">Human</td><td align="left" rowspan="1" colspan="1">Synergistic/Facilitating</td><td align="left" rowspan="1" colspan="1">Scaber 2011 [<xref rid="ppat.1006770.ref187" ref-type="bibr">187</xref>]; Zakikhany 2011 [<xref rid="ppat.1006770.ref111" ref-type="bibr">111</xref>]; Tasher 2011 [<xref rid="ppat.1006770.ref188" ref-type="bibr">188</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Neutral</td><td align="left" rowspan="1" colspan="1">Tamayo 2016 [<xref rid="ppat.1006770.ref189" ref-type="bibr">189</xref>]</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec007"><title>Virus&#x02013;virus interactions</title><p>Within its family, influenza interacts between types (A and B), subtypes (e.g., H3N2, H1N1), and strains. Competitive exclusion due to homologous immunity is widely accepted [<xref rid="ppat.1006770.ref056" ref-type="bibr">56</xref>,<xref rid="ppat.1006770.ref057" ref-type="bibr">57</xref>] and has been applied extensively in models of influenza strain coexistence [<xref rid="ppat.1006770.ref058" ref-type="bibr">58</xref>,<xref rid="ppat.1006770.ref059" ref-type="bibr">59</xref>]. Antigenic change (measured through antigenic distance) occurs constantly in influenza, strongly indicating that the virus escapes from immunity resulting from prior infection by genetic change [<xref rid="ppat.1006770.ref060" ref-type="bibr">60</xref>]. Interestingly, there is mounting evidence that the first influenza infection is important and may affect severity of future infections [<xref rid="ppat.1006770.ref061" ref-type="bibr">61</xref>&#x02013;<xref rid="ppat.1006770.ref063" ref-type="bibr">63</xref>]. Some evidence also supports the finding that influenza can interact with other influenza viruses and noninfluenza respiratory viruses via nonspecific immunity following infection [<xref rid="ppat.1006770.ref064" ref-type="bibr">64</xref>,<xref rid="ppat.1006770.ref065" ref-type="bibr">65</xref>].</p><p>Many noninfluenza viruses are also suspected of interfering with influenza virus acquisition, based on different types of studies (<xref ref-type="table" rid="ppat.1006770.t002">Table 2</xref>). During the 2009 influenza pandemic, Casalegno et al. reported that in France, the second pandemic wave was delayed due to the September rhinovirus epidemic [<xref rid="ppat.1006770.ref066" ref-type="bibr">66</xref>], although this shift was not observed in other countries [<xref rid="ppat.1006770.ref067" ref-type="bibr">67</xref>,<xref rid="ppat.1006770.ref068" ref-type="bibr">68</xref>] and may have been affected by variable reporting rates. Coinfection by the two viruses might also enhance disease severity for individuals [<xref rid="ppat.1006770.ref069" ref-type="bibr">69</xref>&#x02013;<xref rid="ppat.1006770.ref071" ref-type="bibr">71</xref>], although evidence is discordant [<xref rid="ppat.1006770.ref072" ref-type="bibr">72</xref>&#x02013;<xref rid="ppat.1006770.ref074" ref-type="bibr">74</xref>]. Similarly, competitive interaction with respiratory syncytial virus (RSV) has been posited for many years [<xref rid="ppat.1006770.ref075" ref-type="bibr">75</xref>,<xref rid="ppat.1006770.ref076" ref-type="bibr">76</xref>], and some evidence was found for delayed RSV epidemics due to the second wave of the 2009 pandemic in France [<xref rid="ppat.1006770.ref077" ref-type="bibr">77</xref>] and tropical regions [<xref rid="ppat.1006770.ref078" ref-type="bibr">78</xref>,<xref rid="ppat.1006770.ref079" ref-type="bibr">79</xref>]. There is discrepancy in the findings of interaction between influenza and RSV; while most studies found increased severity [<xref rid="ppat.1006770.ref074" ref-type="bibr">74</xref>,<xref rid="ppat.1006770.ref080" ref-type="bibr">80</xref>,<xref rid="ppat.1006770.ref081" ref-type="bibr">81</xref>], others found no effect [<xref rid="ppat.1006770.ref069" ref-type="bibr">69</xref>] and some found less severity [<xref rid="ppat.1006770.ref082" ref-type="bibr">82</xref>]. Competitive interaction with parainfluenza viruses was also inferred, based on less frequent coinfection pairs than expected [<xref rid="ppat.1006770.ref083" ref-type="bibr">83</xref>], but that observation is not consistent across studies [<xref rid="ppat.1006770.ref084" ref-type="bibr">84</xref>&#x02013;<xref rid="ppat.1006770.ref086" ref-type="bibr">86</xref>]. In terms of severity, parainfluenza and influenza coinfection is usually more severe than influenza alone [<xref rid="ppat.1006770.ref069" ref-type="bibr">69</xref>,<xref rid="ppat.1006770.ref071" ref-type="bibr">71</xref>,<xref rid="ppat.1006770.ref087" ref-type="bibr">87</xref>] but not always [<xref rid="ppat.1006770.ref072" ref-type="bibr">72</xref>,<xref rid="ppat.1006770.ref073" ref-type="bibr">73</xref>].</p><table-wrap id="ppat.1006770.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1006770.t002</object-id><label>Table 2</label><caption><title>Viruses that may be affected by interaction with influenza.</title></caption><alternatives><graphic id="ppat.1006770.t002g" xlink:href="ppat.1006770.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" style="background-color:#FFFFFF" rowspan="1" colspan="1">Virus</th><th align="justify" style="background-color:#FFFFFF" rowspan="1" colspan="1">Study system</th><th align="justify" style="background-color:#FFFFFF" rowspan="1" colspan="1">Effect</th><th align="justify" style="background-color:#FFFFFF" rowspan="1" colspan="1">Illustrative publications</th></tr></thead><tbody><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">RSV</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Population incidence</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Competitive</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Anestad 2007 [<xref rid="ppat.1006770.ref190" ref-type="bibr">190</xref>]; Anestad 2009 [<xref rid="ppat.1006770.ref191" ref-type="bibr">191</xref>]; Casalegno 2010 [<xref rid="ppat.1006770.ref077" ref-type="bibr">77</xref>];, Anestad 1987 [<xref rid="ppat.1006770.ref192" ref-type="bibr">192</xref>]; Yang 2012 [<xref rid="ppat.1006770.ref079" ref-type="bibr">79</xref>]; Nishimura 2005 [<xref rid="ppat.1006770.ref193" ref-type="bibr">193</xref>]; Glezen 1980 [<xref rid="ppat.1006770.ref076" ref-type="bibr">76</xref>]; Pascalis 2012 [<xref rid="ppat.1006770.ref083" ref-type="bibr">83</xref>]; Yang 2015 [<xref rid="ppat.1006770.ref067" ref-type="bibr">67</xref>]; van Asten 2016 [<xref rid="ppat.1006770.ref194" ref-type="bibr">194</xref>]; Meningher 2014 [<xref rid="ppat.1006770.ref195" ref-type="bibr">195</xref>]; Velasco-Hernandez 2015 [<xref rid="ppat.1006770.ref117" ref-type="bibr">117</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Neutral</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Navarro-Mari 2012 [<xref rid="ppat.1006770.ref068" ref-type="bibr">68</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Coinfection detection</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Competitive</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Greer 2009 [<xref rid="ppat.1006770.ref084" ref-type="bibr">84</xref>]; Martin 2013 [<xref rid="ppat.1006770.ref196" ref-type="bibr">196</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Laboratory investigation</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Competitive</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Shinjoh 2000 [<xref rid="ppat.1006770.ref197" ref-type="bibr">197</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Rhinovirus</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Population incidence</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Competitive</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Casalegno 2010 [<xref rid="ppat.1006770.ref066" ref-type="bibr">66</xref>]; Casalegno 2010 [<xref rid="ppat.1006770.ref077" ref-type="bibr">77</xref>]; Pascalis 2012 [<xref rid="ppat.1006770.ref083" ref-type="bibr">83</xref>]; Linde 2009 [<xref rid="ppat.1006770.ref198" ref-type="bibr">198</xref>]; Anestad and Nordbo [<xref rid="ppat.1006770.ref199" ref-type="bibr">199</xref>]; Cowling 2012 [<xref rid="ppat.1006770.ref065" ref-type="bibr">65</xref>]; Yang 2015 [<xref rid="ppat.1006770.ref067" ref-type="bibr">67</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Neutral</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Yang 2012 [<xref rid="ppat.1006770.ref079" ref-type="bibr">79</xref>]; Navarro-Mari 2012 [<xref rid="ppat.1006770.ref068" ref-type="bibr">68</xref>]; van Asten 2016 [<xref rid="ppat.1006770.ref194" ref-type="bibr">194</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Coinfection detection</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Competitive</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Tanner 2012 [<xref rid="ppat.1006770.ref200" ref-type="bibr">200</xref>]; Mackay 2013 [<xref rid="ppat.1006770.ref201" ref-type="bibr">201</xref>]; Nisi 2010 [<xref rid="ppat.1006770.ref086" ref-type="bibr">86</xref>]; Greer 2009 [<xref rid="ppat.1006770.ref084" ref-type="bibr">84</xref>]; Martin 2013 [<xref rid="ppat.1006770.ref196" ref-type="bibr">196</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Laboratory investigation</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Competitive</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Pinky and Dobrovolny 2016 [<xref rid="ppat.1006770.ref112" ref-type="bibr">112</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Influenza</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Population incidence</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Competitive</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">van Asten 2016 [<xref rid="ppat.1006770.ref194" ref-type="bibr">194</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Coinfection detection</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Competitive</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Nisii 2010 [<xref rid="ppat.1006770.ref086" ref-type="bibr">86</xref>]; Sonoguchi 1985 [<xref rid="ppat.1006770.ref056" ref-type="bibr">56</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Laboratory studies</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Competitive</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Easton 2011 [<xref rid="ppat.1006770.ref202" ref-type="bibr">202</xref>]; Laurie 2015 [<xref rid="ppat.1006770.ref057" ref-type="bibr">57</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">HPIV</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Population incidence</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Competitive</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Yang 2012 [<xref rid="ppat.1006770.ref067" ref-type="bibr">67</xref>]; Anestad 1987 [<xref rid="ppat.1006770.ref192" ref-type="bibr">192</xref>]; Yang 2015 [<xref rid="ppat.1006770.ref067" ref-type="bibr">67</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Neutral</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Mak 2012 [<xref rid="ppat.1006770.ref078" ref-type="bibr">78</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Coinfection detection</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Competitive</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Pascalis 2012 [<xref rid="ppat.1006770.ref083" ref-type="bibr">83</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Neutral</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Murphy 1975 [<xref rid="ppat.1006770.ref085" ref-type="bibr">85</xref>]; Nisii 2010 [<xref rid="ppat.1006770.ref086" ref-type="bibr">86</xref>]; Greer 2009 [<xref rid="ppat.1006770.ref084" ref-type="bibr">84</xref>]; Martin 2013 [<xref rid="ppat.1006770.ref196" ref-type="bibr">196</xref>]</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Laboratory investigation</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Synergistic/Facilitating</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Goto 2016 [<xref rid="ppat.1006770.ref203" ref-type="bibr">203</xref>]</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Abbreviations: HPIV, human parainfluenza virus; RSV, respiratory syncytial virus.</p></fn></table-wrap-foot></table-wrap><p>The general pattern is that bacteria tend to synergize with influenza, often boosting transmission of either pathogen or increasing invasion of the bacteria following influenza infection. It is not always clear whether this is a true synergy&#x02014;in which both pathogens benefit&#x02014;or rather that influenza facilitates bacterial invasion. In contrast, viral pathogens tend to form competitive interactions with influenza, although whether these are direct, specific interactions with particular other viruses or the result of an &#x02018;early advantage&#x02019; to the first infector remains unclear. This pattern may occur because of the differing natural histories of bacteria and viruses; while the former tends to infect hosts for long time periods, the latter has shorter infections more similar to the natural history of influenza itself. This is a complex system in which each host&#x02013;pathogen or pathogen&#x02013;pathogen interaction phenomenon may impact the others. Surprisingly, however, such interactions remain poorly studied and, in particular, very few modelling studies have addressed these questions.</p></sec></sec><sec id="sec008"><title>Impact of interactions at the population level</title><p>Although coinfections occur at the host level, their consequences are far-reaching (<xref ref-type="fig" rid="ppat.1006770.g002">Fig 2</xref>). Coinfection may alter the natural history, severity, or timing of illness in an individual and thereby modify the morbidity, healthcare-seeking behaviour, and treatment of that individual. Heterogeneity in these can affect the probability of, and timing of, reporting disease, thereby transferring the effect from individual hosts to the population level.</p><fig id="ppat.1006770.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1006770.g002</object-id><label>Fig 2</label><caption><title>Cycle of factors affected by nonneutral interactions at the individual level and their impact on influenza surveillance, treatment, prevention, and control.</title><p>Factors that affect coinfection on an individual scale can feed forward to an effect on population surveillance through their effects on the reporting of infection. Decisions on public health interventions are made in response to population-level data. These interventions then take effect at the individual level, to give a feedback loop both generated and impacted by effects of coinfection.</p></caption><graphic xlink:href="ppat.1006770.g002"/></fig><p>Development and implementation of public health policies rely on analyses of population surveillance data on influenza epidemics and burden. Policies then generate changes in medical interventions at the population level, e.g., change in vaccination targets, or at the individual level, e.g., recommendations for antibiotics or antivirals in certain groups. These public health interventions then have their own impacts on the dynamics of pathogens and coinfections. Therefore, because coinfections may alter surveillance data, and policies based on evidence from surveillance data may alter coinfection or interference risk, there is a complex cycle of dependence, which highlights the difficulty&#x02014;as well as the potential importance&#x02014;of assessing the impact of coinfections (<xref ref-type="fig" rid="ppat.1006770.g002">Fig 2</xref>).</p><p>To date, most of the published quantitative analyses of interactions rely on statistical association between incident cases of influenza-like illness (ILI) and other infections based on regression and correlation analyses [<xref rid="ppat.1006770.ref088" ref-type="bibr">88</xref>,<xref rid="ppat.1006770.ref089" ref-type="bibr">89</xref>]. A major methodological challenge of detecting interactions is that significant correlation between epidemics of two pathogens in surveillance data may result from either a true biological direct or indirect interaction or may be confounding as a result of the two pathogens sharing common ecological conditions (e.g., cold weather). Regression models describe simple functional links between, for example, the incidence time series, onset or peak time, or epidemic magnitude or severity. Despite their apparently simple formulation, they rely on strong statistical assumptions on the shape of the data and the association [<xref rid="ppat.1006770.ref090" ref-type="bibr">90</xref>]. Regression models are also used to calculate correlations between reported time series at different time lags. When properly controlled for confounding variables, they have proved very useful tools to detect signals of associations. Other methods have been proposed through the deployment of seasonal autoregressive integrated moving average (SARIMA) models to analyse time series [<xref rid="ppat.1006770.ref091" ref-type="bibr">91</xref>], Granger causality [<xref rid="ppat.1006770.ref092" ref-type="bibr">92</xref>,<xref rid="ppat.1006770.ref093" ref-type="bibr">93</xref>], or seasonality patterns [<xref rid="ppat.1006770.ref094" ref-type="bibr">94</xref>]. However, these models do not formalize the transmission process or biological mechanism of interaction, so the interaction mechanism cannot be determined nor the strength of interaction quantified. Furthermore, this lack of mechanistic formulation prevents easily interpretable predictions that are required to support public health decision-making.</p><p>Due to the complex phenomena and many feedback loops, mechanistic models are needed to dissect the cause and effect of the different components (<xref ref-type="boxed-text" rid="ppat.1006770.box001">Box 1</xref>) [<xref rid="ppat.1006770.ref095" ref-type="bibr">95</xref>]. The role of modelling is two-fold: first, mathematical modelling provides a common language to integrate heterogeneous mechanisms and test competitive hypotheses. By doing so, models contribute to building basic knowledge about infection processes. Second, modelling enables assessment of potential intervention scenarios by predicting their impact.</p><boxed-text id="ppat.1006770.box001" position="float" orientation="portrait"><sec id="sec009"><title>Box 1. Mathematical modelling definitions</title><p><bold>Mathematical</bold> versus <bold>statistical models</bold>: A <bold>mathematical model</bold> (or <bold>transmission</bold> or <bold>mechanistic model</bold>) is a mechanistic description by mathematical equations of how the number of infected entities changes over time. For example, a mathematical model of transmission between people might explicitly track the number of infected people and describe how many contacts they make, how often these contacts lead to transmission, and how this is affected by temperature. Depending on the scale of the model, entities can be cells, individuals, or groups of individuals (e.g., a household, a city). <bold>Statistical models</bold> do not include a mechanistic link between quantities but only rely on an observed association, often in the form of a probability distribution. So, in the case of the statistical model, you might say that you see more cases when the temperature is low, without explicitly explaining why.</p><p><bold>Individual-based model</bold> versus <bold>compartmental models</bold>: <bold>Individual-based models</bold> (or <bold>agent-based models</bold>) include a description of the properties (e.g., age, immune status, risk factors) of each of the individuals in the studied population. In contrast, <bold>compartmental models</bold> group individuals with similar characteristics together into compartments and look at relationships between these compartments. The most famous compartmental in epidemiology is the SIR model, based on three compartments, Susceptible-Infectious-Recovered, which is the basis of most of the existing models of pathogen transmission. Compartmental models are easier to fit to data (see next section) and interpret. Individual-based models are more flexible when it is important to integrate a wide range of characteristics of the population but are comparatively slow to implement and run, more difficult to interpret, and require good data on each characteristic that is modelled.</p><p><bold>Model fitting</bold>: Models are built around a structure (the mechanisms), which is modulated by parameters governing the rates of change between compartments, disease states, behaviours, etc. Historically, parameters have been estimated using results from studies published in the literature. In recent years, with the increased availability of epidemiological data, modelers try whenever possible to fit the model to data (also called <bold>parameter inference</bold> or <bold>calibration</bold>). For this, they use algorithms that explore &#x02018;parameter space&#x02019;, which is the set of all possible values for parameters, and retain sets of parameters that explain the observed data best. Fitting can be computationally intensive if the model includes many parameters. More efficient fitting algorithms allow fitting of more complex models and thus the study of potentially more interaction mechanisms.</p></sec></boxed-text><p>For these reasons, public health interventions based on modelling of infectious diseases have become informative and effective. For example, in the UK, a transmission model fitted to a vast range of ILI and influenza surveillance data demonstrated that vaccinating children against influenza will have the same protective effect on people over 65 years old as vaccinating those individuals [<xref rid="ppat.1006770.ref096" ref-type="bibr">96</xref>]. This outcome is a consequence of the diminished community transmission that results from reducing infections in children. Such an impact would be impossible to identify without mechanistic models. <xref ref-type="boxed-text" rid="ppat.1006770.box002">Box 2</xref> summarises the potential benefits of coinfection transmission models.</p><boxed-text id="ppat.1006770.box002" position="float" orientation="portrait"><sec id="sec010"><title>Box 2. Benefits of coinfection transmission models</title><list list-type="bullet"><list-item><p>Allow causal relationships to be drawn from the data by testing hypotheses regarding interaction mechanisms
<list list-type="simple"><list-item><label>&#x025cb;</label><p>For example, using models to analyse the cellular dynamics observed in vivo in mouse coinfection experiments, it is possible to design models of hypothesised immunological pathways and determine which most closely fits observed patterns [<xref rid="ppat.1006770.ref097" ref-type="bibr">97</xref>].</p></list-item></list></p></list-item><list-item><p>Evaluate contributions to influenza burden with more precision
<list list-type="simple"><list-item><label>&#x025cb;</label><p>For example, year-to-year influenza epidemics have a different estimated reporting fraction. A model could be used to determine whether coinfection or concurrent epidemics of other viruses are the reason for an increased (or decreased) probability of reporting infection.</p></list-item></list></p></list-item><list-item><p>Predict or project incidence of coinfections, including during pandemics
<list list-type="simple"><list-item><label>&#x025cb;</label><p>For example, fitting multipathogen models to respiratory virus surveillance data would allow quantitative assessment of the hypothesis that during the 2009 pandemic, influenza affected the timing of rhinovirus, RSV, and influenza by competition [<xref rid="ppat.1006770.ref066" ref-type="bibr">66</xref>,<xref rid="ppat.1006770.ref077" ref-type="bibr">77</xref>].</p></list-item></list></p></list-item><list-item><p>Optimize prevention and control of influenza infections and their complications
<list list-type="simple"><list-item><label>&#x025cb;</label><p>For example, a model of influenza and pneumococcal pneumonia could determine optimal target groups for pneumococcal vaccination, based on both the bacterial carriage rates in each age group and the expected influenza vaccination rates in those age groups.</p></list-item></list></p></list-item><list-item><p>Estimate the costs and benefits of intervention strategies
<list list-type="simple"><list-item><label>&#x025cb;</label><p>For example, a model-based analysis of in vitro experimental data could allow assessment of the impact of early antiviral or antibiotic treatment on probability of pneumococcal invasion [<xref rid="ppat.1006770.ref098" ref-type="bibr">98</xref>,<xref rid="ppat.1006770.ref100" ref-type="bibr">100</xref>]. Combined with population, it would be possible to assess the impact on secondary bacterial infections.</p></list-item></list></p></list-item></list></sec></boxed-text></sec><sec id="sec011"><title>Models of influenza interactions</title><p>Despite mounting evidence of influenza&#x02013;bacteria interactions and the concurrent increasing use of dynamic modelling to study infectious diseases in recent decades, influenza interactions have rarely been modelled. Interestingly, previous literature reviews describing evidence of interactions between influenza virus and other respiratory bacterial or viral pathogens neglected mathematical models that, despite their limited number, provide insight into mechanisms of interaction and their consequences [<xref rid="ppat.1006770.ref003" ref-type="bibr">3</xref>,<xref rid="ppat.1006770.ref027" ref-type="bibr">27</xref>]. We have systematically reviewed the literature for models incorporating influenza with bacteria or noninfluenza viruses (details on the search strategies are provided in <xref ref-type="supplementary-material" rid="ppat.1006770.s003">S1 Appendix</xref>, section A).</p><sec id="sec012"><title>Influenza&#x02013;bacteria interaction</title><p>The only influenza&#x02013;bacterium interaction that has been integrated into mathematical modelling studies is the influenza&#x02013;pneumococcus system, both within host and at the population level.</p><p>Several dynamic models of coinfection at the cellular level were proposed relatively recently [<xref rid="ppat.1006770.ref097" ref-type="bibr">97</xref>&#x02013;<xref rid="ppat.1006770.ref101" ref-type="bibr">101</xref>]. In a study combining modelling and empirical data from mice coinfected with two different influenza viruses and two pneumococcus strains, Smith et al. assessed the likelihood of different immunological interaction mechanisms [<xref rid="ppat.1006770.ref097" ref-type="bibr">97</xref>]. They found a role of macrophage dysfunction leading to an increase of bacterial titres and increased virus release during coinfections [<xref rid="ppat.1006770.ref097" ref-type="bibr">97</xref>], although their results suggest that coinfection-induced increase of bacterial adherence and of infected cell death were not very likely. Shrestha et al. used an immune-mediated model of the virus&#x02013;bacterium interaction in the lungs to specifically quantify interaction timing and intensity [<xref rid="ppat.1006770.ref098" ref-type="bibr">98</xref>]. They assumed that the efficiency of alveolar macrophages, which are a critical component of host immunity against bacterial infections, was reduced by viral infection and tested the impact of inoculum size, time of bacterial invasion after influenza infection, and the potential impact of antiviral administration. The model predicted that enhanced susceptibility to invasion would be observed four to six days after influenza infection, suggesting that early antiviral administration after influenza infection (&#x0003c;4 days) could prevent invasive pneumococcal disease. Smith and Smith modelled a nonlinear initial dose threshold, below which bacteria (pneumococcus) declined and above which bacteria increased. Using data from mice experiments, they showed that this threshold was dependent on the degree of virus-induced depletion of alveolar macrophages. Because macrophage depletion varies through the course of influenza infection, this important finding may explain why risk of bacterial invasion also changes over the course of infection, with particularly low dose requirement in the first few days of infection [<xref rid="ppat.1006770.ref099" ref-type="bibr">99</xref>]. In a follow-up study, the same authors analysed published data from influenza&#x02013;pneumococcus coinfected mice treated with antiviral, antibiotic, or immune modulatory agents. They found that antivirals are more efficient at preventing secondary infection when used in the first two days of influenza infection and also found an important benefit of immunotherapy, especially for low bacterial loads [<xref rid="ppat.1006770.ref100" ref-type="bibr">100</xref>]. Lastly, in a within-host model, Boianelli and colleagues investigated the efficacy of different oseltamivir treatment regimens in influenza&#x02013;pneumococcus coinfected individuals using parameters drawn from human and mouse studies. They found that increasing the dose of oseltamivir, but not duration of treatment, might increase both its antiviral and antibacterial efficacy [<xref rid="ppat.1006770.ref101" ref-type="bibr">101</xref>].</p><p>At the population level, there have been several models to assess influenza interactions with bacteria and test hypotheses regarding the main mechanisms [<xref rid="ppat.1006770.ref102" ref-type="bibr">102</xref>&#x02013;<xref rid="ppat.1006770.ref106" ref-type="bibr">106</xref>]. The comparison of pneumococcal transmission models to analyse time series of pneumococcal meningitis and viral respiratory infections in France highlighted two important processes in colonized individuals: (1) a virus-related increase in pneumococcal pathogenicity and (2) an enhanced between-individual transmissibility of bacteria [<xref rid="ppat.1006770.ref102" ref-type="bibr">102</xref>]. Models of transmission of bacterial pneumonia fitted to US data also highlighted significant interactions, mainly due to influenza-associated increase of individual risk of pneumonia [<xref rid="ppat.1006770.ref103" ref-type="bibr">103</xref>,<xref rid="ppat.1006770.ref107" ref-type="bibr">107</xref>]. Recently, in a simulation study, Arduin et al. used a flexible individual-based model of influenza&#x02013;bacteria interaction to assess the population consequences and associated burden of a range of pneumococcus&#x02013;influenza interaction mechanisms [<xref rid="ppat.1006770.ref108" ref-type="bibr">108</xref>]. Population dynamic models have also been used to test the public health impact of control measures [<xref rid="ppat.1006770.ref104" ref-type="bibr">104</xref>&#x02013;<xref rid="ppat.1006770.ref106" ref-type="bibr">106</xref>]. Different strategies of antibiotic use (as treatment or prophylaxis) and of vaccination were assessed by modelling the dual transmission of pneumococcus and influenza [<xref rid="ppat.1006770.ref104" ref-type="bibr">104</xref>]. For a 1918-like pandemic, this model suggested that widespread antibiotic treatment of individuals with pneumonia would significantly lower mortality, whereas antibiotics in prophylaxis would effectively prevent pneumonia cases. A different model evaluated the benefit of vaccinating the UK population against pneumococcus in the context of pandemic influenza using different scenarios: 1918-like, 1957/1968-like, or 2009-like virus [<xref rid="ppat.1006770.ref105" ref-type="bibr">105</xref>]. This indicated that pneumococcal vaccination would have a major impact only for a pandemic with high case fatality and secondary pneumococcal infection rates (e.g., the 1918-like), with less influence in other scenarios.</p></sec><sec id="sec013"><title>Viral interaction</title><p>Influenza&#x02013;influenza interactions predominate in models of two viruses, with limited investigation of influenza&#x02013;RSV interactions and no models of other viruses.</p><p>Within host, several models of multistrain influenza infections were proposed [<xref rid="ppat.1006770.ref109" ref-type="bibr">109</xref>&#x02013;<xref rid="ppat.1006770.ref111" ref-type="bibr">111</xref>], especially examining the interval before the secondary infection. One model of RSV&#x02013;influenza interaction at the cellular level explored the hypothesis of the viruses interacting through competition for resources within the cell [<xref rid="ppat.1006770.ref112" ref-type="bibr">112</xref>]. This indirect competition was sufficient to explain the observed rate of virus replication. The model also explored how the speed of virus replication confers an advantage to the first infecting pathogen and determined the &#x02018;head start&#x02019; on infection that the slower-replicating virus would require to maintain dominance.</p><p>Population models have been used extensively to examine the dynamics of influenza and multistrain influenza systems (for a review see [<xref rid="ppat.1006770.ref113" ref-type="bibr">113</xref>]) although many fewer studies examined multispecies systems. Because the influenza virus comprises two types, multiple subtypes, and potentially numerous strains of each, many viruses may be circulating at any given time, providing varying degrees of cross-protection after recovery and sometimes with complex dynamics of within-species strain replacement due to genetic drift or reassortment. There is evidence of competition between strains, with some models requiring short periods of heterologous immunity after infection to create the ladder-like phylodynamic structure of influenza viruses [<xref rid="ppat.1006770.ref114" ref-type="bibr">114</xref>], although recent studies could capture this feature without this mechanism [<xref rid="ppat.1006770.ref058" ref-type="bibr">58</xref>]. One comprehensive early model tested four mechanisms of interaction between influenza types using data from Tecumseh, Michigan, but the data were insufficient to distinguish the mechanisms [<xref rid="ppat.1006770.ref115" ref-type="bibr">115</xref>]. Influenza&#x02013;influenza models must also account for the complex immune history of hosts, related to which there is mounting evidence that the timing of an individual&#x02019;s influenza encounters, and especially the first infection, shapes their future response [<xref rid="ppat.1006770.ref061" ref-type="bibr">61</xref>&#x02013;<xref rid="ppat.1006770.ref063" ref-type="bibr">63</xref>]. The methods for modelling influenza&#x02013;influenza interactions should be extended into interactions with other viruses.</p><p>One model for pandemic influenza, in which coinfection with other respiratory pathogens leads to enhanced influenza transmission, was proposed to explain the multiple waves of the 1918 influenza pandemic in the UK [<xref rid="ppat.1006770.ref116" ref-type="bibr">116</xref>]. A recent example of influenza and RSV cross-species analysis in a climatically driven model provided some evidence that RSV dominates influenza, but the model was not explicitly fitted to data [<xref rid="ppat.1006770.ref117" ref-type="bibr">117</xref>].</p></sec><sec id="sec014"><title>Illustration from a simple model</title><p>To demonstrate how both synergistic and competitive interactions can be modelled, we used a simple transmission model and simulated the effect of interactions (<xref ref-type="boxed-text" rid="ppat.1006770.box003">Box 3</xref>, Figs <xref ref-type="fig" rid="ppat.1006770.g003">3</xref> and <xref ref-type="fig" rid="ppat.1006770.g004">4</xref> and <xref ref-type="supplementary-material" rid="ppat.1006770.s003">S1 Appendix</xref>, section B). We show how these interactions occurring at the individual level can impact the epidemics at the population level. The &#x02018;bacterial type&#x02019; interaction firstly shows an increase in bacterial prevalence when influenza infection increases bacterial transmission, in a facilitative interaction. In a synergistic interaction, where coinfection increases transmission of both influenza and bacteria, prevalence of bacteria increases, and the epidemic of influenza has a quicker and higher peak. In the &#x02018;viral type&#x02019; competitive interaction, progressively decreasing the probability that a second pathogen can infect an already infected host causes the epidemic peaks to separate in time. It also decreases the peak size of the outcompeted pathogen without altering the number of people infected in total (<xref ref-type="fig" rid="ppat.1006770.g004">Fig 4</xref>).</p><boxed-text id="ppat.1006770.box003" position="float" orientation="portrait"><sec id="sec015"><title>Box 3. A simple model of interaction</title><p>The simple model in <xref ref-type="fig" rid="ppat.1006770.g003">Fig 3</xref> tests two interaction mechanisms: increased (or decreased) infectiousness on coinfection and decreased (or increased) probability of coinfection occurring. These are the two most commonly suggested mechanisms, the first of the &#x02018;bacterial type&#x02019; and the second of the &#x02018;viral type&#x02019; (<xref ref-type="fig" rid="ppat.1006770.g004">Fig 4</xref>).</p><p>In <xref ref-type="fig" rid="ppat.1006770.g003">Fig 3</xref>, all individuals start in the Susceptible (S) class and move to the Infectious classes when they are infected by either pathogen 1 (<italic>I</italic><sub><italic>1</italic></sub>) or 2 (<italic>I</italic><sub><italic>2</italic></sub>).</p><p>Infected (and infectious) compartments are shown in colour, where red is infectious with pathogen 1, blue marks infectious with pathogen 2, and infected and infectious with both pathogens in purple. Infection rates are given by the four forces of infection (<italic>&#x003bb;</italic><sub><italic>1</italic></sub>, <italic>&#x003bb;</italic><sub><italic>2</italic></sub>, <italic>&#x003bb;</italic><sub><italic>12</italic></sub>, <italic>&#x003bb;</italic><sub><italic>21</italic></sub>). After being infected by one pathogen, individuals can either be coinfected by the other pathogen and move to the coinfection compartments in purple (<italic>I</italic><sub><italic>12</italic></sub> or <italic>I</italic><sub><italic>21</italic></sub>), or they can recover at rates <italic>&#x003b3;</italic> and move to the Recovered compartments (<italic>R</italic><sub><italic>1</italic></sub> and <italic>R</italic><sub><italic>2</italic></sub>). Coinfected individuals (<italic>I</italic><sub><italic>12</italic></sub> and <italic>I</italic><sub><italic>21</italic></sub>) recover and remain in the doubly recovered compartments, <italic>R</italic><sub><italic>12</italic></sub> and <italic>R</italic><sub><italic>21</italic></sub>. Individuals in <italic>R</italic><sub><italic>1</italic></sub> or <italic>R</italic><sub><italic>2</italic></sub> are subject to force of infection <italic>&#x003bb;</italic><sub><italic>2</italic></sub> or <italic>&#x003bb;</italic><sub><italic>1</italic></sub>, respectively, i.e., of the pathogen they have not yet had. On infection with the other pathogen, they move to the consecutive infection compartment (<italic>C</italic><sub><italic>12</italic></sub> or <italic>C</italic><sub><italic>21</italic></sub>). After recovery, those individuals move to the doubly recovered compartments (<italic>R</italic><sub><italic>12</italic></sub> and <italic>R</italic><sub><italic>21</italic></sub>).</p><p>Parameters <italic>&#x003b2;</italic><sub><italic>1</italic></sub> and <italic>&#x003b2;</italic><sub><italic>2</italic></sub> are the baseline transmissibility of pathogen 1 and 2, respectively. There are four interaction parameters modulating the pathogen&#x02019;s transmissibility: <italic>&#x003c3;</italic><sub><italic>1</italic></sub> and <italic>&#x003c3;</italic><sub><italic>2</italic></sub> are the change in infectiousness of coinfected classes, where a value less than 1 makes the coinfected class less infectious, and a value greater than 1 means coinfected individuals are more infectious. Parameters <italic>&#x003b4;</italic><sub><italic>1</italic></sub> and <italic>&#x003b4;</italic><sub><italic>2</italic></sub> alter the probability of acquisition of a second infection following a first infection, where a value less than 1 makes coinfection less likely, and a value above 1 makes it more likely.</p><p>Details on the model equations and computer code generating the trajectories are given in <xref ref-type="supplementary-material" rid="ppat.1006770.s003">S1 Appendix</xref>, section B and <xref ref-type="supplementary-material" rid="ppat.1006770.s004">S1 Code</xref>.</p></sec></boxed-text><fig id="ppat.1006770.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1006770.g003</object-id><label>Fig 3</label><caption><title>Illustration of a simple model of two circulating pathogens in interactions.</title><p>Schematic of the compartments and rates of transition between compartments, with equations of the forces of infection by pathogen 1 (&#x003bb;<sub>1</sub>), pathogen 2 (&#x003bb;<sub>2</sub>) for susceptible hosts, and pathogen 1 (&#x003bb;<sub>21</sub>) and pathogen 2 (&#x003bb;<sub>12</sub>) for hosts already infected by the other pathogen. The full system of ordinary differential equations describing the changes of the compartment&#x02019;s populations over time is described in <xref ref-type="supplementary-material" rid="ppat.1006770.s003">S1 Appendix</xref>, section B. Details of the model and parameters are provided in <xref ref-type="boxed-text" rid="ppat.1006770.box003">Box 3</xref>.</p></caption><graphic xlink:href="ppat.1006770.g003"/></fig><fig id="ppat.1006770.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1006770.g004</object-id><label>Fig 4</label><caption><title>Example model outputs showing effect of synergistic and competitive interaction.</title><p><xref ref-type="boxed-text" rid="ppat.1006770.box003">Box 3</xref> gives details on the model that produces these epidemic trajectories. (A) In the baseline enhancing scenario, an endemic bacterial pathogen (blue) occurs at 5% prevalence. An influenza epidemic occurs with no interaction, and the bacterial prevalence does not change. If the presence of influenza coinfection increases bacterial transmissibility by 4-fold (<italic>&#x003c3;</italic><sub><italic>1</italic></sub> = 4), then there is a transient rise in bacterial prevalence. If there is also an increase in influenza transmissibility during coinfection (<italic>&#x003c3;</italic><sub><italic>1</italic></sub> = 4 and <italic>&#x003c3;</italic><sub><italic>2</italic></sub> = 2), then there is also a higher and earlier influenza peak as a result of coinfection. (B) In the baseline competition scenario, the second epidemic pathogen is introduced later than influenza. The two pathogens have the same transmission characteristics (same <italic>&#x003b3;</italic>, same &#x003b2;). If there is only a 50% chance of infection with pathogen 2 when individuals are infected with pathogen 1 (<italic>&#x003b4;</italic><sub><italic>1</italic></sub> = 0.5), then the epidemic trajectory of pathogen 2 is lower and later. If competition is even stronger (<italic>&#x003b4;</italic><sub><italic>1</italic></sub> = 0.1) so there is a 90% reduction in chance of coinfection, the profile of pathogen 2 is even further separated from pathogen 1. Computer code generating these trajectories is given in <xref ref-type="supplementary-material" rid="ppat.1006770.s004">S1 Code</xref>.</p></caption><graphic xlink:href="ppat.1006770.g004"/></fig></sec></sec><sec id="sec016"><title>Limits of the current view</title><p>Historically, scientific and medical studies have tended to focus on host&#x02013;pathogen interactions in an independent manner by studying each pathogen alone. We highlighted here, as others [<xref rid="ppat.1006770.ref003" ref-type="bibr">3</xref>,<xref rid="ppat.1006770.ref027" ref-type="bibr">27</xref>,<xref rid="ppat.1006770.ref028" ref-type="bibr">28</xref>], that many respiratory viruses and bacteria have been linked to influenza epidemiology, based on in vivo evidence and from individual and epidemiological studies. These nonneutral interactions, mostly facilitative for bacteria and competitive for viruses, probably have individual- and population-level effects on influenza pathogenicity, burden, and potentially its epidemic profile.</p><p>Mathematical models are crucial to guide public health decision makers, who, for ethical or cost reasons, cannot conduct large-scale trials. Two examples of interventions based on modelling results and mobilizing important public resources are pandemic preparedness (stockpiling of antivirals, use of vaccine doses) [<xref rid="ppat.1006770.ref118" ref-type="bibr">118</xref>] and national immunization programs [<xref rid="ppat.1006770.ref020" ref-type="bibr">20</xref>]. Neglecting the cocirculating pathogens&#x02014;i.e., adopting influenza tunnel vision&#x02014;and the indirect impact of coinfections may potentially affect the estimation of the risk associated with influenza infection and, consequently, the accuracy of model predictions. Interaction strength may also change from year to year and depend on the circulating influenza strains. For evaluation of interventions, this neglect can lead to overestimation of the impact&#x02014;if burden was measured without considering the changing landscape of coinfection in the population&#x02014;or underestimation&#x02014;if the effect of an intervention does not account for the potentially decreased burden of an interacting pathogen as a result of diminished influenza transmission. For all these reasons, we think that adopting a more holistic approach to modelling of respiratory pathogens will improve their surveillance and the strategy to control them.</p></sec><sec id="sec017"><title>Opportunities</title><p>Considering influenza virus in its ecological context and its interactions as a cause of the associated morbidity and mortality should offer opportunities for prevention and treatment. In addition to influenza vaccines that (partially) protect against infection, antibacterial vaccines are also critical. For example, pneumococcal vaccines have been shown to have good efficacy against influenza-associated nonbacteremic pneumonias [<xref rid="ppat.1006770.ref119" ref-type="bibr">119</xref>,<xref rid="ppat.1006770.ref120" ref-type="bibr">120</xref>]. The 23-valent pneumococcal polysaccharide vaccine significantly lowered the risk of invasive pneumococcal disease and attributed mortality in the elderly [<xref rid="ppat.1006770.ref121" ref-type="bibr">121</xref>]. Better understanding of possible influenza&#x02013;pneumococcus interactions and integrating those into transmission models could potentially enable us to identify synergies between vaccination programs and optimize the use of both vaccines.</p><p>In addition, there may be opportunities for optimization of antibiotic and antiviral prescriptions. First, antibiotics have historically been used to prevent secondary infections [<xref rid="ppat.1006770.ref122" ref-type="bibr">122</xref>,<xref rid="ppat.1006770.ref123" ref-type="bibr">123</xref>]. Increasing rates of antibiotic resistance worldwide led to policies to decrease antibiotic consumption, focusing particular attention on reducing prescriptions for viral infections. Second, neuraminidase inhibitors were found to prevent some secondary bacterial pneumonias in animal experiments, human epidemiological studies, and mathematical modelling studies, beyond the window in which they directly impact the influenza viral load [<xref rid="ppat.1006770.ref098" ref-type="bibr">98</xref>,<xref rid="ppat.1006770.ref124" ref-type="bibr">124</xref>,<xref rid="ppat.1006770.ref125" ref-type="bibr">125</xref>]. Although antivirals may only modestly attenuate influenza symptoms, a body of evidence suggests they could avoid severe and economically important outcomes of influenza infection [<xref rid="ppat.1006770.ref125" ref-type="bibr">125</xref>&#x02013;<xref rid="ppat.1006770.ref128" ref-type="bibr">128</xref>].</p><p>Lastly, accurate burden quantification is crucial to designing and implementing public health interventions against influenza. Focusing efforts to better understand these interactions is therefore critical, especially in the context of pandemic influenza but also to plan for seasonal epidemics, by forecasting the onset and peak times and estimating the expected burden. To improve our knowledge, models can be used to analyse available surveillance and experimental data, generate hypotheses regarding interaction mechanisms at play in transmission or infection, and test their likelihoods. Competing assumptions on the biological interaction processes can be assessed, and the strength of interactions can also be estimated. From a public health viewpoint, such models would help better estimate the burden of influenza virus interactions in terms of morbidity and mortality, the cost-effectiveness of interventions, and, critically, more accurately predict the real impact of control measures.</p></sec><sec id="sec018"><title>Challenges</title><p>Integrating transmission and infection by multiple pathogens into mathematical models poses several challenges. From a methodological perspective, modelling several pathogens with interrelated natural histories makes classical compartmental approaches more difficult. Individual-based frameworks (<xref ref-type="boxed-text" rid="ppat.1006770.box001">Box 1</xref>) are better adapted for this task. For example, this approach could be used to investigate the effect of the interval between influenza infection and bacterial acquisition, which reportedly affects the risk of bacterial invasion [<xref rid="ppat.1006770.ref031" ref-type="bibr">31</xref>,<xref rid="ppat.1006770.ref129" ref-type="bibr">129</xref>]. Individual-based models are often more computationally intensive and can introduce new difficulties in terms of parameter estimation, requiring the design of new methods. Recent developments in statistical inference methods, like particle Markov chain Monte Carlo (pMCMC) or maximum likelihood estimation via iterated filtering (MIF) [<xref rid="ppat.1006770.ref130" ref-type="bibr">130</xref>,<xref rid="ppat.1006770.ref131" ref-type="bibr">131</xref>], now enable modelers to jointly fit complex population-based models to multiple types of data, thereby allowing more data and more diverse types of data to inform the model parameters.</p><p>Epidemiological data represent the second major challenge. To date, modelling studies have been limited by the poor knowledge of respiratory viruses and bacteria circulating in the community, especially because little is known about prevalence, incidence, at-risk populations, and even epidemic profiles in different populations. Deeper understanding of the ecology of the vast number of microorganisms that can contribute is needed. On an individual level, new studies are required to assess the effect of coinfections rather than ecological associations from incidence data. Important features include (i) coinfection-induced alteration of diseases&#x02019; natural histories, e.g., increased acquisition and severity risk, changes of infection durations and generation times; (ii) specific at-risk periods for secondary infection or invasion of the coinfecting pathogen, or at-risk periods for severe outcomes; and (iii) at-risk populations, as characterized by individuals&#x02019; age, comorbidities, or behavioural risk factors.</p><p>For population-level data, in most countries, surveillance of influenza acquisition is based on networks of general practitioners who notify patients consulting for clinical symptoms of ILI [<xref rid="ppat.1006770.ref132" ref-type="bibr">132</xref>]. Surveillance data streams based on syndromic surveillance [<xref rid="ppat.1006770.ref133" ref-type="bibr">133</xref>], inpatient data [<xref rid="ppat.1006770.ref134" ref-type="bibr">134</xref>], and pathogen testing [<xref rid="ppat.1006770.ref135" ref-type="bibr">135</xref>,<xref rid="ppat.1006770.ref136" ref-type="bibr">136</xref>] should be combined, and linked at the patient level, to better identify noninfluenza infections or anomalous epidemics that could signal interaction. Improvement of data quality in patient records and detection of the biases inherent in different types of surveillance data are critical to achieve this goal. The latter could be reached by developing new microbiological tools, including new sampling kits able to rapidly detect multiple pathogens for use during medical consultations.</p><p>Public health decision-making for interacting pathogens is a difficult but important challenge. When multiple competing treatment options are available, a coherent framework is needed to determine the best strategy. While the question goes beyond influenza to interactions and coinfections for respiratory viruses in general (e.g., RSV), influenza is one of the most studied viral infections and is therefore the ideal first candidate to develop a more holistic mathematical modelling approach.</p></sec><sec sec-type="conclusions" id="sec019"><title>Conclusion</title><p>In this study, we examined the epidemiological and biological evidence supporting influenza virus interference and interaction with other pathogens. We highlighted opportunities to improve knowledge and control of the virus, if we can move forward from the tunnel vision of single-pathogen models. It is time to develop a more holistic approach to pathogen dynamics in mathematical modelling, with novel methodological innovations, and further efforts in data collection and surveillance. The motivation to do so lies in the real opportunity to improve public health practices and create better, more cost-effective interventions against influenza.</p></sec><sec sec-type="supplementary-material" id="sec020"><title>Supporting information</title><supplementary-material content-type="local-data" id="ppat.1006770.s001"><label>S1 Fig</label><caption><title>PRISMA diagram for search for influenza&#x02013;bacteria interactions.</title><p>(TIF)</p></caption><media xlink:href="ppat.1006770.s001.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1006770.s002"><label>S2 Fig</label><caption><title>PRISMA diagram for search for influenza&#x02013;other virus interactions.</title><p>(TIF)</p></caption><media xlink:href="ppat.1006770.s002.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1006770.s003"><label>S1 Appendix</label><caption><title>Microsoft Word document providing details on the search strategy and the mathematical model.</title><p>(DOCX)</p></caption><media xlink:href="ppat.1006770.s003.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1006770.s004"><label>S1 Code</label><caption><title>Computer code of the coinfection model.</title><p>(R)</p></caption><media xlink:href="ppat.1006770.s004.R"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors are grateful to Elizabeth Miller and Matthieu Domenech de Celles for helpful comments on an early version of the manuscript. The authors also thank John Edmunds for suggesting writing this review following a talk by LO at Public Health England. Finally, they would like to thank the three anonymous reviewers for very helpful and constructive comments.</p></ack><ref-list><title>References</title><ref id="ppat.1006770.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Webster</surname><given-names>RG</given-names></name>, <name><surname>Monto</surname><given-names>A. S.</given-names></name>, <name><surname>Braciale</surname><given-names>T. J.</given-names></name> &#x00026; <name><surname>Lamb</surname><given-names>R. A.</given-names></name> (<year>2013</year>) <article-title>Textbook of Influenza</article-title>.</mixed-citation></ref><ref id="ppat.1006770.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>de Steenhuijsen Piters</surname><given-names>WAA</given-names></name>, <name><surname>Sanders</surname><given-names>EAM</given-names></name>, <name><surname>Bogaert</surname><given-names>D</given-names></name>, <name><surname>Grice</surname><given-names>E</given-names></name>, <name><surname>Segre</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>The role of the local microbial ecosystem in respiratory health and disease</article-title>. <source>Philosophical transactions of the Royal Society of London Series B, Biological sciences</source>
<volume>370</volume>: <fpage>244</fpage>&#x02013;<lpage>253</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Bosch</surname><given-names>AATM</given-names></name>, <name><surname>Biesbroek</surname><given-names>G</given-names></name>, <name><surname>Trzcinski</surname><given-names>K</given-names></name>, <name><surname>Sanders</surname><given-names>EAM</given-names></name>, <name><surname>Bogaert</surname><given-names>D</given-names></name> (<year>2013</year>) <article-title>Viral and bacterial interactions in the upper respiratory tract</article-title>. <source>PLoS Pathog</source>
<volume>9</volume>: <fpage>e1003057</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1003057">10.1371/journal.ppat.1003057</ext-link></comment>
<?supplied-pmid 23326226?><pub-id pub-id-type="pmid">23326226</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Yamin</surname><given-names>D</given-names></name>, <name><surname>Balicer</surname><given-names>RD</given-names></name>, <name><surname>Galvani</surname><given-names>AP</given-names></name> (<year>2014</year>) <article-title>Cost-effectiveness of influenza vaccination in prior pneumonia patients in Israel</article-title>. <source>Vaccine</source>
<volume>32</volume>: <fpage>4198</fpage>&#x02013;<lpage>4205</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2014.05.015">10.1016/j.vaccine.2014.05.015</ext-link></comment>
<?supplied-pmid 24930716?><pub-id pub-id-type="pmid">24930716</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Bedford</surname><given-names>T</given-names></name>, <name><surname>Riley</surname><given-names>S</given-names></name>, <name><surname>Barr</surname><given-names>IG</given-names></name>, <name><surname>Broor</surname><given-names>S</given-names></name>, <name><surname>Chadha</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Global circulation patterns of seasonal influenza viruses vary with antigenic drift</article-title>. <source>Nature</source>
<volume>523</volume>: <fpage>217</fpage>&#x02013;<lpage>220</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature14460">10.1038/nature14460</ext-link></comment>
<?supplied-pmid 26053121?><pub-id pub-id-type="pmid">26053121</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Hayward</surname><given-names>AC</given-names></name>, <name><surname>Fragaszy</surname><given-names>EB</given-names></name>, <name><surname>Bermingham</surname><given-names>A</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Copas</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study</article-title>. <source>Lancet Respir Med</source>
<volume>2</volume>: <fpage>445</fpage>&#x02013;<lpage>454</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S2213-2600(14)70034-7">10.1016/S2213-2600(14)70034-7</ext-link></comment>
<?supplied-pmid 24717637?><pub-id pub-id-type="pmid">24717637</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>de Francisco Shapovalova</surname><given-names>N</given-names></name>, <name><surname>Donadel</surname><given-names>M</given-names></name>, <name><surname>Jit</surname><given-names>M</given-names></name>, <name><surname>Hutubessy</surname><given-names>R</given-names></name> (<year>2015</year>) <article-title>A systematic review of the social and economic burden of influenza in low- and middle-income countries</article-title>. <source>Vaccine</source>
<volume>33</volume>: <fpage>6537</fpage>&#x02013;<lpage>6544</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2015.10.066">10.1016/j.vaccine.2015.10.066</ext-link></comment>
<?supplied-pmid 26597032?><pub-id pub-id-type="pmid">26597032</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Brundage</surname><given-names>JF</given-names></name>, <name><surname>Shanks</surname><given-names>GD</given-names></name> (<year>2008</year>) <article-title>Deaths from bacterial pneumonia during 1918&#x02013;19 influenza pandemic</article-title>. <source>Emerging Infectious Diseases</source>
<volume>14</volume>: <fpage>1193</fpage>&#x02013;<lpage>1199</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid1408.071313">10.3201/eid1408.071313</ext-link></comment>
<?supplied-pmid 18680641?><pub-id pub-id-type="pmid">18680641</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Joseph</surname><given-names>C</given-names></name>, <name><surname>Togawa</surname><given-names>Y</given-names></name>, <name><surname>Shindo</surname><given-names>N</given-names></name> (<year>2013</year>) <article-title>Bacterial and viral infections associated with influenza</article-title>. <source>Influenza and Other Respiratory Viruses</source>
<volume>7</volume>: <fpage>105</fpage>&#x02013;<lpage>113</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/irv.12089">10.1111/irv.12089</ext-link></comment>
<?supplied-pmid 24034494?><pub-id pub-id-type="pmid">24034494</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Morens</surname><given-names>DM</given-names></name>, <name><surname>Taubenberger</surname><given-names>JK</given-names></name>, <name><surname>Fauci</surname><given-names>AS</given-names></name> (<year>2008</year>) <article-title>Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness</article-title>. <source>The Journal of infectious diseases</source>
<volume>198</volume>: <fpage>962</fpage>&#x02013;<lpage>970</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1086/591708">10.1086/591708</ext-link></comment>
<?supplied-pmid 18710327?><pub-id pub-id-type="pmid">18710327</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Grassly</surname><given-names>NC</given-names></name>, <name><surname>Fraser</surname><given-names>C</given-names></name> (<year>2008</year>) <article-title>Mathematical models of infectious disease transmission</article-title>. <source>Nat Rev Microbiol</source>
<volume>6</volume>: <fpage>477</fpage>&#x02013;<lpage>487</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrmicro1845">10.1038/nrmicro1845</ext-link></comment>
<?supplied-pmid 18533288?><pub-id pub-id-type="pmid">18533288</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Neher</surname><given-names>RA</given-names></name>, <name><surname>Bedford</surname><given-names>T</given-names></name> (<year>2015</year>) <article-title>nextflu: real-time tracking of seasonal influenza virus evolution in humans</article-title>. <source>Bioinformatics</source>
<volume>31</volume>: <fpage>3546</fpage>&#x02013;<lpage>3548</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btv381">10.1093/bioinformatics/btv381</ext-link></comment>
<?supplied-pmid 26115986?><pub-id pub-id-type="pmid">26115986</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Viboud</surname><given-names>C</given-names></name>, <name><surname>Bjornstad</surname><given-names>ON</given-names></name>, <name><surname>Smith</surname><given-names>DL</given-names></name>, <name><surname>Simonsen</surname><given-names>L</given-names></name>, <name><surname>Miller</surname><given-names>MA</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Synchrony, waves, and spatial hierarchies in the spread of influenza</article-title>. <source>Science</source>
<volume>312</volume>: <fpage>447</fpage>&#x02013;<lpage>451</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1125237">10.1126/science.1125237</ext-link></comment>
<?supplied-pmid 16574822?><pub-id pub-id-type="pmid">16574822</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>JT</given-names></name>, <name><surname>Riley</surname><given-names>S</given-names></name>, <name><surname>Fraser</surname><given-names>C</given-names></name>, <name><surname>Leung</surname><given-names>GM</given-names></name> (<year>2006</year>) <article-title>Reducing the impact of the next influenza pandemic using household-based public health interventions</article-title>. <source>PLoS Med</source>
<volume>3</volume>: <fpage>e361</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.0030361">10.1371/journal.pmed.0030361</ext-link></comment>
<?supplied-pmid 16881729?><pub-id pub-id-type="pmid">16881729</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Longini</surname><given-names>IM</given-names><suffix>Jr.</suffix></name>, <name><surname>Halloran</surname><given-names>ME</given-names></name>, <name><surname>Nizam</surname><given-names>A</given-names></name>, <name><surname>Yang</surname><given-names>Y</given-names></name> (<year>2004</year>) <article-title>Containing pandemic influenza with antiviral agents</article-title>. <source>Am J Epidemiol</source>
<volume>159</volume>: <fpage>623</fpage>&#x02013;<lpage>633</lpage>. <?supplied-pmid 15033640?><pub-id pub-id-type="pmid">15033640</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Gaglani</surname><given-names>MJ</given-names></name>, <name><surname>Piedra</surname><given-names>PA</given-names></name>, <name><surname>Herschler</surname><given-names>GB</given-names></name>, <name><surname>Griffith</surname><given-names>ME</given-names></name>, <name><surname>Kozinetz</surname><given-names>CA</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000&#x02013;2001 influenza A(H1N1) and B epidemic in healthy children</article-title>. <source>Arch Pediatr Adolesc Med</source>
<volume>158</volume>: <fpage>65</fpage>&#x02013;<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/archpedi.158.1.65">10.1001/archpedi.158.1.65</ext-link></comment>
<?supplied-pmid 14706961?><pub-id pub-id-type="pmid">14706961</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Matrajt</surname><given-names>L</given-names></name>, <name><surname>Halloran</surname><given-names>ME</given-names></name>, <name><surname>Longini</surname><given-names>IM</given-names><suffix>Jr.</suffix></name> (<year>2013</year>) <article-title>Optimal vaccine allocation for the early mitigation of pandemic influenza</article-title>. <source>PLoS Comput Biol</source>
<volume>9</volume>: <fpage>e1002964</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pcbi.1002964">10.1371/journal.pcbi.1002964</ext-link></comment>
<?supplied-pmid 23555207?><pub-id pub-id-type="pmid">23555207</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>House</surname><given-names>T</given-names></name>, <name><surname>Baguelin</surname><given-names>M</given-names></name>, <name><surname>Van Hoek</surname><given-names>AJ</given-names></name>, <name><surname>White</surname><given-names>PJ</given-names></name>, <name><surname>Sadique</surname><given-names>Z</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic</article-title>. <source>Proc Biol Sci</source>
<volume>278</volume>: <fpage>2753</fpage>&#x02013;<lpage>2760</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1098/rspb.2010.2688">10.1098/rspb.2010.2688</ext-link></comment>
<?supplied-pmid 21288945?><pub-id pub-id-type="pmid">21288945</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Ferguson</surname><given-names>NM</given-names></name>, <name><surname>Cummings</surname><given-names>DA</given-names></name>, <name><surname>Fraser</surname><given-names>C</given-names></name>, <name><surname>Cajka</surname><given-names>JC</given-names></name>, <name><surname>Cooley</surname><given-names>PC</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Strategies for mitigating an influenza pandemic</article-title>. <source>Nature</source>
<volume>442</volume>: <fpage>448</fpage>&#x02013;<lpage>452</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature04795">10.1038/nature04795</ext-link></comment>
<?supplied-pmid 16642006?><pub-id pub-id-type="pmid">16642006</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Baguelin</surname><given-names>M</given-names></name>, <name><surname>Flasche</surname><given-names>S</given-names></name>, <name><surname>Camacho</surname><given-names>A</given-names></name>, <name><surname>Demiris</surname><given-names>N</given-names></name>, <name><surname>Miller</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study</article-title>. <source>PLoS Med</source>
<volume>10</volume>: <fpage>e1001527</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.1001527">10.1371/journal.pmed.1001527</ext-link></comment>
<?supplied-pmid 24115913?><pub-id pub-id-type="pmid">24115913</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Opatowski</surname><given-names>L</given-names></name>, <name><surname>Fraser</surname><given-names>C</given-names></name>, <name><surname>Griffin</surname><given-names>J</given-names></name>, <name><surname>de Silva</surname><given-names>E</given-names></name>, <name><surname>Van Kerkhove</surname><given-names>MD</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Transmission characteristics of the 2009 H1N1 influenza pandemic: comparison of 8 Southern hemisphere countries</article-title>. <source>PLoS Pathog</source>
<volume>7</volume>: <fpage>e1002225</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1002225">10.1371/journal.ppat.1002225</ext-link></comment>
<?supplied-pmid 21909272?><pub-id pub-id-type="pmid">21909272</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Kucharski</surname><given-names>AJ</given-names></name>, <name><surname>Kwok</surname><given-names>KO</given-names></name>, <name><surname>Wei</surname><given-names>VW</given-names></name>, <name><surname>Cowling</surname><given-names>BJ</given-names></name>, <name><surname>Read</surname><given-names>JM</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>The contribution of social behaviour to the transmission of influenza A in a human population</article-title>. <source>PLoS Pathog</source>
<volume>10</volume>: <fpage>e1004206</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1004206">10.1371/journal.ppat.1004206</ext-link></comment>
<?supplied-pmid 24968312?><pub-id pub-id-type="pmid">24968312</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Cauchemez</surname><given-names>S</given-names></name>, <name><surname>Bhattarai</surname><given-names>A</given-names></name>, <name><surname>Marchbanks</surname><given-names>TL</given-names></name>, <name><surname>Fagan</surname><given-names>RP</given-names></name>, <name><surname>Ostroff</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>108</volume>: <fpage>2825</fpage>&#x02013;<lpage>2830</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1008895108">10.1073/pnas.1008895108</ext-link></comment>
<?supplied-pmid 21282645?><pub-id pub-id-type="pmid">21282645</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Apolloni</surname><given-names>A</given-names></name>, <name><surname>Poletto</surname><given-names>C</given-names></name>, <name><surname>Colizza</surname><given-names>V</given-names></name> (<year>2013</year>) <article-title>Age-specific contacts and travel patterns in the spatial spread of 2009 H1N1 influenza pandemic</article-title>. <source>BMC Infect Dis</source>
<volume>13</volume>: <fpage>176</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2334-13-176">10.1186/1471-2334-13-176</ext-link></comment>
<?supplied-pmid 23587010?><pub-id pub-id-type="pmid">23587010</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Shaman</surname><given-names>J</given-names></name>, <name><surname>Pitzer</surname><given-names>VE</given-names></name>, <name><surname>Viboud</surname><given-names>C</given-names></name>, <name><surname>Grenfell</surname><given-names>BT</given-names></name>, <name><surname>Lipsitch</surname><given-names>M</given-names></name> (<year>2010</year>) <article-title>Absolute humidity and the seasonal onset of influenza in the continental United States</article-title>. <source>PLoS Biol</source>
<volume>8</volume>: <fpage>e1000316</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.1000316">10.1371/journal.pbio.1000316</ext-link></comment>
<?supplied-pmid 20186267?><pub-id pub-id-type="pmid">20186267</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Baguelin</surname><given-names>M</given-names></name>, <name><surname>Hoek</surname><given-names>AJ</given-names></name>, <name><surname>Jit</surname><given-names>M</given-names></name>, <name><surname>Flasche</surname><given-names>S</given-names></name>, <name><surname>White</surname><given-names>PJ</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation</article-title>. <source>Vaccine</source>
<volume>28</volume>: <fpage>2370</fpage>&#x02013;<lpage>2384</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2010.01.002">10.1016/j.vaccine.2010.01.002</ext-link></comment>
<?supplied-pmid 20096762?><pub-id pub-id-type="pmid">20096762</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Mina</surname><given-names>MJ</given-names></name>, <name><surname>Klugman</surname><given-names>KP</given-names></name> (<year>2014</year>) <article-title>The role of influenza in the severity and transmission of respiratory bacterial disease</article-title>. <source>The Lancet Respiratory medicine</source>
<volume>2</volume>: <fpage>750</fpage>&#x02013;<lpage>763</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S2213-2600(14)70131-6">10.1016/S2213-2600(14)70131-6</ext-link></comment>
<?supplied-pmid 25131494?><pub-id pub-id-type="pmid">25131494</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Short</surname><given-names>K</given-names></name>, <name><surname>Habets</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship?</article-title>
<source>Future Microbiology</source>: <fpage>609</fpage>&#x02013;<lpage>624</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2217/fmb.12.29">10.2217/fmb.12.29</ext-link></comment>
<?supplied-pmid 22568716?><pub-id pub-id-type="pmid">22568716</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>DaPalma</surname><given-names>T</given-names></name>, <name><surname>Doonan</surname><given-names>BP</given-names></name>, <name><surname>Trager</surname><given-names>NM</given-names></name>, <name><surname>Kasman</surname><given-names>LM</given-names></name> (<year>2010</year>) <article-title>A systematic approach to virus-virus interactions</article-title>. <source>Virus research</source>
<volume>149</volume>: <fpage>1</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.virusres.2010.01.002">10.1016/j.virusres.2010.01.002</ext-link></comment>
<?supplied-pmid 20093154?><pub-id pub-id-type="pmid">20093154</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Abramson</surname><given-names>JS</given-names></name>, <name><surname>Mills</surname><given-names>EL</given-names></name>, <name><surname>Giebink</surname><given-names>GS</given-names></name>, <name><surname>Quie</surname><given-names>PG</given-names></name> (<year>1982</year>) <article-title>Depression of monocyte and polymorphonuclear leukocyte oxidative metabolism and bactericidal capacity by influenza A virus</article-title>. <source>Infection and immunity</source>
<volume>35</volume>: <fpage>350</fpage>&#x02013;<lpage>355</lpage>. <?supplied-pmid 7054126?><pub-id pub-id-type="pmid">7054126</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Rynda-Apple</surname><given-names>A</given-names></name>, <name><surname>Robinson</surname><given-names>KM</given-names></name>, <name><surname>Alcorn</surname><given-names>JF</given-names></name> (<year>2015</year>) <article-title>Influenza and bacterial superinfection: Illuminating the immunologic mechanisms of disease</article-title>. <source>Infection and Immunity</source>
<volume>83</volume>: <fpage>3764</fpage>&#x02013;<lpage>3770</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/IAI.00298-15">10.1128/IAI.00298-15</ext-link></comment>
<?supplied-pmid 26216421?><pub-id pub-id-type="pmid">26216421</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Ghoneim</surname><given-names>HE</given-names></name>, <name><surname>Thomas</surname><given-names>PG</given-names></name>, <name><surname>McCullers</surname><given-names>Ja</given-names></name> (<year>2013</year>) <article-title>Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections</article-title>. <source>Journal of immunology (Baltimore, Md: 1950)</source>
<volume>191</volume>: <fpage>1250</fpage>&#x02013;<lpage>1259</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Sen</surname><given-names>GC</given-names></name> (<year>2001</year>) <article-title>Viruses and interferons</article-title>. <source>Annu Rev Microbiol</source>
<volume>55</volume>: <fpage>255</fpage>&#x02013;<lpage>281</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev.micro.55.1.255">10.1146/annurev.micro.55.1.255</ext-link></comment>
<?supplied-pmid 11544356?><pub-id pub-id-type="pmid">11544356</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Loh</surname><given-names>E</given-names></name>, <name><surname>Kugelberg</surname><given-names>E</given-names></name>, <name><surname>Tracy</surname><given-names>A</given-names></name>, <name><surname>Zhang</surname><given-names>Q</given-names></name>, <name><surname>Gollan</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Temperature triggers immune evasion by Neisseria meningitidis</article-title>. <source>Nature</source>
<volume>502</volume>: <fpage>237</fpage>&#x02013;<lpage>240</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature12616">10.1038/nature12616</ext-link></comment>
<?supplied-pmid 24067614?><pub-id pub-id-type="pmid">24067614</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Braun</surname><given-names>LE</given-names></name>, <name><surname>Sutter</surname><given-names>DE</given-names></name>, <name><surname>Eichelberger</surname><given-names>MC</given-names></name>, <name><surname>Pletneva</surname><given-names>L</given-names></name>, <name><surname>Kokai-Kun</surname><given-names>JF</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Co-infection of the cotton rat (Sigmodon hispidus) with Staphylococcus aureus and influenza A virus results in synergistic disease</article-title>. <source>Microbial Pathogenesis</source>
<volume>43</volume>: <fpage>208</fpage>&#x02013;<lpage>216</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.micpath.2007.03.005">10.1016/j.micpath.2007.03.005</ext-link></comment>
<?supplied-pmid 17689046?><pub-id pub-id-type="pmid">17689046</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>AM</given-names></name>, <name><surname>McCullers</surname><given-names>JA</given-names></name> (<year>2014</year>) <article-title>Secondary bacterial infections in influenza virus infection pathogenesis</article-title>. <source>Current topics in microbiology and immunology</source>
<volume>385</volume>: <fpage>327</fpage>&#x02013;<lpage>356</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/82_2014_394">10.1007/82_2014_394</ext-link></comment>
<?supplied-pmid 25027822?><pub-id pub-id-type="pmid">25027822</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Tashiro</surname><given-names>M</given-names></name>, <name><surname>Ciborowski</surname><given-names>P</given-names></name>, <name><surname>Reinacher</surname><given-names>M</given-names></name>, <name><surname>Pulverer</surname><given-names>G</given-names></name>, <name><surname>Klenk</surname><given-names>HD</given-names></name>, <etal>et al</etal> (<year>1987</year>) <article-title>Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity</article-title>. <source>Virology</source>
<volume>157</volume>: <fpage>421</fpage>&#x02013;<lpage>430</lpage>. <?supplied-pmid 3029981?><pub-id pub-id-type="pmid">3029981</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Rohani</surname><given-names>P</given-names></name>, <name><surname>Earn</surname><given-names>DJ</given-names></name>, <name><surname>Finkenst&#x000e4;dt</surname><given-names>B</given-names></name>, <name><surname>Grenfell</surname><given-names>BT</given-names></name> (<year>1998</year>) <article-title>Population dynamic interference among childhood diseases</article-title>. <source>Proceedings Biological sciences / The Royal Society</source>
<volume>265</volume>: <fpage>2033</fpage>&#x02013;<lpage>2041</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Rohani</surname><given-names>P</given-names></name>, <name><surname>Green</surname><given-names>CJ</given-names></name>, <name><surname>Mantilla-Beniers</surname><given-names>NB</given-names></name>, <name><surname>Grenfell</surname><given-names>BT</given-names></name> (<year>2003</year>) <article-title>Ecological interference between fatal diseases</article-title>. <source>Nature</source>
<volume>422</volume>: <fpage>885</fpage>&#x02013;<lpage>888</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature01542">10.1038/nature01542</ext-link></comment>
<?supplied-pmid 12712203?><pub-id pub-id-type="pmid">12712203</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Turner</surname><given-names>RD</given-names></name>, <name><surname>Bothamley</surname><given-names>GH</given-names></name> (<year>2015</year>) <article-title>Cough and the transmission of tuberculosis</article-title>. <source>The Journal of infectious diseases</source>
<volume>211</volume>: <fpage>1367</fpage>&#x02013;<lpage>1372</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/infdis/jiu625">10.1093/infdis/jiu625</ext-link></comment>
<?supplied-pmid 25387581?><pub-id pub-id-type="pmid">25387581</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Cohen</surname><given-names>R</given-names></name>, <name><surname>Varon</surname><given-names>E</given-names></name>, <name><surname>Doit</surname><given-names>C</given-names></name>, <name><surname>Schlemmer</surname><given-names>C</given-names></name>, <name><surname>Romain</surname><given-names>O</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation</article-title>. <source>Vaccine</source>
<volume>33</volume>: <fpage>5118</fpage>&#x02013;<lpage>5126</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2015.08.010">10.1016/j.vaccine.2015.08.010</ext-link></comment>
<?supplied-pmid 26271823?><pub-id pub-id-type="pmid">26271823</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Yildirim</surname><given-names>I</given-names></name>, <name><surname>Little</surname><given-names>BA</given-names></name>, <name><surname>Finkelstein</surname><given-names>J</given-names></name>, <name><surname>Lee</surname><given-names>G</given-names></name>, <name><surname>Hanage</surname><given-names>WP</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Surveillance of pneumococcal colonization and invasive pneumococcal disease reveals shift in prevalent carriage serotypes in Massachusetts' children to relatively low invasiveness</article-title>. <source>Vaccine</source>
<volume>35</volume>: <fpage>4002</fpage>&#x02013;<lpage>4009</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2017.05.077">10.1016/j.vaccine.2017.05.077</ext-link></comment>
<?supplied-pmid 28645717?><pub-id pub-id-type="pmid">28645717</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Barbour</surname><given-names>ML</given-names></name> (<year>1996</year>) <article-title>Conjugate vaccines and the carriage of Haemophilus influenzae type b</article-title>. <source>Emerg Infect Dis</source>
<volume>2</volume>: <fpage>176</fpage>&#x02013;<lpage>182</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid0203.960303">10.3201/eid0203.960303</ext-link></comment>
<?supplied-pmid 8903227?><pub-id pub-id-type="pmid">8903227</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Hammitt</surname><given-names>LL</given-names></name>, <name><surname>Crane</surname><given-names>RJ</given-names></name>, <name><surname>Karani</surname><given-names>A</given-names></name>, <name><surname>Mutuku</surname><given-names>A</given-names></name>, <name><surname>Morpeth</surname><given-names>SC</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study</article-title>. <source>Lancet Glob Health</source>
<volume>4</volume>: <fpage>e185</fpage>&#x02013;<lpage>194</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S2214-109X(15)00316-2">10.1016/S2214-109X(15)00316-2</ext-link></comment>
<?supplied-pmid 26853149?><pub-id pub-id-type="pmid">26853149</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>McCullers</surname><given-names>JA</given-names></name> (<year>2006</year>) <article-title>Insights into the interaction between influenza virus and pneumococcus</article-title>. <source>Clinical microbiology reviews</source>
<volume>19</volume>: <fpage>571</fpage>&#x02013;<lpage>582</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/CMR.00058-05">10.1128/CMR.00058-05</ext-link></comment>
<?supplied-pmid 16847087?><pub-id pub-id-type="pmid">16847087</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>H</given-names></name>, <name><surname>Haber</surname><given-names>M</given-names></name>, <name><surname>Ray</surname><given-names>S</given-names></name>, <name><surname>Farley</surname><given-names>MM</given-names></name>, <name><surname>Panozzo</surname><given-names>CA</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Invasive pneumococcal pneumonia and respiratory virus co-infections</article-title>. <source>Emerg Infect Dis</source>
<volume>18</volume>: <fpage>294</fpage>&#x02013;<lpage>297</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid1802.102025">10.3201/eid1802.102025</ext-link></comment>
<?supplied-pmid 22305270?><pub-id pub-id-type="pmid">22305270</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>PE</given-names></name>, <name><surname>Musher</surname><given-names>DM</given-names></name>, <name><surname>Glezen</surname><given-names>WP</given-names></name>, <name><surname>Rodriguez-Barradas</surname><given-names>MC</given-names></name>, <name><surname>Nahm</surname><given-names>WK</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses</article-title>. <source>Clin Infect Dis</source>
<volume>22</volume>: <fpage>100</fpage>&#x02013;<lpage>106</lpage>. <?supplied-pmid 8824973?><pub-id pub-id-type="pmid">8824973</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Watson</surname><given-names>M</given-names></name>, <name><surname>Gilmour</surname><given-names>R</given-names></name>, <name><surname>Menzies</surname><given-names>R</given-names></name>, <name><surname>Ferson</surname><given-names>M</given-names></name>, <name><surname>McIntyre</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>The association of respiratory viruses, temperature, and other climatic parameters with the incidence of invasive pneumococcal disease in Sydney, Australia</article-title>. <source>Clin Infect Dis</source>
<volume>42</volume>: <fpage>211</fpage>&#x02013;<lpage>215</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1086/498897">10.1086/498897</ext-link></comment>
<?supplied-pmid 16355331?><pub-id pub-id-type="pmid">16355331</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Toschke</surname><given-names>AM</given-names></name>, <name><surname>Arenz</surname><given-names>S</given-names></name>, <name><surname>von Kries</surname><given-names>R</given-names></name>, <name><surname>Puppe</surname><given-names>W</given-names></name>, <name><surname>Weigl</surname><given-names>JA</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>No temporal association between influenza outbreaks and invasive pneumococcal infections</article-title>. <source>Arch Dis Child</source>
<volume>93</volume>: <fpage>218</fpage>&#x02013;<lpage>220</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/adc.2006.098996">10.1136/adc.2006.098996</ext-link></comment>
<?supplied-pmid 17405858?><pub-id pub-id-type="pmid">17405858</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Sun</surname><given-names>K</given-names></name>, <name><surname>Metzger</surname><given-names>DW</given-names></name> (<year>2014</year>) <article-title>Influenza Infection Suppresses NADPH Oxidase-Dependent Phagocytic Bacterial Clearance and Enhances Susceptibility to Secondary Methicillin-Resistant Staphylococcus aureus Infection</article-title>. <source>Journal of immunology (Baltimore, Md: 1950)</source>
<volume>192</volume>: <fpage>3301</fpage>&#x02013;<lpage>3307</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>LN</given-names></name>, <name><surname>Dias</surname><given-names>P</given-names></name>, <name><surname>Han</surname><given-names>D</given-names></name>, <name><surname>Yoon</surname><given-names>S</given-names></name>, <name><surname>Shea</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>A mouse model of lethal synergism between influenza virus and Haemophilus influenzae</article-title>. <source>The American journal of pathology</source>
<volume>176</volume>: <fpage>800</fpage>&#x02013;<lpage>811</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2353/ajpath.2010.090596">10.2353/ajpath.2010.090596</ext-link></comment>
<?supplied-pmid 20042666?><pub-id pub-id-type="pmid">20042666</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Hubert</surname><given-names>B</given-names></name>, <name><surname>Watier</surname><given-names>L</given-names></name>, <name><surname>Garnerin</surname><given-names>P</given-names></name>, <name><surname>Richardson</surname><given-names>S</given-names></name> (<year>1992</year>) <article-title>Meningococcal disease and influenza-like syndrome: a new approach to an old question</article-title>. <source>The Journal of infectious diseases</source>
<volume>166</volume>: <fpage>542</fpage>&#x02013;<lpage>545</lpage>. <?supplied-pmid 1500737?><pub-id pub-id-type="pmid">1500737</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Rameix-Welti</surname><given-names>M-A</given-names></name>, <name><surname>Zarantonelli</surname><given-names>ML</given-names></name>, <name><surname>Giorgini</surname><given-names>D</given-names></name>, <name><surname>Ruckly</surname><given-names>C</given-names></name>, <name><surname>Marasescu</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules</article-title>. <source>Infection and immunity</source>
<volume>77</volume>: <fpage>3588</fpage>&#x02013;<lpage>3595</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/IAI.00155-09">10.1128/IAI.00155-09</ext-link></comment>
<?supplied-pmid 19528219?><pub-id pub-id-type="pmid">19528219</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Walaza</surname><given-names>S</given-names></name>, <name><surname>Tempia</surname><given-names>S</given-names></name>, <name><surname>Dawood</surname><given-names>H</given-names></name>, <name><surname>Variava</surname><given-names>E</given-names></name>, <name><surname>Moyes</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Influenza virus infection is associated with increased risk of death amongst patients hospitalized with confirmed pulmonary tuberculosis in South Africa, 2010&#x02013;2011</article-title>. <source>BMC Infectious Diseases</source>
<volume>15</volume>: <fpage>26</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12879-015-0746-x">10.1186/s12879-015-0746-x</ext-link></comment>
<?supplied-pmid 25623944?><pub-id pub-id-type="pmid">25623944</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Fl&#x000f3;rido</surname><given-names>M</given-names></name>, <name><surname>Grima</surname><given-names>Ma</given-names></name>, <name><surname>Gillis</surname><given-names>CM</given-names></name>, <name><surname>Xia</surname><given-names>Y</given-names></name>, <name><surname>Turner</surname><given-names>SJ</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Influenza A virus infection impairs mycobacteria-specific T cell responses and mycobacterial clearance in the lung during pulmonary coinfection</article-title>. <source>J Immunol</source>
<volume>191</volume>: <fpage>302</fpage>&#x02013;<lpage>311</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4049/jimmunol.1202824">10.4049/jimmunol.1202824</ext-link></comment>
<?supplied-pmid 23698750?><pub-id pub-id-type="pmid">23698750</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Sonoguchi</surname><given-names>T</given-names></name>, <name><surname>Naito</surname><given-names>H</given-names></name>, <name><surname>Hara</surname><given-names>M</given-names></name>, <name><surname>Takeuchi</surname><given-names>Y</given-names></name>, <name><surname>Fukumi</surname><given-names>H</given-names></name> (<year>1985</year>) <article-title>Cross-Subtype Protection in Humans During Sequential, Overlapping, and/or Concurrent Epidemics Caused by H3N2 and H1N1 Influenza Viruses</article-title>. <source>Journal of Infectious Diseases</source>
<volume>151</volume>: <fpage>81</fpage>&#x02013;<lpage>88</lpage>. <?supplied-pmid 3965596?><pub-id pub-id-type="pmid">3965596</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Laurie</surname><given-names>KL</given-names></name>, <name><surname>Guarnaccia</surname><given-names>TA</given-names></name>, <name><surname>Carolan</surname><given-names>LA</given-names></name>, <name><surname>Yan</surname><given-names>AWC</given-names></name>, <name><surname>Aban</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model</article-title>. <source>Journal of Infectious Diseases</source>
<volume>212</volume>: <fpage>1</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">25395186</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Bedford</surname><given-names>T</given-names></name>, <name><surname>Rambaut</surname><given-names>A</given-names></name>, <name><surname>Pascual</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>Canalization of the evolutionary trajectory of the human influenza virus</article-title>. <source>BMC biology</source>
<volume>10</volume>: <fpage>38</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1741-7007-10-38">10.1186/1741-7007-10-38</ext-link></comment>
<?supplied-pmid 22546494?><pub-id pub-id-type="pmid">22546494</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Boni</surname><given-names>MF</given-names></name>, <name><surname>Gog</surname><given-names>JR</given-names></name>, <name><surname>Andreasen</surname><given-names>V</given-names></name>, <name><surname>Christiansen</surname><given-names>FB</given-names></name> (<year>2004</year>) <article-title>Influenza drift and epidemic size: the race between generating and escaping immunity</article-title>. <source>Theoretical population biology</source>
<volume>65</volume>: <fpage>179</fpage>&#x02013;<lpage>191</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tpb.2003.10.002">10.1016/j.tpb.2003.10.002</ext-link></comment>
<?supplied-pmid 14766191?><pub-id pub-id-type="pmid">14766191</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>DJ</given-names></name>, <name><surname>Lapedes</surname><given-names>AS</given-names></name>, <name><surname>de Jong</surname><given-names>JC</given-names></name>, <name><surname>Bestebroer</surname><given-names>TM</given-names></name>, <name><surname>Rimmelzwaan</surname><given-names>GF</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Mapping the antigenic and genetic evolution of influenza virus</article-title>. <source>Science</source>
<volume>305</volume>: <fpage>371</fpage>&#x02013;<lpage>376</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1097211">10.1126/science.1097211</ext-link></comment>
<?supplied-pmid 15218094?><pub-id pub-id-type="pmid">15218094</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Davenport</surname><given-names>FM</given-names></name>, <name><surname>Hennessy</surname><given-names>AV</given-names></name>, <name><surname>Francis</surname><given-names>T</given-names><suffix>Jr.</suffix></name> (<year>1953</year>) <article-title>Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus</article-title>. <source>J Exp Med</source>
<volume>98</volume>: <fpage>641</fpage>&#x02013;<lpage>656</lpage>. <?supplied-pmid 13109114?><pub-id pub-id-type="pmid">13109114</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Gostic</surname><given-names>KM</given-names></name>, <name><surname>Ambrose</surname><given-names>M</given-names></name>, <name><surname>Worobey</surname><given-names>M</given-names></name>, <name><surname>Lloyd-Smith</surname><given-names>JO</given-names></name> (<year>2016</year>) <article-title>Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting</article-title>. <source>Science</source>
<volume>354</volume>: <fpage>722</fpage>&#x02013;<lpage>726</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.aag1322">10.1126/science.aag1322</ext-link></comment>
<?supplied-pmid 27846599?><pub-id pub-id-type="pmid">27846599</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Kucharski</surname><given-names>AJ</given-names></name>, <name><surname>Gog</surname><given-names>JR</given-names></name> (<year>2012</year>) <article-title>The role of social contacts and original antigenic sin in shaping the age pattern of immunity to seasonal influenza</article-title>. <source>PLoS Comput Biol</source>
<volume>8</volume>: <fpage>e1002741</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pcbi.1002741">10.1371/journal.pcbi.1002741</ext-link></comment>
<?supplied-pmid 23133346?><pub-id pub-id-type="pmid">23133346</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Skowronski</surname><given-names>DM</given-names></name>, <name><surname>De Serres</surname><given-names>G</given-names></name>, <name><surname>Crowcroft</surname><given-names>NS</given-names></name>, <name><surname>Janjua</surname><given-names>NZ</given-names></name>, <name><surname>Boulianne</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Association between the 2008&#x02013;09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring&#x02013;Summer 2009: Four Observational Studies from Canada</article-title>. <source>PLoS Med</source>
<volume>7</volume>: <fpage>e1000258</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.1000258">10.1371/journal.pmed.1000258</ext-link></comment>
<?supplied-pmid 20386731?><pub-id pub-id-type="pmid">20386731</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Cowling</surname><given-names>BJ</given-names></name>, <name><surname>Fang</surname><given-names>VJ</given-names></name>, <name><surname>Nishiura</surname><given-names>H</given-names></name>, <name><surname>Chan</surname><given-names>K-H</given-names></name>, <name><surname>Ng</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine</article-title>. <source>Clinical infectious diseases: an official publication of the Infectious Diseases Society of America</source>
<volume>54</volume>: <fpage>1778</fpage>&#x02013;<lpage>1783</lpage>.<pub-id pub-id-type="pmid">22423139</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Casalegno</surname><given-names>JS</given-names></name>, <name><surname>Ottmann</surname><given-names>M</given-names></name>, <name><surname>Duchamp</surname><given-names>MB</given-names></name>, <name><surname>Escuret</surname><given-names>V</given-names></name>, <name><surname>Billaud</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Rhinoviruses delayed the circulation of the pandemic influenza A (H1N1) 2009 virus in France</article-title>. <source>Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases</source>
<volume>16</volume>: <fpage>326</fpage>&#x02013;<lpage>329</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref067"><label>67</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>L</given-names></name>, <name><surname>Chan</surname><given-names>KH</given-names></name>, <name><surname>Suen</surname><given-names>LKP</given-names></name>, <name><surname>Chan</surname><given-names>KP</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Impact of the 2009 H1N1 Pandemic on Age-Specific Epidemic Curves of Other Respiratory Viruses: A Comparison of Pre-Pandemic, Pandemic and Post-Pandemic Periods in a Subtropical City</article-title>. <source>PLoS ONE</source>
<volume>10</volume>: <fpage>e0125447</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0125447">10.1371/journal.pone.0125447</ext-link></comment>
<?supplied-pmid 25928217?><pub-id pub-id-type="pmid">25928217</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref068"><label>68</label><mixed-citation publication-type="journal"><name><surname>Navarro-Mar&#x000ed;</surname><given-names>JM</given-names></name>, <name><surname>P&#x000e9;rez-Ruiz</surname><given-names>M</given-names></name>, <name><surname>Gal&#x000e1;n Montemayor</surname><given-names>JC</given-names></name>, <name><surname>Marcos Maeso</surname><given-names>M&#x000c1;</given-names></name>, <name><surname>Reina</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Circulation of other respiratory viruses and viral co-infection during the 2009 pandemic influenza</article-title>. <source>Enfermedades infecciosas y microbiolog&#x000ed;a cl&#x000ed;nica</source>
<volume>30</volume>
<issue>Suppl 4</issue>: <fpage>25</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">23116789</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref069"><label>69</label><mixed-citation publication-type="journal"><name><surname>Yoshida</surname><given-names>L-M</given-names></name>, <name><surname>Suzuki</surname><given-names>M</given-names></name>, <name><surname>Nguyen</surname><given-names>HA</given-names></name>, <name><surname>Le</surname><given-names>MN</given-names></name>, <name><surname>Dinh Vu</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Respiratory syncytial virus: co-infection and paediatric lower respiratory tract infections</article-title>. <source>The European respiratory journal</source>
<volume>42</volume>: <fpage>461</fpage>&#x02013;<lpage>469</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1183/09031936.00101812">10.1183/09031936.00101812</ext-link></comment>
<?supplied-pmid 23645407?><pub-id pub-id-type="pmid">23645407</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref070"><label>70</label><mixed-citation publication-type="journal"><name><surname>Richard</surname><given-names>N</given-names></name>, <name><surname>Komurian-Pradel</surname><given-names>F</given-names></name>, <name><surname>Javouhey</surname><given-names>E</given-names></name>, <name><surname>Perret</surname><given-names>M</given-names></name>, <name><surname>Rajoharison</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>The Impact of Dual Viral Infection in Infants Admitted to a Pediatric Intensive Care Unit Associated with Severe Bronchiolitis</article-title>. <source>The Pediatric Infectious Disease Journal</source>
<volume>27</volume>: <fpage>213</fpage>&#x02013;<lpage>217</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/INF.0b013e31815b4935">10.1097/INF.0b013e31815b4935</ext-link></comment>
<?supplied-pmid 18277932?><pub-id pub-id-type="pmid">18277932</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref071"><label>71</label><mixed-citation publication-type="journal"><name><surname>Marcos</surname><given-names>MA</given-names></name>, <name><surname>Ram&#x000f3;n</surname><given-names>S</given-names></name>, <name><surname>Ant&#x000f3;n</surname><given-names>A</given-names></name>, <name><surname>Martinez</surname><given-names>E</given-names></name>, <name><surname>Vilella</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1</article-title>. <source>The European respiratory journal</source>
<volume>38</volume>: <fpage>739</fpage>&#x02013;<lpage>742</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1183/09031936.00168610">10.1183/09031936.00168610</ext-link></comment>
<?supplied-pmid 21885422?><pub-id pub-id-type="pmid">21885422</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref072"><label>72</label><mixed-citation publication-type="journal"><name><surname>Schnepf</surname><given-names>N</given-names></name>, <name><surname>Resche-Rigon</surname><given-names>M</given-names></name>, <name><surname>Chaillon</surname><given-names>A</given-names></name>, <name><surname>Scemla</surname><given-names>A</given-names></name>, <name><surname>Gras</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>High burden of non-influenza viruses in influenza-like illness in the early weeks of H1N1v epidemic in France</article-title>. <source>PLoS ONE</source>
<volume>6</volume>: <fpage>e23514</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0023514">10.1371/journal.pone.0023514</ext-link></comment>
<?supplied-pmid 21858150?><pub-id pub-id-type="pmid">21858150</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref073"><label>73</label><mixed-citation publication-type="journal"><name><surname>Rhedin</surname><given-names>S</given-names></name>, <name><surname>Hamrin</surname><given-names>J</given-names></name>, <name><surname>Naucler</surname><given-names>P</given-names></name>, <name><surname>Bennet</surname><given-names>R</given-names></name>, <name><surname>Rotz&#x000e9;n-&#x000d6;stlund</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Respiratory Viruses in Hospitalized Children with Influenza-Like Illness during the H1n1 2009 Pandemic in Sweden</article-title>. <source>PLoS ONE</source>
<volume>7</volume>: <fpage>e51491</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0051491">10.1371/journal.pone.0051491</ext-link></comment>
<?supplied-pmid 23272110?><pub-id pub-id-type="pmid">23272110</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref074"><label>74</label><mixed-citation publication-type="journal"><name><surname>Esper</surname><given-names>FP</given-names></name>, <name><surname>Spahlinger</surname><given-names>T</given-names></name>, <name><surname>Zhou</surname><given-names>L</given-names></name> (<year>2011</year>) <article-title>Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease</article-title>. <source>The Journal of infection</source>
<volume>63</volume>: <fpage>260</fpage>&#x02013;<lpage>266</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jinf.2011.04.004">10.1016/j.jinf.2011.04.004</ext-link></comment>
<?supplied-pmid 21546090?><pub-id pub-id-type="pmid">21546090</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref075"><label>75</label><mixed-citation publication-type="journal"><name><surname>Anestad</surname><given-names>G</given-names></name> (<year>1982</year>) <article-title>Interference between outbreaks of respiratory syncytial virus and influenza virus infection</article-title>. <source>Lancet (London, England)</source>
<volume>1</volume>: <fpage>502</fpage>.</mixed-citation></ref><ref id="ppat.1006770.ref076"><label>76</label><mixed-citation publication-type="journal"><name><surname>Glezen</surname><given-names>WP</given-names></name>, <name><surname>Paredes</surname><given-names>A</given-names></name>, <name><surname>Taber</surname><given-names>LH</given-names></name> (<year>1980</year>) <article-title>Influenza in children. Relationship to other respiratory agents</article-title>. <source>JAMA</source>
<volume>243</volume>: <fpage>1345</fpage>&#x02013;<lpage>1349</lpage>. <?supplied-pmid 6244421?><pub-id pub-id-type="pmid">6244421</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref077"><label>77</label><mixed-citation publication-type="journal"><name><surname>Casalegno</surname><given-names>JS</given-names></name>, <name><surname>Ottmann</surname><given-names>M</given-names></name>, <name><surname>Bouscambert-Duchamp</surname><given-names>M</given-names></name>, <name><surname>Valette</surname><given-names>M</given-names></name>, <name><surname>Morfin</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Impact of the 2009 influenza A(H1N1) pandemic wave on the pattern of hibernal respiratory virus epidemics, France, 2009</article-title>. <source>Euro surveillance: bulletin Europ&#x000e9;en sur les maladies transmissibles = European communicable disease bulletin</source>
<volume>15</volume>: <fpage>1</fpage>.</mixed-citation></ref><ref id="ppat.1006770.ref078"><label>78</label><mixed-citation publication-type="journal"><name><surname>Mak</surname><given-names>GC</given-names></name>, <name><surname>Wong</surname><given-names>AH</given-names></name>, <name><surname>Ho</surname><given-names>WYY</given-names></name>, <name><surname>Lim</surname><given-names>W</given-names></name> (<year>2012</year>) <article-title>The impact of pandemic influenza A (H1N1) 2009 on the circulation of respiratory viruses 2009&#x02013;2011</article-title>. <source>Influenza and other respiratory viruses</source>
<volume>6</volume>: <fpage>e6</fpage>&#x02013;<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1750-2659.2011.00323.x">10.1111/j.1750-2659.2011.00323.x</ext-link></comment>
<?supplied-pmid 22212717?><pub-id pub-id-type="pmid">22212717</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref079"><label>79</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Ren</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>W</given-names></name>, <name><surname>Vernet</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Influenza A/H1N1 2009 pandemic and respiratory virus infections, Beijing, 2009&#x02013;2010</article-title>. <source>PLoS ONE</source>
<volume>7</volume>: <fpage>e45807</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0045807">10.1371/journal.pone.0045807</ext-link></comment>
<?supplied-pmid 23029253?><pub-id pub-id-type="pmid">23029253</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref080"><label>80</label><mixed-citation publication-type="journal"><name><surname>Aberle</surname><given-names>JHMA</given-names></name>, <name><surname>Stephan</surname><given-names>W. MD*</given-names></name>; <name><surname>Pracher</surname><given-names>Elisabeth MD&#x02021;</given-names></name>; <name><surname>Hutter</surname><given-names>Hans-Peter MD&#x02020;</given-names></name>; <name><surname>Kundi</surname><given-names>Michael MD&#x02020;</given-names></name>; <name><surname>Popow-Kraupp</surname><given-names>Therese MD*</given-names></name> (<year>2005</year>) <article-title>Single Versus Dual Respiratory Virus Infections in Hospitali&#x02026;: The Pediatric Infectious Disease Journal</article-title>. <source>The pediatric infectious disease journal</source>
<volume>24</volume>.</mixed-citation></ref><ref id="ppat.1006770.ref081"><label>81</label><mixed-citation publication-type="journal"><name><surname>Goka</surname><given-names>E</given-names></name>, <name><surname>Vallely</surname><given-names>P</given-names></name>, <name><surname>Mutton</surname><given-names>K</given-names></name>, <name><surname>Klapper</surname><given-names>P</given-names></name> (<year>2013</year>) <article-title>Influenza A viruses dual and multiple infections with other respiratory viruses and risk of hospitalisation and mortality</article-title>. <source>Influenza Other Respir Viruses</source>
<volume>7</volume>: <fpage>1079</fpage>&#x02013;<lpage>1087</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/irv.12020">10.1111/irv.12020</ext-link></comment>
<?supplied-pmid 23078095?><pub-id pub-id-type="pmid">23078095</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref082"><label>82</label><mixed-citation publication-type="journal"><name><surname>Walzl</surname><given-names>G</given-names></name>, <name><surname>Tafuro</surname><given-names>S</given-names></name>, <name><surname>Moss</surname><given-names>P</given-names></name>, <name><surname>Openshaw</surname><given-names>PJ</given-names></name>, <name><surname>Hussell</surname><given-names>T</given-names></name> (<year>2000</year>) <article-title>Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology</article-title>. <source>The Journal of experimental medicine</source>
<volume>192</volume>: <fpage>1317</fpage>&#x02013;<lpage>1326</lpage>. <?supplied-pmid 11067880?><pub-id pub-id-type="pmid">11067880</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref083"><label>83</label><mixed-citation publication-type="journal"><name><surname>Pascalis</surname><given-names>H</given-names></name>, <name><surname>Temmam</surname><given-names>S</given-names></name>, <name><surname>Turpin</surname><given-names>M</given-names></name>, <name><surname>Rollot</surname><given-names>O</given-names></name>, <name><surname>Flahault</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Intense Co-Circulation of Non-Influenza Respiratory Viruses during the First Wave of Pandemic Influenza pH1N1/2009: A Cohort Study in Reunion Island</article-title>. <source>PLoS ONE</source>
<volume>7</volume>: <fpage>e44755</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0044755">10.1371/journal.pone.0044755</ext-link></comment>
<?supplied-pmid 22984554?><pub-id pub-id-type="pmid">22984554</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref084"><label>84</label><mixed-citation publication-type="journal"><name><surname>Greer</surname><given-names>RM</given-names></name>, <name><surname>McErlean</surname><given-names>P</given-names></name>, <name><surname>Arden</surname><given-names>KE</given-names></name>, <name><surname>Faux</surname><given-names>CE</given-names></name>, <name><surname>Nitsche</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Do rhinoviruses reduce the probability of viral co-detection during acute respiratory tract infections?</article-title>
<source>Journal of Clinical Virology</source>
<volume>45</volume>: <fpage>10</fpage>&#x02013;<lpage>15</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jcv.2009.03.008">10.1016/j.jcv.2009.03.008</ext-link></comment>
<?supplied-pmid 19376742?><pub-id pub-id-type="pmid">19376742</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref085"><label>85</label><mixed-citation publication-type="journal"><name><surname>Murphy</surname><given-names>BR</given-names></name>, <name><surname>Richman</surname><given-names>DD</given-names></name>, <name><surname>Chalhub</surname><given-names>EG</given-names></name>, <name><surname>Uhlendorf</surname><given-names>CP</given-names></name>, <name><surname>Baron</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>1975</year>) <article-title>Failure of attenuated temperature-sensitive influenza A (H3N2) virus to induce heterologous interference in humans to parainfluenza type 1 virus</article-title>. <source>Infection and immunity</source>
<volume>12</volume>: <fpage>62</fpage>&#x02013;<lpage>68</lpage>. <?supplied-pmid 166929?><pub-id pub-id-type="pmid">166929</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref086"><label>86</label><mixed-citation publication-type="journal"><name><surname>Nisii</surname><given-names>C</given-names></name>, <name><surname>Meschi</surname><given-names>S</given-names></name>, <name><surname>Selleri</surname><given-names>M</given-names></name>, <name><surname>Bordi</surname><given-names>L</given-names></name>, <name><surname>Castilletti</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Frequency of detection of upper respiratory tract viruses in patients tested for pandemic H1N1/09 viral infection</article-title>. <source>Journal of clinical microbiology</source>
<volume>48</volume>: <fpage>3383</fpage>&#x02013;<lpage>3385</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JCM.01179-10">10.1128/JCM.01179-10</ext-link></comment>
<?supplied-pmid 20592147?><pub-id pub-id-type="pmid">20592147</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref087"><label>87</label><mixed-citation publication-type="journal"><name><surname>Goka</surname><given-names>EA</given-names></name>, <name><surname>Vallely</surname><given-names>PJ</given-names></name>, <name><surname>Mutton</surname><given-names>KJ</given-names></name>, <name><surname>Klapper</surname><given-names>PE</given-names></name> (<year>2014</year>) <article-title>Single and multiple respiratory virus infections and severity of respiratory disease: a systematic review</article-title>. <source>Paediatric respiratory reviews</source>
<volume>15</volume>: <fpage>363</fpage>&#x02013;<lpage>370</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.prrv.2013.11.001">10.1016/j.prrv.2013.11.001</ext-link></comment>
<?supplied-pmid 24361079?><pub-id pub-id-type="pmid">24361079</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref088"><label>88</label><mixed-citation publication-type="journal"><name><surname>Nicoli</surname><given-names>EJ</given-names></name>, <name><surname>Trotter</surname><given-names>CL</given-names></name>, <name><surname>Turner</surname><given-names>KME</given-names></name>, <name><surname>Colijn</surname><given-names>C</given-names></name>, <name><surname>Waight</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UK</article-title>. <source>The Journal of infection</source>
<volume>66</volume>: <fpage>512</fpage>&#x02013;<lpage>520</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jinf.2013.02.007">10.1016/j.jinf.2013.02.007</ext-link></comment>
<?supplied-pmid 23473714?><pub-id pub-id-type="pmid">23473714</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref089"><label>89</label><mixed-citation publication-type="journal"><name><surname>Weinberger</surname><given-names>DM</given-names></name>, <name><surname>Harboe</surname><given-names>ZB</given-names></name>, <name><surname>Krause</surname><given-names>TG</given-names></name>, <name><surname>Miller</surname><given-names>M</given-names></name>, <name><surname>Konradsen</surname><given-names>HB</given-names></name> (<year>2013</year>) <article-title>Serotype-specific effect of influenza on adult invasive pneumococcal pneumonia</article-title>. <source>Journal of Infectious Diseases</source>: <fpage>1</fpage>&#x02013;<lpage>22</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref090"><label>90</label><mixed-citation publication-type="journal"><name><surname>Gilca</surname><given-names>R</given-names></name>, <name><surname>De Serres</surname><given-names>G</given-names></name>, <name><surname>Skowronski</surname><given-names>D</given-names></name>, <name><surname>Boivin</surname><given-names>G</given-names></name>, <name><surname>Buckeridge</surname><given-names>DL</given-names></name> (<year>2009</year>) <article-title>The need for validation of statistical methods for estimating respiratory virus-attributable hospitalization</article-title>. <source>Am J Epidemiol</source>
<volume>170</volume>: <fpage>925</fpage>&#x02013;<lpage>936</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/aje/kwp195">10.1093/aje/kwp195</ext-link></comment>
<?supplied-pmid 19679751?><pub-id pub-id-type="pmid">19679751</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref091"><label>91</label><mixed-citation publication-type="journal"><name><surname>Hendriks</surname><given-names>W</given-names></name>, <name><surname>Boshuizen</surname><given-names>H</given-names></name>, <name><surname>Dekkers</surname><given-names>A</given-names></name>, <name><surname>Knol</surname><given-names>M</given-names></name>, <name><surname>Donker</surname><given-names>GA</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Temporal cross-correlation between influenza-like illnesses and invasive pneumococcal disease in The Netherlands</article-title>. <source>Influenza Other Respir Viruses</source>
<volume>11</volume>: <fpage>130</fpage>&#x02013;<lpage>137</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/irv.12442">10.1111/irv.12442</ext-link></comment>
<?supplied-pmid 27943624?><pub-id pub-id-type="pmid">27943624</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref092"><label>92</label><mixed-citation publication-type="journal"><name><surname>Upshur</surname><given-names>RE</given-names></name>, <name><surname>Moineddin</surname><given-names>R</given-names></name>, <name><surname>Crighton</surname><given-names>EJ</given-names></name>, <name><surname>Mamdani</surname><given-names>M</given-names></name> (<year>2006</year>) <article-title>Interactions of viral pathogens on hospital admissions for pneumonia, croup and chronic obstructive pulmonary diseases: results of a multivariate time-series analysis</article-title>. <source>Epidemiol Infect</source>
<volume>134</volume>: <fpage>1174</fpage>&#x02013;<lpage>1178</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1017/S0950268806006236">10.1017/S0950268806006236</ext-link></comment>
<?supplied-pmid 16623988?><pub-id pub-id-type="pmid">16623988</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref093"><label>93</label><mixed-citation publication-type="book"><name><surname>Randuineau</surname><given-names>B</given-names></name> (<year>2015</year>) <source>Interactions between pathogens: what are the impacts on public health</source>: <publisher-name>Universite Pierre et Marie Curie</publisher-name>.</mixed-citation></ref><ref id="ppat.1006770.ref094"><label>94</label><mixed-citation publication-type="journal"><name><surname>Domenech de Celles</surname><given-names>M</given-names></name>, <name><surname>Arduin</surname><given-names>H</given-names></name>, <name><surname>Varon</surname><given-names>E</given-names></name>, <name><surname>Souty</surname><given-names>C</given-names></name>, <name><surname>Boelle</surname><given-names>PY</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Characterizing and Comparing the Seasonality of Influenza-Like Illnesses and Invasive Pneumococcal Diseases Using Seasonal Waveforms</article-title>. <source>Am J Epidemiol</source>.</mixed-citation></ref><ref id="ppat.1006770.ref095"><label>95</label><mixed-citation publication-type="journal"><name><surname>Boianelli</surname><given-names>A</given-names></name>, <name><surname>Nguyen</surname><given-names>VK</given-names></name>, <name><surname>Ebensen</surname><given-names>T</given-names></name>, <name><surname>Schulze</surname><given-names>K</given-names></name>, <name><surname>Wilk</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Modelling Influenza Virus Infection: A Roadmap for Influenza Research</article-title>. <source>Viruses</source>
<volume>7</volume>: <fpage>5274</fpage>&#x02013;<lpage>5304</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/v7102875">10.3390/v7102875</ext-link></comment>
<?supplied-pmid 26473911?><pub-id pub-id-type="pmid">26473911</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref096"><label>96</label><mixed-citation publication-type="journal"><name><surname>Hodgson</surname><given-names>D</given-names></name>, <name><surname>Baguelin</surname><given-names>M</given-names></name>, <name><surname>van Leeuwen</surname><given-names>E</given-names></name>, <name><surname>Panovska-Griffiths</surname><given-names>J</given-names></name>, <name><surname>Ramsay</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis</article-title>. <source>Lancet Public Health</source>
<volume>2</volume>: <fpage>e74</fpage>&#x02013;<lpage>e81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S2468-2667(16)30044-5">10.1016/S2468-2667(16)30044-5</ext-link></comment>
<?supplied-pmid 28299371?><pub-id pub-id-type="pmid">28299371</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref097"><label>97</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>AM</given-names></name>, <name><surname>Adler</surname><given-names>FR</given-names></name>, <name><surname>Ribeiro</surname><given-names>RM</given-names></name>, <name><surname>Gutenkunst</surname><given-names>RN</given-names></name>, <name><surname>McAuley</surname><given-names>JL</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae</article-title>. <source>PLoS Pathog</source>
<volume>9</volume>: <fpage>e1003238</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1003238">10.1371/journal.ppat.1003238</ext-link></comment>
<?supplied-pmid 23555251?><pub-id pub-id-type="pmid">23555251</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref098"><label>98</label><mixed-citation publication-type="journal"><name><surname>Shrestha</surname><given-names>S</given-names></name>, <name><surname>Foxman</surname><given-names>B</given-names></name>, <name><surname>Dawid</surname><given-names>S</given-names></name>, <name><surname>Aiello</surname><given-names>AE</given-names></name>, <name><surname>Davis</surname><given-names>BM</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Time and dose-dependent risk of pneumococcal pneumonia following influenza: a model for within-host interaction between influenza and Streptococcus pneumoniae</article-title>. <source>Journal of the Royal Society, Interface / the Royal Society</source>
<volume>10</volume>: <fpage>20130233</fpage>.</mixed-citation></ref><ref id="ppat.1006770.ref099"><label>99</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>AM</given-names></name>, <name><surname>Smith</surname><given-names>AP</given-names></name> (<year>2016</year>) <article-title>A Critical, Nonlinear Threshold Dictates Bacterial Invasion and Initial Kinetics During Influenza</article-title>. <source>Sci Rep</source>
<volume>6</volume>: <fpage>38703</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/srep38703">10.1038/srep38703</ext-link></comment>
<?supplied-pmid 27974820?><pub-id pub-id-type="pmid">27974820</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref100"><label>100</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>AM</given-names></name> (<year>2017</year>) <article-title>Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza</article-title>. <source>J Pharmacokinet Pharmacodyn</source>
<volume>44</volume>: <fpage>81</fpage>&#x02013;<lpage>93</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10928-016-9494-9">10.1007/s10928-016-9494-9</ext-link></comment>
<?supplied-pmid 27679506?><pub-id pub-id-type="pmid">27679506</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref101"><label>101</label><mixed-citation publication-type="journal"><name><surname>Boianelli</surname><given-names>A</given-names></name>, <name><surname>Sharma-Chawla</surname><given-names>N</given-names></name>, <name><surname>Bruder</surname><given-names>D</given-names></name>, <name><surname>Hernandez-Vargas</surname><given-names>EA</given-names></name> (<year>2016</year>) <article-title>Oseltamivir PK/PD Modelling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection</article-title>. <source>Front Cell Infect Microbiol</source>
<volume>6</volume>: <fpage>60</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcimb.2016.00060">10.3389/fcimb.2016.00060</ext-link></comment>
<?supplied-pmid 27379214?><pub-id pub-id-type="pmid">27379214</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref102"><label>102</label><mixed-citation publication-type="journal"><name><surname>Opatowski</surname><given-names>L</given-names></name>, <name><surname>Varon</surname><given-names>E</given-names></name>, <name><surname>Dupont</surname><given-names>C</given-names></name>, <name><surname>Temime</surname><given-names>L</given-names></name>, <name><surname>van der Werf</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: insights from statistical and mathematical models</article-title>. <source>Proceedings Biological sciences / The Royal Society</source>
<volume>280</volume>: <fpage>20130519</fpage>.</mixed-citation></ref><ref id="ppat.1006770.ref103"><label>103</label><mixed-citation publication-type="journal"><name><surname>Shrestha</surname><given-names>S</given-names></name>, <name><surname>Foxman</surname><given-names>B</given-names></name>, <name><surname>Berus</surname><given-names>J</given-names></name>, <name><surname>van Panhuis</surname><given-names>WG</given-names></name>, <name><surname>Steiner</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>The role of influenza in the epidemiology of pneumonia</article-title>. <source>Scientific Reports</source>
<volume>5</volume>: <fpage>15314</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/srep15314">10.1038/srep15314</ext-link></comment>
<?supplied-pmid 26486591?><pub-id pub-id-type="pmid">26486591</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref104"><label>104</label><mixed-citation publication-type="journal"><name><surname>Chien</surname><given-names>YW</given-names></name>, <name><surname>Levin</surname><given-names>BR</given-names></name>, <name><surname>Klugman</surname><given-names>KP</given-names></name> (<year>2012</year>) <article-title>The anticipated severity of a "1918-like" influenza pandemic in contemporary populations: The contribution of antibacterial interventions</article-title>. <source>PLoS ONE</source>
<volume>7</volume>.</mixed-citation></ref><ref id="ppat.1006770.ref105"><label>105</label><mixed-citation publication-type="journal"><name><surname>Crowe</surname><given-names>S</given-names></name>, <name><surname>Utley</surname><given-names>M</given-names></name>, <name><surname>Walker</surname><given-names>G</given-names></name>, <name><surname>Grove</surname><given-names>P</given-names></name>, <name><surname>Pagel</surname><given-names>C</given-names></name> (<year>2011</year>) <article-title>A model to evaluate mass vaccination against pneumococcus as a countermeasure against pandemic influenza</article-title>. <source>Vaccine</source>
<volume>29</volume>: <fpage>5065</fpage>&#x02013;<lpage>5077</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2011.04.034">10.1016/j.vaccine.2011.04.034</ext-link></comment>
<?supplied-pmid 21539879?><pub-id pub-id-type="pmid">21539879</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref106"><label>106</label><mixed-citation publication-type="journal"><name><surname>Handel</surname><given-names>A</given-names></name>, <name><surname>Longini</surname><given-names>IM</given-names></name>, <name><surname>Antia</surname><given-names>R</given-names></name> (<year>2009</year>) <article-title>Intervention strategies for an influenza pandemic taking into account secondary bacterial infections</article-title>. <source>Epidemics</source>
<volume>1</volume>: <fpage>185</fpage>&#x02013;<lpage>195</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.epidem.2009.09.001">10.1016/j.epidem.2009.09.001</ext-link></comment>
<?supplied-pmid 20161493?><pub-id pub-id-type="pmid">20161493</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref107"><label>107</label><mixed-citation publication-type="journal"><name><surname>Shrestha</surname><given-names>S</given-names></name>, <name><surname>Foxman</surname><given-names>B</given-names></name>, <name><surname>Weinberger</surname><given-names>DM</given-names></name>, <name><surname>Steiner</surname><given-names>C</given-names></name>, <name><surname>Viboud</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Identifying the Interaction Between Influenza and Pneumococcal Pneumonia Using Incidence Data</article-title>. <source>Science Translational Medicine</source>
<volume>5</volume>: <fpage>191ra184</fpage>&#x02013;<lpage>191ra184</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref108"><label>108</label><mixed-citation publication-type="journal"><name><surname>Arduin</surname><given-names>H</given-names></name>, <name><surname>Domenech de Celles</surname><given-names>M</given-names></name>, <name><surname>Guillemot</surname><given-names>D</given-names></name>, <name><surname>Watier</surname><given-names>L</given-names></name>, <name><surname>Opatowski</surname><given-names>L</given-names></name> (<year>2017</year>) <article-title>An agent-based model simulation of influenza interactions at the host level: insight into the influenza-related burden of pneumococcal infections</article-title>. <source>BMC Infect Dis</source>
<volume>17</volume>: <fpage>382</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12879-017-2464-z">10.1186/s12879-017-2464-z</ext-link></comment>
<?supplied-pmid 28577533?><pub-id pub-id-type="pmid">28577533</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref109"><label>109</label><mixed-citation publication-type="journal"><name><surname>Yan</surname><given-names>AWC</given-names></name>, <name><surname>Cao</surname><given-names>P</given-names></name>, <name><surname>Heffernan</surname><given-names>JM</given-names></name>, <name><surname>McVernon</surname><given-names>J</given-names></name>, <name><surname>Quinn</surname><given-names>KM</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host</article-title>. <source>Journal of Theoretical Biology</source>
<volume>413</volume>: <fpage>34</fpage>&#x02013;<lpage>49</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jtbi.2016.11.008">10.1016/j.jtbi.2016.11.008</ext-link></comment>
<?supplied-pmid 27856216?><pub-id pub-id-type="pmid">27856216</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref110"><label>110</label><mixed-citation publication-type="journal"><name><surname>Cao</surname><given-names>P</given-names></name>, <name><surname>Yan</surname><given-names>AWC</given-names></name>, <name><surname>Heffernan</surname><given-names>JM</given-names></name>, <name><surname>Petrie</surname><given-names>S</given-names></name>, <name><surname>Moss</surname><given-names>RG</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies</article-title>. <source>PLoS Comput Biol</source>
<volume>11</volume>: <fpage>e1004334</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pcbi.1004334">10.1371/journal.pcbi.1004334</ext-link></comment>
<?supplied-pmid 26284917?><pub-id pub-id-type="pmid">26284917</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref111"><label>111</label><mixed-citation publication-type="journal"><name><surname>Zakikhany</surname><given-names>K</given-names></name>, <name><surname>Degail</surname><given-names>MA</given-names></name>, <name><surname>Lamagni</surname><given-names>T</given-names></name>, <name><surname>Waight</surname><given-names>P</given-names></name>, <name><surname>Guy</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Increase in invasive streptococcus pyogenes and streptococcus pneumoniae infections in England, December 2010 to January 2011</article-title>. <source>Eurosurveillance</source>
<volume>16</volume>: <fpage>1</fpage>&#x02013;<lpage>4</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref112"><label>112</label><mixed-citation publication-type="journal"><name><surname>Pinky</surname><given-names>L</given-names></name>, <name><surname>Dobrovolny</surname><given-names>HM</given-names></name> (<year>2016</year>) <article-title>Coinfections of the Respiratory Tract: Viral Competition for Resources</article-title>. <source>PLoS ONE</source>
<volume>11</volume>: <fpage>e0155589</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0155589">10.1371/journal.pone.0155589</ext-link></comment>
<?supplied-pmid 27196110?><pub-id pub-id-type="pmid">27196110</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref113"><label>113</label><mixed-citation publication-type="journal"><name><surname>Kucharski</surname><given-names>AJ</given-names></name>, <name><surname>Andreasen</surname><given-names>V</given-names></name>, <name><surname>Gog</surname><given-names>JR</given-names></name> (<year>2016</year>) <article-title>Capturing the dynamics of pathogens with many strains</article-title>. <source>J Math Biol</source>
<volume>72</volume>: <fpage>1</fpage>&#x02013;<lpage>24</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00285-015-0873-4">10.1007/s00285-015-0873-4</ext-link></comment>
<?supplied-pmid 25800537?><pub-id pub-id-type="pmid">25800537</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref114"><label>114</label><mixed-citation publication-type="journal"><name><surname>Ferguson</surname><given-names>NM</given-names></name>, <name><surname>Galvani</surname><given-names>AP</given-names></name>, <name><surname>Bush</surname><given-names>RM</given-names></name> (<year>2003</year>) <article-title>Ecological and immunological determinants of influenza evolution</article-title>. <source>Nature</source>
<volume>422</volume>: <fpage>428</fpage>&#x02013;<lpage>433</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature01509">10.1038/nature01509</ext-link></comment>
<?supplied-pmid 12660783?><pub-id pub-id-type="pmid">12660783</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref115"><label>115</label><mixed-citation publication-type="journal"><name><surname>ACKERMAN</surname><given-names>E</given-names></name>, <name><surname>LONGINI</surname><given-names>IM</given-names></name>, <name><surname>SEAHOLM</surname><given-names>SK</given-names></name>, <name><surname>HEDIN</surname><given-names>&#x000c5;S</given-names></name> (<year>1990</year>) <article-title>Simulation of Mechanisms of Viral Interference in Influenza</article-title>. <source>International Journal of Epidemiology</source>
<volume>19</volume>: <fpage>444</fpage>&#x02013;<lpage>454</lpage>. <?supplied-pmid 2376460?><pub-id pub-id-type="pmid">2376460</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref116"><label>116</label><mixed-citation publication-type="journal"><name><surname>Merler</surname><given-names>S</given-names></name>, <name><surname>Poletti</surname><given-names>P</given-names></name>, <name><surname>Ajelli</surname><given-names>M</given-names></name>, <name><surname>Caprile</surname><given-names>B</given-names></name>, <name><surname>Manfredi</surname><given-names>P</given-names></name> (<year>2008</year>) <article-title>Coinfection can trigger multiple pandemic waves</article-title>. <source>Journal of Theoretical Biology</source>
<volume>254</volume>: <fpage>499</fpage>&#x02013;<lpage>507</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jtbi.2008.06.004">10.1016/j.jtbi.2008.06.004</ext-link></comment>
<?supplied-pmid 18606170?><pub-id pub-id-type="pmid">18606170</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref117"><label>117</label><mixed-citation publication-type="journal"><name><surname>Velasco-Hern&#x000e1;ndez</surname><given-names>JX</given-names></name>, <name><surname>N&#x000fa;&#x000f1;ez-L&#x000f3;pez</surname><given-names>M</given-names></name>, <name><surname>Comas-Garc&#x000ed;a</surname><given-names>A</given-names></name>, <name><surname>Cherpitel</surname><given-names>DEN</given-names></name>, <name><surname>Ocampo</surname><given-names>MC</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Superinfection between Influenza and RSV Alternating Patterns in San Luis Potos&#x000ed; State, M&#x000e9;xico</article-title>. <source>PLoS ONE</source>
<volume>10</volume>: <fpage>e0115674</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0115674">10.1371/journal.pone.0115674</ext-link></comment>
<?supplied-pmid 25803450?><pub-id pub-id-type="pmid">25803450</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref118"><label>118</label><mixed-citation publication-type="journal"><name><surname>Araz</surname><given-names>OM</given-names></name>, <name><surname>Galvani</surname><given-names>A</given-names></name>, <name><surname>Meyers</surname><given-names>LA</given-names></name> (<year>2012</year>) <article-title>Geographic prioritization of distributing pandemic influenza vaccines</article-title>. <source>Health Care Management Science</source>
<volume>15</volume>: <fpage>175</fpage>&#x02013;<lpage>187</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10729-012-9199-6">10.1007/s10729-012-9199-6</ext-link></comment>
<?supplied-pmid 22618029?><pub-id pub-id-type="pmid">22618029</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref119"><label>119</label><mixed-citation publication-type="journal"><name><surname>Sa</surname><given-names>Madhi</given-names></name>, <name><surname>Klugman</surname><given-names>KP</given-names></name> (<year>2004</year>) <article-title>A role for Streptococcus pneumoniae in virus-associated pneumonia</article-title>. <source>Nature medicine</source>
<volume>10</volume>: <fpage>811</fpage>&#x02013;<lpage>813</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nm1077">10.1038/nm1077</ext-link></comment>
<?supplied-pmid 15247911?><pub-id pub-id-type="pmid">15247911</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref120"><label>120</label><mixed-citation publication-type="journal"><name><surname>Simonsen</surname><given-names>L</given-names></name>, <name><surname>Taylor</surname><given-names>RJ</given-names></name>, <name><surname>Young-Xu</surname><given-names>Y</given-names></name>, <name><surname>Haber</surname><given-names>M</given-names></name>, <name><surname>May</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States</article-title>. <source>MBio</source>
<volume>2</volume>: <fpage>e00309</fpage>&#x02013;<lpage>00310</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/mBio.00309-10">10.1128/mBio.00309-10</ext-link></comment>
<?supplied-pmid 21264063?><pub-id pub-id-type="pmid">21264063</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref121"><label>121</label><mixed-citation publication-type="journal"><name><surname>Tsai</surname><given-names>Y-H</given-names></name>, <name><surname>Hsieh</surname><given-names>M-J</given-names></name>, <name><surname>Chang</surname><given-names>C-J</given-names></name>, <name><surname>Wen</surname><given-names>Y-W</given-names></name>, <name><surname>Hu</surname><given-names>H-C</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old&#x02014;Taiwan's PPV vaccination program</article-title>. <source>Vaccine</source>
<volume>33</volume>: <fpage>2897</fpage>&#x02013;<lpage>2902</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2015.04.068">10.1016/j.vaccine.2015.04.068</ext-link></comment>
<?supplied-pmid 25936662?><pub-id pub-id-type="pmid">25936662</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref122"><label>122</label><mixed-citation publication-type="journal"><name><surname>Fleming-Dutra</surname><given-names>KE</given-names></name>, <name><surname>Hersh</surname><given-names>AL</given-names></name>, <name><surname>Shapiro</surname><given-names>DJ</given-names></name>, <name><surname>Bartoces</surname><given-names>M</given-names></name>, <name><surname>Enns</surname><given-names>EA</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010&#x02013;2011</article-title>. <source>JAMA</source>
<volume>315</volume>: <fpage>1864</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jama.2016.4151">10.1001/jama.2016.4151</ext-link></comment>
<?supplied-pmid 27139059?><pub-id pub-id-type="pmid">27139059</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref123"><label>123</label><mixed-citation publication-type="journal"><name><surname>Polgreen</surname><given-names>PM</given-names></name>, <name><surname>Yang</surname><given-names>M</given-names></name>, <name><surname>Laxminarayan</surname><given-names>R</given-names></name>, <name><surname>Cavanaugh</surname><given-names>JE</given-names></name> (<year>2011</year>) <article-title>Respiratory fluoroquinolone use and influenza</article-title>. <source>Infection control and hospital epidemiology</source>
<volume>32</volume>: <fpage>706</fpage>&#x02013;<lpage>709</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1086/660859">10.1086/660859</ext-link></comment>
<?supplied-pmid 21666403?><pub-id pub-id-type="pmid">21666403</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref124"><label>124</label><mixed-citation publication-type="journal"><name><surname>Mina</surname><given-names>MJ</given-names></name>, <name><surname>Klugman</surname><given-names>KP</given-names></name>, <name><surname>McCullers</surname><given-names>JA</given-names></name> (<year>2013</year>) <article-title>Live Attenuated Influenza Vaccine, But Not Pneumococcal Conjugate Vaccine, Protects Against Increased Density and Duration of Pneumococcal Carriage After Influenza Infection in Pneumococcal Colonized Mice</article-title>. <source>Journal of Infectious Diseases</source>
<volume>208</volume>: <fpage>1281</fpage>&#x02013;<lpage>1285</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/infdis/jit317">10.1093/infdis/jit317</ext-link></comment>
<?supplied-pmid 23852122?><pub-id pub-id-type="pmid">23852122</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref125"><label>125</label><mixed-citation publication-type="journal"><name><surname>Muthuri</surname><given-names>SG</given-names></name>, <name><surname>Venkatesan</surname><given-names>S</given-names></name>, <name><surname>Myles</surname><given-names>PR</given-names></name>, <name><surname>Leonardi-Bee</surname><given-names>J</given-names></name>, <name><surname>Al Khuwaitir</surname><given-names>TSA</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data</article-title>. <source>The Lancet Respiratory medicine</source>
<volume>2</volume>: <fpage>395</fpage>&#x02013;<lpage>404</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S2213-2600(14)70041-4">10.1016/S2213-2600(14)70041-4</ext-link></comment>
<?supplied-pmid 24815805?><pub-id pub-id-type="pmid">24815805</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref126"><label>126</label><mixed-citation publication-type="journal"><name><surname>Fry</surname><given-names>AM</given-names></name> (<year>2014</year>) <article-title>Effectiveness of neuraminidase inhibitors for severe influenza</article-title>. <source>The Lancet Respiratory Medicine</source>. pp. <fpage>346</fpage>&#x02013;<lpage>348</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S2213-2600(14)70068-2">10.1016/S2213-2600(14)70068-2</ext-link></comment>
<?supplied-pmid 24815800?><pub-id pub-id-type="pmid">24815800</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref127"><label>127</label><mixed-citation publication-type="journal"><name><surname>McCullers</surname><given-names>Ja</given-names></name> (<year>2014</year>) <article-title>The public health policy implications of understanding metabiosis</article-title>. <source>Cell host &#x00026; microbe</source>
<volume>16</volume>: <fpage>3</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">25011101</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref128"><label>128</label><mixed-citation publication-type="journal"><name><surname>McCullers</surname><given-names>JA</given-names></name> (<year>2011</year>) <article-title>Preventing and treating secondary bacterial infections with antiviral agents</article-title>. <source>Antivir Ther</source>
<volume>16</volume>: <fpage>123</fpage>&#x02013;<lpage>135</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3851/IMP1730">10.3851/IMP1730</ext-link></comment>
<?supplied-pmid 21447860?><pub-id pub-id-type="pmid">21447860</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref129"><label>129</label><mixed-citation publication-type="journal"><name><surname>McCullers</surname><given-names>Ja</given-names></name>, <name><surname>Rehg</surname><given-names>JE</given-names></name> (<year>2002</year>) <article-title>Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor</article-title>. <source>The Journal of infectious diseases</source>
<volume>186</volume>: <fpage>341</fpage>&#x02013;<lpage>350</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1086/341462">10.1086/341462</ext-link></comment>
<?supplied-pmid 12134230?><pub-id pub-id-type="pmid">12134230</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref130"><label>130</label><mixed-citation publication-type="journal"><name><surname>Andrieu</surname><given-names>C</given-names></name>, <name><surname>Doucet</surname><given-names>A</given-names></name>, <name><surname>Holenstein</surname><given-names>R</given-names></name> (<year>2010</year>) <article-title>Particle Markov chain Monte Carlo methods</article-title>. <source>Journal of the Royal Statistical Society Series B-Statistical Methodology</source>
<volume>72</volume>: <fpage>269</fpage>&#x02013;<lpage>342</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref131"><label>131</label><mixed-citation publication-type="journal"><name><surname>King</surname><given-names>AA</given-names></name>, <name><surname>Nguyen</surname><given-names>D</given-names></name>, <name><surname>Ionides</surname><given-names>EL</given-names></name> (<year>2016</year>) <article-title>Statistical Inference for Partially Observed Markov Processes via the R Package pomp</article-title>. <source>Journal of Statistical Software</source>
<volume>69</volume>.</mixed-citation></ref><ref id="ppat.1006770.ref132"><label>132</label><mixed-citation publication-type="journal"><name><surname>Monto</surname><given-names>AS</given-names></name> (<year>2002</year>) <article-title>Epidemiology of viral respiratory infections</article-title>. <source>The American Journal of Medicine</source>
<volume>112</volume>: <fpage>4</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">11812400</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref133"><label>133</label><mixed-citation publication-type="other">Stewart M, Loschen W, Kass-Hout T Enabling ESSENCE to Process and Export Meaningful Use Syndromic Surveillance Data.</mixed-citation></ref><ref id="ppat.1006770.ref134"><label>134</label><mixed-citation publication-type="journal"><name><surname>Warren-Gash</surname><given-names>C</given-names></name>, <name><surname>Bhaskaran</surname><given-names>K</given-names></name>, <name><surname>Hayward</surname><given-names>A</given-names></name>, <name><surname>Leung</surname><given-names>GM</given-names></name>, <name><surname>Lo</surname><given-names>S-V</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong</article-title>. <source>The Journal of infectious diseases</source>
<volume>203</volume>: <fpage>1710</fpage>&#x02013;<lpage>1718</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/infdis/jir171">10.1093/infdis/jir171</ext-link></comment>
<?supplied-pmid 21606529?><pub-id pub-id-type="pmid">21606529</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref135"><label>135</label><mixed-citation publication-type="journal"><name><surname>Mustaquim</surname><given-names>D</given-names></name> (<year>2014</year>) <article-title>The Evolution of the WHO/NREVSS Influenza Surveillance System: The Challenges and Opportunities that Accompany Electronic Laboratory Data</article-title>. <source>Online Journal of Public Health Informatics</source>
<volume>6</volume>.</mixed-citation></ref><ref id="ppat.1006770.ref136"><label>136</label><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>H</given-names></name>, <name><surname>Green</surname><given-names>H</given-names></name>, <name><surname>Lackenby</surname><given-names>A</given-names></name>, <name><surname>Donati</surname><given-names>M</given-names></name>, <name><surname>Ellis</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>A new laboratory-based surveillance system (Respiratory DataMart System) for influenza and other respiratory viruses in England: results and experience from 2009 to 2012</article-title>. <source>Eurosurveillance</source>
<volume>19</volume>: <fpage>20680</fpage>
<?supplied-pmid 24480060?><pub-id pub-id-type="pmid">24480060</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref137"><label>137</label><mixed-citation publication-type="journal"><name><surname>Wolf</surname><given-names>AI</given-names></name>, <name><surname>Strauman</surname><given-names>MC</given-names></name>, <name><surname>Mozdzanowska</surname><given-names>K</given-names></name>, <name><surname>Whittle</surname><given-names>JRR</given-names></name>, <name><surname>Williams</surname><given-names>KL</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Coinfection with Streptococcus pneumoniae Modulates the B Cell Response to Influenza Virus</article-title>. <source>Journal of Virology</source>
<volume>88</volume>: <fpage>11995</fpage>&#x02013;<lpage>12005</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.01833-14">10.1128/JVI.01833-14</ext-link></comment>
<?supplied-pmid 25100838?><pub-id pub-id-type="pmid">25100838</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref138"><label>138</label><mixed-citation publication-type="journal"><name><surname>Siegel Steven</surname><given-names>J</given-names></name>, <name><surname>Roche Aoife</surname><given-names>M</given-names></name>, <name><surname>Weiser Jeffrey</surname><given-names>N</given-names></name> (<year>2014</year>) <article-title>Influenza Promotes Pneumococcal Growth during Coinfection by Providing Host Sialylated Substrates as a Nutrient Source</article-title>. <source>Cell Host &#x00026; Microbe</source>
<volume>16</volume>: <fpage>55</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="pmid">25011108</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref139"><label>139</label><mixed-citation publication-type="journal"><name><surname>McCullers</surname><given-names>Ja</given-names></name>, <name><surname>McAuley</surname><given-names>JL</given-names></name>, <name><surname>Browall</surname><given-names>S</given-names></name>, <name><surname>Iverson</surname><given-names>AR</given-names></name>, <name><surname>Boyd</surname><given-names>KL</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets</article-title>. <source>The Journal of infectious diseases</source>
<volume>202</volume>: <fpage>1287</fpage>&#x02013;<lpage>1295</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1086/656333">10.1086/656333</ext-link></comment>
<?supplied-pmid 20822454?><pub-id pub-id-type="pmid">20822454</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref140"><label>140</label><mixed-citation publication-type="journal"><name><surname>Peltola</surname><given-names>VT</given-names></name>, <name><surname>Boyd</surname><given-names>KL</given-names></name>, <name><surname>McAuley</surname><given-names>JL</given-names></name>, <name><surname>Rehg</surname><given-names>JE</given-names></name>, <name><surname>McCullers</surname><given-names>JA</given-names></name> (<year>2006</year>) <article-title>Bacterial sinusitis and otitis media following influenza virus infection in ferrets</article-title>. <source>Infection and immunity</source>
<volume>74</volume>: <fpage>2562</fpage>&#x02013;<lpage>2567</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/IAI.74.5.2562-2567.2006">10.1128/IAI.74.5.2562-2567.2006</ext-link></comment>
<?supplied-pmid 16622191?><pub-id pub-id-type="pmid">16622191</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref141"><label>141</label><mixed-citation publication-type="journal"><name><surname>Walters</surname><given-names>K-A</given-names></name>, <name><surname>D'Agnillo</surname><given-names>F</given-names></name>, <name><surname>Sheng</surname><given-names>Z-M</given-names></name>, <name><surname>Kindrachuk</surname><given-names>J</given-names></name>, <name><surname>Schwartzman</surname><given-names>LM</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>1918 pandemic influenza virus and Streptococcus pneumoniae co-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans</article-title>. <source>The Journal of Pathology</source>
<volume>238</volume>: <fpage>85</fpage>&#x02013;<lpage>97</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/path.4638">10.1002/path.4638</ext-link></comment>
<?supplied-pmid 26383585?><pub-id pub-id-type="pmid">26383585</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref142"><label>142</label><mixed-citation publication-type="journal"><name><surname>Nakamura</surname><given-names>S</given-names></name>, <name><surname>Davis</surname><given-names>KM</given-names></name>, <name><surname>Weiser</surname><given-names>JN</given-names></name>, <name><surname>Bogaert</surname><given-names>D</given-names></name>, <name><surname>Groot</surname><given-names>RD</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice</article-title>. <source>Journal of Clinical Investigation</source>
<volume>121</volume>: <fpage>3657</fpage>&#x02013;<lpage>3665</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI57762">10.1172/JCI57762</ext-link></comment>
<?supplied-pmid 21841308?><pub-id pub-id-type="pmid">21841308</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref143"><label>143</label><mixed-citation publication-type="journal"><name><surname>Walter</surname><given-names>ND</given-names></name>, <name><surname>Taylor</surname><given-names>TH</given-names></name>, <name><surname>Shay</surname><given-names>DK</given-names></name>, <name><surname>Thompson</surname><given-names>WW</given-names></name>, <name><surname>Brammer</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States</article-title>. <source>Clinical infectious diseases: an official publication of the Infectious Diseases Society of America</source>
<volume>50</volume>: <fpage>175</fpage>&#x02013;<lpage>183</lpage>.<pub-id pub-id-type="pmid">20014948</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref144"><label>144</label><mixed-citation publication-type="journal"><name><surname>Nelson</surname><given-names>GE</given-names></name>, <name><surname>Gershman</surname><given-names>Ka</given-names></name>, <name><surname>Swerdlow</surname><given-names>DL</given-names></name>, <name><surname>Beall</surname><given-names>BW</given-names></name>, <name><surname>Moore</surname><given-names>MR</given-names></name> (<year>2012</year>) <article-title>Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USA</article-title>. <source>Emerging infectious diseases</source>
<volume>18</volume>: <fpage>208</fpage>&#x02013;<lpage>216</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid1802.110714">10.3201/eid1802.110714</ext-link></comment>
<?supplied-pmid 22306234?><pub-id pub-id-type="pmid">22306234</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref145"><label>145</label><mixed-citation publication-type="journal"><name><surname>Jansen</surname><given-names>AGSC</given-names></name>, <name><surname>Sanders</surname><given-names>EAM</given-names></name>, <name><surname>VAN DER Ende</surname><given-names>A</given-names></name>, <name><surname>VAN Loon</surname><given-names>AM</given-names></name>, <name><surname>Hoes</surname><given-names>AW</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity?</article-title>
<source>Epidemiology and infection</source>
<volume>136</volume>: <fpage>1448</fpage>&#x02013;<lpage>1454</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1017/S0950268807000271">10.1017/S0950268807000271</ext-link></comment>
<?supplied-pmid 18211724?><pub-id pub-id-type="pmid">18211724</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref146"><label>146</label><mixed-citation publication-type="journal"><name><surname>Kuster</surname><given-names>SP</given-names></name>, <name><surname>Tuite</surname><given-names>AR</given-names></name>, <name><surname>Kwong</surname><given-names>JC</given-names></name>, <name><surname>McGeer</surname><given-names>A</given-names></name>, <name><surname>Fisman</surname><given-names>DN</given-names></name> (<year>2011</year>) <article-title>Evaluation of coseasonality of influenza and invasive pneumococcal disease: results from prospective surveillance</article-title>. <source>PLoS Med</source>
<volume>8</volume>: <fpage>e1001042</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.1001042">10.1371/journal.pmed.1001042</ext-link></comment>
<?supplied-pmid 21687693?><pub-id pub-id-type="pmid">21687693</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref147"><label>147</label><mixed-citation publication-type="journal"><name><surname>Ampofo</surname><given-names>K</given-names></name>, <name><surname>Bender</surname><given-names>J</given-names></name>, <name><surname>Sheng</surname><given-names>X</given-names></name>, <name><surname>Korgenski</surname><given-names>K</given-names></name>, <name><surname>Daly</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection</article-title>. <source>Pediatrics</source>
<volume>122</volume>: <fpage>229</fpage>&#x02013;<lpage>237</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1542/peds.2007-3192">10.1542/peds.2007-3192</ext-link></comment>
<?supplied-pmid 18676537?><pub-id pub-id-type="pmid">18676537</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref148"><label>148</label><mixed-citation publication-type="journal"><name><surname>Grabowska</surname><given-names>K</given-names></name>, <name><surname>Hogberg</surname><given-names>L</given-names></name>, <name><surname>Penttinen</surname><given-names>P</given-names></name>, <name><surname>Svensson</surname><given-names>A</given-names></name>, <name><surname>Ekdahl</surname><given-names>K</given-names></name> (<year>2006</year>) <article-title>Occurrence of invasive pneumococcal disease and number of excess cases due to influenza</article-title>. <source>BMC Infect Dis</source>
<volume>6</volume>: <fpage>58</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2334-6-58">10.1186/1471-2334-6-58</ext-link></comment>
<?supplied-pmid 16549029?><pub-id pub-id-type="pmid">16549029</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref149"><label>149</label><mixed-citation publication-type="journal"><name><surname>Murdoch</surname><given-names>DR</given-names></name>, <name><surname>Jennings</surname><given-names>LC</given-names></name> (<year>2009</year>) <article-title>Association of respiratory virus activity and environmental factors with the incidence of invasive pneumococcal disease</article-title>. <source>J Infect</source>
<volume>58</volume>: <fpage>37</fpage>&#x02013;<lpage>46</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jinf.2008.10.011">10.1016/j.jinf.2008.10.011</ext-link></comment>
<?supplied-pmid 19042025?><pub-id pub-id-type="pmid">19042025</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref150"><label>150</label><mixed-citation publication-type="journal"><name><surname>Edwards</surname><given-names>LJ</given-names></name>, <name><surname>Markey</surname><given-names>PG</given-names></name>, <name><surname>Cook</surname><given-names>HM</given-names></name>, <name><surname>Trauer</surname><given-names>JM</given-names></name>, <name><surname>Krause</surname><given-names>VL</given-names></name> (<year>2011</year>) <article-title>The relationship between influenza and invasive pneumococcal disease in the Northern Territory, 2005&#x02013;2009</article-title>. <source>Med J Aust</source>
<volume>194</volume>: <fpage>207</fpage>
<?supplied-pmid 21401468?><pub-id pub-id-type="pmid">21401468</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref151"><label>151</label><mixed-citation publication-type="journal"><name><surname>Weinberger</surname><given-names>DM</given-names></name>, <name><surname>Harboe</surname><given-names>ZB</given-names></name>, <name><surname>Viboud</surname><given-names>C</given-names></name>, <name><surname>Krause</surname><given-names>TG</given-names></name>, <name><surname>Miller</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Pneumococcal disease seasonality: incidence, severity and the role of influenza activity</article-title>. <source>Eur Respir J</source>
<volume>43</volume>: <fpage>833</fpage>&#x02013;<lpage>841</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1183/09031936.00056813">10.1183/09031936.00056813</ext-link></comment>
<?supplied-pmid 24036243?><pub-id pub-id-type="pmid">24036243</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref152"><label>152</label><mixed-citation publication-type="journal"><name><surname>Grijalva</surname><given-names>CG</given-names></name>, <name><surname>Griffin</surname><given-names>MR</given-names></name>, <name><surname>Edwards</surname><given-names>KM</given-names></name>, <name><surname>Williams</surname><given-names>JV</given-names></name>, <name><surname>Gil</surname><given-names>AI</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>The role of influenza and parainfluenza infections in nasopharyngeal pneumococcal acquisition among young children</article-title>. <source>Clin Infect Dis</source>
<volume>58</volume>: <fpage>1369</fpage>&#x02013;<lpage>1376</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/cid/ciu148">10.1093/cid/ciu148</ext-link></comment>
<?supplied-pmid 24621951?><pub-id pub-id-type="pmid">24621951</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref153"><label>153</label><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>H</given-names></name>, <name><surname>Haber</surname><given-names>M</given-names></name>, <name><surname>Ray</surname><given-names>S</given-names></name>, <name><surname>Farley</surname><given-names>MM</given-names></name>, <name><surname>Panozzo</surname><given-names>CA</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Invasive pneumococcal pneumonia and respiratory virus co-infections</article-title>. <source>Emerging infectious diseases</source>
<volume>18</volume>: <fpage>294</fpage>&#x02013;<lpage>297</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid1802.102025">10.3201/eid1802.102025</ext-link></comment>
<?supplied-pmid 22305270?><pub-id pub-id-type="pmid">22305270</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref154"><label>154</label><mixed-citation publication-type="journal"><name><surname>Damasio</surname><given-names>GAC</given-names></name>, <name><surname>Pereira</surname><given-names>LA</given-names></name>, <name><surname>Moreira</surname><given-names>SDR</given-names></name>, <name><surname>Duarte dos Santos</surname><given-names>CN</given-names></name>, <name><surname>Dalla-Costa</surname><given-names>LM</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Does virus-bacteria coinfection increase the clinical severity of acute respiratory infection?</article-title>
<source>Journal of Medical Virology</source>
<volume>87</volume>: <fpage>1456</fpage>&#x02013;<lpage>1461</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jmv.24210">10.1002/jmv.24210</ext-link></comment>
<?supplied-pmid 25976175?><pub-id pub-id-type="pmid">25976175</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref155"><label>155</label><mixed-citation publication-type="journal"><name><surname>Niemann</surname><given-names>S</given-names></name>, <name><surname>Ehrhardt</surname><given-names>C</given-names></name>, <name><surname>Medina</surname><given-names>E</given-names></name>, <name><surname>Warnking</surname><given-names>K</given-names></name>, <name><surname>Tuchscherr</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Combined action of influenza virus and Staphylococcus aureus panton-valentine leukocidin provokes severe lung epithelium damage</article-title>. <source>The Journal of infectious diseases</source>
<volume>206</volume>: <fpage>1138</fpage>&#x02013;<lpage>1148</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/infdis/jis468">10.1093/infdis/jis468</ext-link></comment>
<?supplied-pmid 22837490?><pub-id pub-id-type="pmid">22837490</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref156"><label>156</label><mixed-citation publication-type="journal"><name><surname>Davison</surname><given-names>VE</given-names></name>, <name><surname>Sanford</surname><given-names>BA</given-names></name> (<year>1982</year>) <article-title>Factors influencing adherence of Staphylococcus aureus to influenza A virus-infected cell cultures</article-title>. <source>Infection and Immunity</source>
<volume>37</volume>: <fpage>946</fpage>&#x02013;<lpage>955</lpage>. <?supplied-pmid 6813268?><pub-id pub-id-type="pmid">6813268</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref157"><label>157</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>WJ</given-names></name>, <name><surname>Sarawar</surname><given-names>S</given-names></name>, <name><surname>Nguyen</surname><given-names>P</given-names></name>, <name><surname>Daly</surname><given-names>K</given-names></name>, <name><surname>Rehg</surname><given-names>JE</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>Lethal synergism between influenza infection and staphylococcal enterotoxin B in mice</article-title>. <source>J Immunol</source>
<volume>157</volume>: <fpage>5049</fpage>&#x02013;<lpage>5060</lpage>. <?supplied-pmid 8943414?><pub-id pub-id-type="pmid">8943414</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref158"><label>158</label><mixed-citation publication-type="journal"><name><surname>Chertow</surname><given-names>DS</given-names></name>, <name><surname>Kindrachuk</surname><given-names>J</given-names></name>, <name><surname>Sheng</surname><given-names>Z-M</given-names></name>, <name><surname>Pujanauski</surname><given-names>LM</given-names></name>, <name><surname>Cooper</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Influenza A and Methicillin-resistant Staphylococcus aureus Co-infection in Rhesus Macaques &#x02010;&#x02010; A Model of Severe Pneumonia</article-title>. <source>Antiviral Research</source>.</mixed-citation></ref><ref id="ppat.1006770.ref159"><label>159</label><mixed-citation publication-type="journal"><name><surname>Iverson</surname><given-names>AR</given-names></name>, <name><surname>Boyd</surname><given-names>KL</given-names></name>, <name><surname>McAuley</surname><given-names>JL</given-names></name>, <name><surname>Plano</surname><given-names>LR</given-names></name>, <name><surname>Hart</surname><given-names>ME</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Influenza virus primes mice for pneumonia from Staphylococcus aureus</article-title>. <source>The Journal of infectious diseases</source>
<volume>203</volume>: <fpage>880</fpage>&#x02013;<lpage>888</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/infdis/jiq113">10.1093/infdis/jiq113</ext-link></comment>
<?supplied-pmid 21278211?><pub-id pub-id-type="pmid">21278211</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref160"><label>160</label><mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>KM</given-names></name>, <name><surname>Choi</surname><given-names>SM</given-names></name>, <name><surname>McHugh</surname><given-names>KJ</given-names></name>, <name><surname>Mandalapu</surname><given-names>S</given-names></name>, <name><surname>Enelow</surname><given-names>RI</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Influenza A Exacerbates Staphylococcus aureus Pneumonia by Attenuating IL-1 Production in Mice</article-title>. <source>The Journal of Immunology</source>
<volume>191</volume>: <fpage>5153</fpage>&#x02013;<lpage>5159</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4049/jimmunol.1301237">10.4049/jimmunol.1301237</ext-link></comment>
<?supplied-pmid 24089191?><pub-id pub-id-type="pmid">24089191</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref161"><label>161</label><mixed-citation publication-type="journal"><name><surname>Sherertz</surname><given-names>RJ</given-names></name>, <name><surname>Reagan</surname><given-names>DR</given-names></name>, <name><surname>Hampton</surname><given-names>KD</given-names></name>, <name><surname>Robertson</surname><given-names>KL</given-names></name>, <name><surname>Streed</surname><given-names>SA</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>A cloud adult: the Staphylococcus aureus-virus interaction revisited</article-title>. <source>Ann Intern Med</source>
<volume>124</volume>: <fpage>539</fpage>&#x02013;<lpage>547</lpage>. <?supplied-pmid 8597316?><pub-id pub-id-type="pmid">8597316</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref162"><label>162</label><mixed-citation publication-type="journal"><name><surname>Hageman</surname><given-names>JC</given-names></name>, <name><surname>Uyeki</surname><given-names>TM</given-names></name>, <name><surname>Francis</surname><given-names>JS</given-names></name>, <name><surname>Jernigan</surname><given-names>DB</given-names></name>, <name><surname>Wheeler</surname><given-names>JG</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Severe community-acquired pneumonia due to Staphylococcus aureus, 2003&#x02013;04 influenza season</article-title>. <source>Emerging infectious diseases</source>
<volume>12</volume>: <fpage>894</fpage>&#x02013;<lpage>899</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3201/eid1206.051141">10.3201/eid1206.051141</ext-link></comment>
<?supplied-pmid 16707043?><pub-id pub-id-type="pmid">16707043</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref163"><label>163</label><mixed-citation publication-type="journal"><name><surname>Finelli</surname><given-names>L</given-names></name>, <name><surname>Fiore</surname><given-names>A</given-names></name>, <name><surname>Dhara</surname><given-names>R</given-names></name>, <name><surname>Brammer</surname><given-names>L</given-names></name>, <name><surname>Shay</surname><given-names>DK</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection</article-title>. <source>Pediatrics</source>
<volume>122</volume>: <fpage>805</fpage>&#x02013;<lpage>811</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1542/peds.2008-1336">10.1542/peds.2008-1336</ext-link></comment>
<?supplied-pmid 18829805?><pub-id pub-id-type="pmid">18829805</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref164"><label>164</label><mixed-citation publication-type="journal"><name><surname>Reed</surname><given-names>C</given-names></name>, <name><surname>Kallen</surname><given-names>AJ</given-names></name>, <name><surname>Patton</surname><given-names>M</given-names></name>, <name><surname>Arnold</surname><given-names>KE</given-names></name>, <name><surname>Farley</surname><given-names>MM</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Infection With Community-Onset Staphylococcus aureus and Influenza Virus in Hospitalized Children</article-title>. <source>The Pediatric Infectious Disease Journal</source>
<volume>28</volume>: <fpage>572</fpage>&#x02013;<lpage>576</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/INF.0b013e31819d8b71">10.1097/INF.0b013e31819d8b71</ext-link></comment>
<?supplied-pmid 19478685?><pub-id pub-id-type="pmid">19478685</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref165"><label>165</label><mixed-citation publication-type="journal"><name><surname>Kobayashi</surname><given-names>SD</given-names></name>, <name><surname>Olsen</surname><given-names>RJ</given-names></name>, <name><surname>LaCasse</surname><given-names>RA</given-names></name>, <name><surname>Safronetz</surname><given-names>D</given-names></name>, <name><surname>Ashraf</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Seasonal H3N2 influenza A virus fails to enhance Staphylococcus aureus co-infection in a non-human primate respiratory tract infection model</article-title>. <source>Virulence</source>
<volume>4</volume>: <fpage>707</fpage>&#x02013;<lpage>715</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4161/viru.26572">10.4161/viru.26572</ext-link></comment>
<?supplied-pmid 24104465?><pub-id pub-id-type="pmid">24104465</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref166"><label>166</label><mixed-citation publication-type="journal"><name><surname>Michaels</surname><given-names>RH</given-names></name>, <name><surname>Myerowitz</surname><given-names>RL</given-names></name>, <name><surname>Klaw</surname><given-names>R</given-names></name> (<year>1977</year>) <article-title>Potentiation of experimental meningitis due to Haemophilus influenzae by influenza A virus</article-title>. <source>The Journal of infectious diseases</source>
<volume>135</volume>: <fpage>641</fpage>&#x02013;<lpage>645</lpage>. <?supplied-pmid 300760?><pub-id pub-id-type="pmid">300760</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref167"><label>167</label><mixed-citation publication-type="journal"><name><surname>Bakaletz</surname><given-names>LO</given-names></name>, <name><surname>Hoepf</surname><given-names>TM</given-names></name>, <name><surname>Demaria</surname><given-names>TF</given-names></name>, <name><surname>Lim</surname><given-names>DJ</given-names></name> (<year>1988</year>) <article-title>The Effect of Antecedent Influenza A Virus Infection on the Adherence of Hemophilus Influenzae to Chinchilla Tracheal Epithelium</article-title>. <source>Am ~ Otalaryngol</source>
<volume>9</volume>: <fpage>127</fpage>&#x02013;<lpage>134</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref168"><label>168</label><mixed-citation publication-type="journal"><name><surname>Francis</surname><given-names>T</given-names></name>, <name><surname>De Torregrosa</surname><given-names>MV</given-names></name> (<year>1945</year>) <article-title>Combined infection of mice with H. Influenzae and influenza virus by the intranasal route</article-title>. <source>Journal of Infectious Diseases</source>
<volume>76</volume>: <fpage>70</fpage>&#x02013;<lpage>77</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref169"><label>169</label><mixed-citation publication-type="journal"><name><surname>Read</surname><given-names>RC</given-names></name>, <name><surname>Goodwin</surname><given-names>L</given-names></name>, <name><surname>Parsons</surname><given-names>MA</given-names></name>, <name><surname>Silcocks</surname><given-names>P</given-names></name>, <name><surname>Kaczmarski</surname><given-names>EB</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Coinfection with influenza B virus does not affect association of Neisseria meningitidis with human nasopharyngeal mucosa in organ culture</article-title>. <source>Infection and immunity</source>
<volume>67</volume>: <fpage>3082</fpage>&#x02013;<lpage>3086</lpage>. <?supplied-pmid 10338524?><pub-id pub-id-type="pmid">10338524</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref170"><label>170</label><mixed-citation publication-type="journal"><name><surname>Cartwright</surname><given-names>KA</given-names></name>, <name><surname>Jones</surname><given-names>DM</given-names></name>, <name><surname>Smith</surname><given-names>AJ</given-names></name>, <name><surname>Stuart</surname><given-names>JM</given-names></name>, <name><surname>Kaczmarski</surname><given-names>EB</given-names></name>, <etal>et al</etal> (<year>1991</year>) <article-title>Influenza A and meningococcal disease</article-title>. <source>Lancet (London, England)</source>
<volume>338</volume>: <fpage>554</fpage>&#x02013;<lpage>557</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref171"><label>171</label><mixed-citation publication-type="journal"><name><surname>Jacobs</surname><given-names>JH</given-names></name>, <name><surname>Viboud</surname><given-names>C</given-names></name>, <name><surname>Tchetgen</surname><given-names>ET</given-names></name>, <name><surname>Schwartz</surname><given-names>J</given-names></name>, <name><surname>Steiner</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>The Association of Meningococcal Disease with Influenza in the United States, 1989&#x02013;2009</article-title>. <source>PLoS ONE</source>
<volume>9</volume>: <fpage>e107486</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0107486">10.1371/journal.pone.0107486</ext-link></comment>
<?supplied-pmid 25265409?><pub-id pub-id-type="pmid">25265409</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref172"><label>172</label><mixed-citation publication-type="journal"><name><surname>Brundage</surname><given-names>JF</given-names></name> (<year>2006</year>) <article-title>Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness</article-title>. <source>The Lancet Infectious diseases</source>
<volume>6</volume>: <fpage>303</fpage>&#x02013;<lpage>312</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1473-3099(06)70466-2">10.1016/S1473-3099(06)70466-2</ext-link></comment>
<?supplied-pmid 16631551?><pub-id pub-id-type="pmid">16631551</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref173"><label>173</label><mixed-citation publication-type="journal"><name><surname>Makras</surname><given-names>P</given-names></name>, <name><surname>Alexiou-Daniel</surname><given-names>S</given-names></name>, <name><surname>Antoniadis</surname><given-names>A</given-names></name>, <name><surname>Hatzigeorgiou</surname><given-names>D</given-names></name> (<year>2001</year>) <article-title>Outbreak of meningococcal disease after an influenza B epidemic at a Hellenic Air Force recruit training center</article-title>. <source>Clinical infectious diseases: an official publication of the Infectious Diseases Society of America</source>
<volume>33</volume>: <fpage>e48</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">11512107</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref174"><label>174</label><mixed-citation publication-type="journal"><name><surname>Florido</surname><given-names>M</given-names></name>, <name><surname>Pillay</surname><given-names>R</given-names></name>, <name><surname>Gillis</surname><given-names>CM</given-names></name>, <name><surname>Xia</surname><given-names>Y</given-names></name>, <name><surname>Turner</surname><given-names>SJ</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection</article-title>. <source>European Journal of Immunology</source>
<volume>45</volume>: <fpage>780</fpage>&#x02013;<lpage>793</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/eji.201444954">10.1002/eji.201444954</ext-link></comment>
<?supplied-pmid 25430701?><pub-id pub-id-type="pmid">25430701</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref175"><label>175</label><mixed-citation publication-type="journal"><name><surname>Volkert</surname><given-names>M</given-names></name>, <name><surname>Pierce</surname><given-names>C</given-names></name>, <name><surname>Horsfall</surname><given-names>FL</given-names></name>, <name><surname>Dubos</surname><given-names>RJ</given-names></name> (<year>1947</year>) <article-title>THE ENHANCING EFFECT OF CONCURRENT INFECTION WITH PNEUMOTROPIC VIRUSES ON PULMONARY TUBERCULOSIS IN MICE</article-title>. <source>The Journal of experimental medicine</source>
<volume>86</volume>: <fpage>203</fpage>&#x02013;<lpage>214</lpage>. <?supplied-pmid 19871671?><pub-id pub-id-type="pmid">19871671</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref176"><label>176</label><mixed-citation publication-type="journal"><name><surname>Redford</surname><given-names>PS</given-names></name>, <name><surname>Mayer-Barber</surname><given-names>KD</given-names></name>, <name><surname>McNab</surname><given-names>FW</given-names></name>, <name><surname>Stavropoulos</surname><given-names>E</given-names></name>, <name><surname>Wack</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway</article-title>. <source>The Journal of infectious diseases</source>
<volume>209</volume>: <fpage>270</fpage>&#x02013;<lpage>274</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/infdis/jit424">10.1093/infdis/jit424</ext-link></comment>
<?supplied-pmid 23935205?><pub-id pub-id-type="pmid">23935205</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref177"><label>177</label><mixed-citation publication-type="journal"><name><surname>Walaza</surname><given-names>S</given-names></name>, <name><surname>Cohen</surname><given-names>C</given-names></name>, <name><surname>Nanoo</surname><given-names>A</given-names></name>, <name><surname>Cohen</surname><given-names>AL</given-names></name>, <name><surname>McAnerney</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Excess mortality associated with influenza among tuberculosis deaths in South Africa, 1999&#x02013;2009</article-title>. <source>PLoS ONE</source>
<volume>10</volume>: <fpage>1999</fpage>&#x02013;<lpage>2009</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref178"><label>178</label><mixed-citation publication-type="journal"><name><surname>Oei</surname><given-names>W</given-names></name>, <name><surname>Nishiura</surname><given-names>H</given-names></name>, <name><surname>Oei</surname><given-names>W</given-names></name>, <name><surname>Nishiura</surname><given-names>H</given-names></name> (<year>2012</year>) <article-title>The Relationship between Tuberculosis and Influenza Death during the Influenza (H1N1) Pandemic from 1918&#x02013;19</article-title>. <source>Computational and Mathematical Methods in Medicine</source>
<volume>2012</volume>: <fpage>1</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref179"><label>179</label><mixed-citation publication-type="journal"><name><surname>Noymer</surname><given-names>A</given-names></name> (<year>2011</year>) <article-title>The 1918 influenza pandemic hastened the decline of tuberculosis in the United States: An age, period, cohort analysis</article-title>. <source>Vaccine</source>
<volume>29</volume>: <fpage>B38</fpage>&#x02013;<lpage>B41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2011.02.053">10.1016/j.vaccine.2011.02.053</ext-link></comment>
<?supplied-pmid 21757102?><pub-id pub-id-type="pmid">21757102</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref180"><label>180</label><mixed-citation publication-type="journal"><name><surname>Noymer</surname><given-names>A</given-names></name> (<year>2009</year>) <article-title>Testing the influenza&#x02013;tuberculosis selective mortality hypothesis with Union Army data</article-title>. <source>Social Science &#x00026; Medicine</source>
<volume>68</volume>: <fpage>1599</fpage>&#x02013;<lpage>1608</lpage>.<pub-id pub-id-type="pmid">19304361</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref181"><label>181</label><mixed-citation publication-type="journal"><name><surname>Z&#x000fc;rcher</surname><given-names>K</given-names></name>, <name><surname>Zwahlen</surname><given-names>M</given-names></name>, <name><surname>Ballif</surname><given-names>M</given-names></name>, <name><surname>Rieder</surname><given-names>HL</given-names></name>, <name><surname>Egger</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland</article-title>. <source>PLoS ONE</source>
<volume>11</volume>: <fpage>e0162575</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0162575">10.1371/journal.pone.0162575</ext-link></comment>
<?supplied-pmid 27706149?><pub-id pub-id-type="pmid">27706149</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref182"><label>182</label><mixed-citation publication-type="journal"><name><surname>Roth</surname><given-names>S</given-names></name>, <name><surname>Whitehead</surname><given-names>S</given-names></name>, <name><surname>Thamthitiwat</surname><given-names>S</given-names></name>, <name><surname>Chittaganpitch</surname><given-names>M</given-names></name>, <name><surname>Maloney</surname><given-names>SA</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Concurrent influenza virus infection and tuberculosis in patients hospitalized with respiratory illness in Thailand</article-title>. <source>Influenza and other Respiratory Viruses</source>
<volume>7</volume>: <fpage>244</fpage>&#x02013;<lpage>248</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1750-2659.2012.00413.x">10.1111/j.1750-2659.2012.00413.x</ext-link></comment>
<?supplied-pmid 22817684?><pub-id pub-id-type="pmid">22817684</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref183"><label>183</label><mixed-citation publication-type="journal"><name><surname>Klonoski</surname><given-names>JM</given-names></name>, <name><surname>Hurtig</surname><given-names>HR</given-names></name>, <name><surname>Juber</surname><given-names>BA</given-names></name>, <name><surname>Schuneman</surname><given-names>MJ</given-names></name>, <name><surname>Bickett</surname><given-names>TE</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus:S. pyogenes super-infection</article-title>. <source>Vaccine</source>
<volume>32</volume>: <fpage>5241</fpage>&#x02013;<lpage>5249</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2014.06.093">10.1016/j.vaccine.2014.06.093</ext-link></comment>
<?supplied-pmid 25077423?><pub-id pub-id-type="pmid">25077423</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref184"><label>184</label><mixed-citation publication-type="journal"><name><surname>Okamoto</surname><given-names>S</given-names></name>, <name><surname>Kawabata</surname><given-names>S</given-names></name>, <name><surname>Nakagawa</surname><given-names>I</given-names></name>, <name><surname>Okuno</surname><given-names>Y</given-names></name>, <name><surname>Goto</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Influenza A Virus-Infected Hosts Boost an Invasive Type of Streptococcus pyogenes Infection in Mice</article-title>. <source>Journal of Virology</source>
<volume>77</volume>: <fpage>4104</fpage>&#x02013;<lpage>4112</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.77.7.4104-4112.2003">10.1128/JVI.77.7.4104-4112.2003</ext-link></comment>
<?supplied-pmid 12634369?><pub-id pub-id-type="pmid">12634369</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref185"><label>185</label><mixed-citation publication-type="journal"><name><surname>Okamoto</surname><given-names>S</given-names></name>, <name><surname>Kawabata</surname><given-names>S</given-names></name>, <name><surname>Terao</surname><given-names>Y</given-names></name>, <name><surname>Fujitaka</surname><given-names>H</given-names></name>, <name><surname>Okuno</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>The Streptococcus pyogenes Capsule Is Required for Adhesion of Bacteria to Virus-Infected Alveolar Epithelial Cells and Lethal Bacterial-Viral Superinfection</article-title>. <source>Infection and Immunity</source>
<volume>72</volume>: <fpage>6068</fpage>&#x02013;<lpage>6075</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/IAI.72.10.6068-6075.2004">10.1128/IAI.72.10.6068-6075.2004</ext-link></comment>
<?supplied-pmid 15385511?><pub-id pub-id-type="pmid">15385511</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref186"><label>186</label><mixed-citation publication-type="journal"><name><surname>Hafez</surname><given-names>MM</given-names></name>, <name><surname>Abdel-Wahab</surname><given-names>KSE</given-names></name>, <name><surname>El-Fouhil</surname><given-names>DFI</given-names></name> (<year>2010</year>) <article-title>Augmented adherence and internalization of group A Streptococcus pyogenes to influenza A virus infected MDCK cells</article-title>. <source>Journal of Basic Microbiology</source>
<volume>50</volume>: <fpage>S46</fpage>&#x02013;<lpage>S57</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jobm.200900427">10.1002/jobm.200900427</ext-link></comment>
<?supplied-pmid 20967785?><pub-id pub-id-type="pmid">20967785</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref187"><label>187</label><mixed-citation publication-type="journal"><name><surname>Scaber</surname><given-names>J</given-names></name>, <name><surname>Saeed</surname><given-names>S</given-names></name>, <name><surname>Ihekweazu</surname><given-names>C</given-names></name>, <name><surname>Efstratiou</surname><given-names>A</given-names></name>, <name><surname>Mccarthy</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Group A streptococcal infections during the seasonal influenza outbreak 2010/11 in South East England</article-title>. <source>Euro Surveill</source>
<volume>16</volume>.</mixed-citation></ref><ref id="ppat.1006770.ref188"><label>188</label><mixed-citation publication-type="journal"><name><surname>Tasher</surname><given-names>D</given-names></name>, <name><surname>Stein</surname><given-names>M</given-names></name>, <name><surname>Sim&#x000f5;es</surname><given-names>EAF</given-names></name>, <name><surname>Shohat</surname><given-names>T</given-names></name>, <name><surname>Bromberg</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Invasive bacterial infections in relation to influenza outbreaks, 2006&#x02013;2010</article-title>. <source>Clinical infectious diseases: an official publication of the Infectious Diseases Society of America</source>
<volume>53</volume>: <fpage>1199</fpage>&#x02013;<lpage>1207</lpage>.<pub-id pub-id-type="pmid">22021918</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref189"><label>189</label><mixed-citation publication-type="journal"><name><surname>Tamayo</surname><given-names>E</given-names></name>, <name><surname>Montes</surname><given-names>M</given-names></name>, <name><surname>Vicente</surname><given-names>D</given-names></name>, <name><surname>P&#x000e9;rez-Trallero</surname><given-names>E</given-names></name>, <name><surname>Welch</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Streptococcus pyogenes Pneumonia in Adults: Clinical Presentation and Molecular Characterization of Isolates 2006&#x02013;2015</article-title>. <source>PLoS ONE</source>
<volume>11</volume>: <fpage>e0152640</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0152640">10.1371/journal.pone.0152640</ext-link></comment>
<?supplied-pmid 27027618?><pub-id pub-id-type="pmid">27027618</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref190"><label>190</label><mixed-citation publication-type="journal"><name><surname>Anestad</surname><given-names>G</given-names></name>, <name><surname>Vainio</surname><given-names>K</given-names></name>, <name><surname>Hungnes</surname><given-names>O</given-names></name> (<year>2007</year>) <article-title>Interference between outbreaks of epidemic viruses</article-title>. <source>Scandinavian journal of infectious diseases</source>
<volume>39</volume>: <fpage>653</fpage>&#x02013;<lpage>654</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/00365540701253860">10.1080/00365540701253860</ext-link></comment>
<?supplied-pmid 17577842?><pub-id pub-id-type="pmid">17577842</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref191"><label>191</label><mixed-citation publication-type="journal"><name><surname>&#x000c5;nestad</surname><given-names>G</given-names></name> (<year>2009</year>) <article-title>Surveillance of respiratory viral infections by rapid immunofluorescence diagnosis, with emphasis on virus interference</article-title>. <source>Epidemiology and Infection</source>
<volume>99</volume>: <fpage>523</fpage>.</mixed-citation></ref><ref id="ppat.1006770.ref192"><label>192</label><mixed-citation publication-type="journal"><name><surname>Anestad</surname><given-names>G</given-names></name> (<year>1987</year>) <article-title>Surveillance of respiratory viral infections by rapid immunofluorescence diagnosis, with emphasis on virus interference</article-title>. <source>Epidemiol Infect</source>
<volume>99</volume>: <fpage>523</fpage>&#x02013;<lpage>531</lpage>. <?supplied-pmid 2824225?><pub-id pub-id-type="pmid">2824225</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref193"><label>193</label><mixed-citation publication-type="journal"><name><surname>Nishimura</surname><given-names>N</given-names></name>, <name><surname>Nishio</surname><given-names>H</given-names></name>, <name><surname>Lee</surname><given-names>MJ</given-names></name>, <name><surname>Uemura</surname><given-names>K</given-names></name> (<year>2005</year>) <article-title>The clinical features of respiratory syncytial virus: lower respiratory tract infection after upper respiratory tract infection due to influenza virus</article-title>. <source>Pediatr Int</source>
<volume>47</volume>: <fpage>412</fpage>&#x02013;<lpage>416</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1442-200x.2005.02099.x">10.1111/j.1442-200x.2005.02099.x</ext-link></comment>
<?supplied-pmid 16091079?><pub-id pub-id-type="pmid">16091079</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref194"><label>194</label><mixed-citation publication-type="journal"><name><surname>van Asten</surname><given-names>L</given-names></name>, <name><surname>Bijkerk</surname><given-names>P</given-names></name>, <name><surname>Fanoy</surname><given-names>E</given-names></name>, <name><surname>van Ginkel</surname><given-names>A</given-names></name>, <name><surname>Suijkerbuijk</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Early occurrence of influenza A epidemics coincided with changes in occurrence of other respiratory virus infections</article-title>. <source>Influenza and other respiratory viruses</source>
<volume>10</volume>: <fpage>14</fpage>&#x02013;<lpage>26</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/irv.12348">10.1111/irv.12348</ext-link></comment>
<?supplied-pmid 26369646?><pub-id pub-id-type="pmid">26369646</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref195"><label>195</label><mixed-citation publication-type="journal"><name><surname>Meningher</surname><given-names>T</given-names></name>, <name><surname>Hindiyeh</surname><given-names>M</given-names></name>, <name><surname>Regev</surname><given-names>L</given-names></name>, <name><surname>Sherbany</surname><given-names>H</given-names></name>, <name><surname>Mendelson</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Relationships between A(H1N1)pdm09 influenza infection and infections with other respiratory viruses</article-title>. <source>Influenza and other respiratory viruses</source>
<volume>8</volume>: <fpage>422</fpage>&#x02013;<lpage>430</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/irv.12249">10.1111/irv.12249</ext-link></comment>
<?supplied-pmid 24698156?><pub-id pub-id-type="pmid">24698156</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref196"><label>196</label><mixed-citation publication-type="journal"><name><surname>Martin</surname><given-names>ET</given-names></name>, <name><surname>Fairchok</surname><given-names>MP</given-names></name>, <name><surname>Stednick</surname><given-names>ZJ</given-names></name>, <name><surname>Kuypers</surname><given-names>J</given-names></name>, <name><surname>Englund</surname><given-names>JA</given-names></name> (<year>2013</year>) <article-title>Epidemiology of multiple respiratory viruses in childcare attendees</article-title>. <source>The Journal of infectious diseases</source>
<volume>207</volume>: <fpage>982</fpage>&#x02013;<lpage>989</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/infdis/jis934">10.1093/infdis/jis934</ext-link></comment>
<?supplied-pmid 23288925?><pub-id pub-id-type="pmid">23288925</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref197"><label>197</label><mixed-citation publication-type="journal"><name><surname>Shinjoh</surname><given-names>M</given-names></name>, <name><surname>Omoe</surname><given-names>K</given-names></name>, <name><surname>Saito</surname><given-names>N</given-names></name>, <name><surname>Matsuo</surname><given-names>N</given-names></name>, <name><surname>Nerome</surname><given-names>K</given-names></name> (<year>2000</year>) <article-title>In vitro growth profiles of respiratory syncytial virus in the presence of influenza virus</article-title>. <source>Acta Virol</source>
<volume>44</volume>: <fpage>91</fpage>&#x02013;<lpage>97</lpage>. <?supplied-pmid 10989700?><pub-id pub-id-type="pmid">10989700</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref198"><label>198</label><mixed-citation publication-type="journal"><name><surname>Linde</surname><given-names>A</given-names></name>, <name><surname>Rotzen-Ostlund</surname><given-names>M</given-names></name>, <name><surname>Zweygberg-Wirgart</surname><given-names>B</given-names></name>, <name><surname>Rubinova</surname><given-names>S</given-names></name>, <name><surname>Brytting</surname><given-names>M</given-names></name> (<year>2009</year>) <article-title>Does viral interference affect spread of influenza?</article-title>
<source>Euro Surveill</source>
<volume>14</volume>.</mixed-citation></ref><ref id="ppat.1006770.ref199"><label>199</label><mixed-citation publication-type="journal"><name><surname>Anestad</surname><given-names>G</given-names></name>, <name><surname>Nordbo</surname><given-names>SA</given-names></name> (<year>2011</year>) <article-title>Virus interference. Did rhinoviruses activity hamper the progress of the 2009 influenza A (H1N1) pandemic in Norway?</article-title>
<source>Med Hypotheses</source>
<volume>77</volume>: <fpage>1132</fpage>&#x02013;<lpage>1134</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.mehy.2011.09.021">10.1016/j.mehy.2011.09.021</ext-link></comment>
<?supplied-pmid 21975051?><pub-id pub-id-type="pmid">21975051</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref200"><label>200</label><mixed-citation publication-type="journal"><name><surname>Tanner</surname><given-names>H</given-names></name>, <name><surname>Boxall</surname><given-names>E</given-names></name>, <name><surname>Osman</surname><given-names>H</given-names></name> (<year>2012</year>) <article-title>Respiratory viral infections during the 2009&#x02013;2010 winter season in Central England, UK: incidence and patterns of multiple virus co-infections</article-title>. <source>European journal of clinical microbiology &#x00026; infectious diseases: official publication of the European Society of Clinical Microbiology</source>
<volume>31</volume>: <fpage>3001</fpage>&#x02013;<lpage>3006</lpage>.</mixed-citation></ref><ref id="ppat.1006770.ref201"><label>201</label><mixed-citation publication-type="journal"><name><surname>Mackay</surname><given-names>IM</given-names></name>, <name><surname>Lambert</surname><given-names>SB</given-names></name>, <name><surname>Faux</surname><given-names>CE</given-names></name>, <name><surname>Arden</surname><given-names>KE</given-names></name>, <name><surname>Nissen</surname><given-names>MD</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Community-wide, contemporaneous circulation of a broad spectrum of human rhinoviruses in healthy Australian preschool-aged children during a 12-month period</article-title>. <source>The Journal of infectious diseases</source>
<volume>207</volume>: <fpage>1433</fpage>&#x02013;<lpage>1441</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/infdis/jis476">10.1093/infdis/jis476</ext-link></comment>
<?supplied-pmid 22829638?><pub-id pub-id-type="pmid">22829638</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref202"><label>202</label><mixed-citation publication-type="journal"><name><surname>Easton</surname><given-names>AJ</given-names></name>, <name><surname>Scott</surname><given-names>PD</given-names></name>, <name><surname>Edworthy</surname><given-names>NL</given-names></name>, <name><surname>Meng</surname><given-names>B</given-names></name>, <name><surname>Marriott</surname><given-names>AC</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo</article-title>. <source>Vaccine</source>
<volume>29</volume>: <fpage>2777</fpage>&#x02013;<lpage>2784</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2011.01.102">10.1016/j.vaccine.2011.01.102</ext-link></comment>
<?supplied-pmid 21320545?><pub-id pub-id-type="pmid">21320545</pub-id></mixed-citation></ref><ref id="ppat.1006770.ref203"><label>203</label><mixed-citation publication-type="journal"><name><surname>Goto</surname><given-names>H</given-names></name>, <name><surname>Ihira</surname><given-names>H</given-names></name>, <name><surname>Morishita</surname><given-names>K</given-names></name>, <name><surname>Tsuchiya</surname><given-names>M</given-names></name>, <name><surname>Ohta</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Enhanced growth of influenza A virus by coinfection with human parainfluenza virus type 2</article-title>. <source>Med Microbiol Immunol</source>
<volume>205</volume>: <fpage>209</fpage>&#x02013;<lpage>218</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00430-015-0441-y">10.1007/s00430-015-0441-y</ext-link></comment>
<?supplied-pmid 26582554?><pub-id pub-id-type="pmid">26582554</pub-id></mixed-citation></ref></ref-list></back></article>